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Abstract 
Compartmentation contributes at controlling the mammalian metabolism and is 
important in aging and diseases. Systems biology methods were applied to study 
compartmentation between cytosol and mitochondria. 
A mathematical modeling platform for non-stationary 13C metabolic flux analysis (Inst-
13CMFA) was developed and tested. It was then extended to model also extracellular 
labeling. First, fluxes were determined for the CHO-K1 cell line metabolism using only 
extracellular labeling and one labeled substrate. The results indicate that the cells adapt 
to sustain fast growth and to manage the complex media. Then, high resolution of 
compartment fluxes, reversibility and intracompartmental concentrations resulted by 
applying Inst-13CMFA to data from two labeling experiments. In both studies, pentose 
phosphate pathway carried a large flux. The produced NADPH is used by fatty acid 
synthesis and for mitigating oxidative stress. Differences in labeling were described by a 
model with pyruvate channeling. 
Selectively permeabilized CHO-K1 cells were fed mitochondrial substrates. Using the 
elementary mode decomposition of the mitochondrial network, the observed 
extracellular rates were distributed into elementary mode fluxes. This evidenced activity 
of pathways and regulatory effects. 
By combining more systems biology methods, this thesis constructed a larger picture for 
characterizing the complex metabolism of CHO-K1 cells and uncovered many new 
characterstics of metabolic compartmentation. 
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Zusammenfassung 
Die Kompartimentierung des Stoffwechsels trägt dazu bei den Stoffwechsel des Säugetiers 
zu regulieren. Methoden aus der Systembiologie wurden angewendet um die 
Kompartimentierung zu untersuchen. 
Eine Modellierungsplattform für nichtstationäre 13C Stoffwechsel-Flussanalyse (Inst-
13CMFA) wurde erarbeitet und getestet. Die Plattform wurde erweitert um Änderungen in 
der extrazellulären Isotopenmarkierung aufzunehmen. Flüsse wurden für die CHO-K1 
Zelllinien bestimmt durch die Verwendung von extrazellulärer Markierung. Flusswerte 
deuten darauf hin, dass sich die Zellen hinsichtlich schnellem Wachstum und der 
komplexen Medienzusammensetzung anpassen. Eine hohe Auflösung von Parametern 
wurde erreicht, indem Inst-13CMFA auf die Daten aus zwei Markierungsexperimenten 
angewendet wurde. In beiden Studien trug die Pentosephosphatweg einen hohen Fluss 
um NADPH zur Fettsäuresynthese und um oxidativen Stress zu vermeiden. Weiterhin 
lieferte das Channeling von Pyruvat eine Erklärung für Unterschiede Markierungen. 
Selektiv permeabilisierten CHO-K1 Zellen wurden verschiedene Substrate zugeführt. 
Unter Anwendung der Elementarmoden Zerlegung auf das mitochondriale Netzwerk 
konnte die Aktivität von Stoffwechselpfaden und regulierenden Effekten belegt werden. 
Indem weitere Methoden der Systembiologie angewandt wurden, trägt diese Dissertation 
dazu bei ein umfassenderes Bild des Stoffwechsels von CHO-K1 Zellen zu erstellen. 
Gleichzeitig wurden neue Fragen in Bezug auf Kompartmentflüsse aufgeworfen. 
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c - cytosolic 
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1. Introduction 
Chapter 1 
1. Introduction in systems biology for metabolism analysis 
of eukaryotic cells 
 
“We are prone to thinking by analogy […] but very little in our human experience is truly 
comparable to the immensely crowded, membrane-subdivided interior of a eukaryotic 
cell or the intricately layered structures of a mammalian tissue. So in our daily efforts to 
understand how cells work, we are faced with a challenge: how do we develop intuition 
that works at the microscopic scale? ” (Flamholz et al., 2014). One could further ask “how 
does one harness the complexity of the eukaryotic cell to answer practical questions?” A 
complex problem requires a complex solution. Sustained research in molecular biology 
and the emergence of “omics” technologies supply vast information concerning the 
components, the structure and the interactions within the cell. However, without a 
rigorous modeling framework, this knowledge provides little insight on how the systems 
properties emerge, what are the goals of the cell and how its behavior could be predicted. 
Systems biology, an explosively developing scientific field, addresses the question by 
observing multiple components simultaneously and by integrating those using rigorous 
mathematical models (Sauer et al., 2007). Biological systems are inherently complex, and 
in the case of eukaryotic cells, structural organization and compartmentation adds 
another layer of complexity when compared to the prokaryotic cell, as it was noted for 
yeast (Castrillo and Oliver, 2011), mammalian cells (Niklas and Heinzle, 2012) or plants 
(Lucas et al., 2011). 
Studying the metabolism of eukaryotic cells at systemic level is of essential importance 
for designing and improving recombinant organisms (Carinhas et al., 2012; Dietmair et al., 
2012; Liu; Zurbriggen et al., 2012), with the goal of increasing yield or producing desired 
glycosylation pattern in therapeutic proteins. Concerning mammalian organisms, the 
development of new treatments or diagnosis strategies benefits greatly from an in depth 
understanding of disease mechanisms and drug toxicity at the metabolic level (Bugrim et 
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1. Introduction 
al., 2004; DeBerardinis and Thompson, 2012; Kell, 2006). The eukaryotic cell (Fig. 1.1) 
distinguishes itself from the prokaryotic cell by the separation of the nucleus and 
organelles from the cytosol using enclosure within a system of endomembranes. The 
major role of compartmentation is to confine metabolic processes to distinct 
compartments in which it is possible to create different environments with respect to 
metabolite concentrations, enzymes and pH. Metabolite and protein traffic between 
compartments and cytosol is tightly regulated by selective membrane permeability and 
via membrane transporters (Schell and Rutter, 2013). Isoenzymes enable the same 
reaction to occur in different subcellular compartments under sometimes very different 
conditions, especially related to substrate availability and cofactor concentrations. This 
confers the eukaryotic cell a high degree of flexibility in controlling metabolic pathways. 
The cytosol is structured by a 3D meshwork called cytoskeleton that provides spatial 
organization of the organelles in the cytoplasm and also confers shape to the cell (de 
Forges et al., 2012). Enzymes can associate in transient or permanent complexes favored 
by the 3D structure, leading to substrate channeling (Jandt et al., 2013; Zhang, 2011) in 
some metabolic pathways. Other than enhancing reaction rates, enzyme complexes can 
protect unstable intermediates, create microenvironments for otherwise kinetically 
unfavorable reaction and isolate toxic of inhibitory intermediates from the rest of the cell. 
 
Figure 1.1. Scheme of a mammalian cell 
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1. Introduction 
1.1. Mitochondria 
Mitochondria evolved as specific organelles by inclusion of protobacteria in the precursor 
of the eukaryotic cell. Although the mitochondrial genome contains a small number of 
genes coding for the respiratory complex and genes needed for mitochondrial replication, 
mitochondrial proteome contains a wealth of over 1000 proteins and varies highly 
depending on the organism and cell type (Friedman and Nunnari, 2014; Pagliarini et al., 
2008). The mitochondrial metabolism is responsible for producing most of the energy in 
the eukaryotic cell by combining the TCA cycle activity with oxidative phosphorylation. 
Electrons are transferred from NADH or succinate to oxygen and ATP is produced from 
ADP by using the proton gradient generated by the electron transfer. Most NADH is 
produced by the TCA cycle through the oxidation of organic acids involved in the cycle. 
Mitochondrial carriers (Table 1.1) belonging to the mitochondrial carrier family (Kuan and 
Saier, 1993) are proteins encoded in the nucleus, and though they are characterized by 
relatively low homology, they share a common topology (Hamel et al., 2004). They are 
localized in the mitochondrial inner membrane and control the shuttling of various 
metabolites, cofactors and ions across the mitochondrial membrane. In the framework of 
cellular metabolism, the tightly regulated transport process is essential in maintaining 
distinct compartmented microenvironments and the membrane potential (Schell and 
Rutter, 2013). 
Owing to evolution of different roles organelles play in the cell, their membranes exhibit 
distinct compositions (van Meer et al., 2008). In comparison to the plasma membrane, 
the mitochondrial membrane contains almost no sterols and includes cardiolipin, a lipid 
unique to the mitochondria. This property enables the use of detergents, e.g. digitonin or 
saponin, to selectively permeabilize only the plasma membrane, leaving the mitochondria 
intact (Kuznetsov et al., 2008; Niklas et al., 2011a). Such “ghost cells” can be utilized for 
respiration studies (Wahrheit et al., 2015), analysis of compartmented enzyme activity 
(Wahrheit et al., 2014b) or other studies of the mitochondrial metabolism. 
Considering the central role the mitochondrial metabolism plays in the functioning of the 
eukaryotic cell, mitochondrial dysfunctions are responsible for many diseases e.g. 
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diabetes type II, cancer or neurodegenerative diseases (Balaban, 2010; Pagliarini et al., 
2008; Palmieri, 2008; Wallace, 2012) and play a key role in the aging process (Bratic and 
Larsson, 2013). Also, the many bioprocesses that use eukaryotic cells for the production of 
small molecules or recombinant proteins rely on an optimal use of substrates and on the 
energy supplied by the TCA cycle (Klein et al., 2015). 
1.2. Systems biology of mammalian cells 
In the post-genomic era, where great amounts of genomic, transcriptome and proteomic 
data become available at a fast pace and sustained research effort is employed to 
coagulate this data into knowledge through systems biology, metabolism tends to be 
overlooked as the main reflection and influence of the physiological state of the cell (Ray, 
2010). Metabolism is however the final manifestation of the entire genetic-transcriptome-
proteomic apparatus. In-depth knowledge of the eukaryotic cell metabolism can impact 
how new treatments for diseases are conceived or the design of new strains and 
bioprocesses (Niklas and Heinzle, 2012). Compartmentation complicates systems biology 
studies of the metabolism because of the addition of new pools of the same metabolite 
(Fig. 1.2), the existence of compartmented isoenzymes and limited information on the 
properties of mitochondrial carriers (Wahrheit et al., 2011a).  
 
Figure 1.2. Compartmentation of metabolite A between the extracellular media (extra), cytosol (cyt) and 
mitochondria (mit). The connection between the pools is made via specific transporters. 
Channeling effects and enzyme associations (al-Habori, 1995; Niklas et al., 2011b; Zhang, 
2011) create permanent or temporary environments where certain metabolites are isolated 
from their bulk pools and reaction kinetics are very different compared to the in vitro 
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situation. Within this dissertation, the term “pool” will refer to a metabolite 
concentration confined to a cell compartment. 
The metabolism of mammalian cells differs from that of plants and fungi due to its 
characteristic use of more and sometimes complex substrates and also the wider range of 
secreted metabolites. The central carbon metabolism (Fig. 1.3) is comprised of glycolysis, 
pentose phosphate pathway (PPP), mitochondrial transport, TCA cycle, anaplerotic and 
cataplerotic reactions and the amino acid metabolism. Although it differs greatly among 
organisms and cell types, a typical mammalian cell takes up glucose as the main carbon 
source, glutamine as carbon and nitrogen source, it can simultaneously take up and 
produce non-essential amino acids, it takes up essential amino acids mostly for protein 
synthesis and it can secrete lactate as a side product. Isoenzymes catalyze certain 
reactions from the TCA cycle, anaplerosis/cataplerosis or amino acid metabolism 
simultaneously in different compartments (Table 1.2). 
 
Figure 1.3. General scheme of the mammalian cell metabolism. Abbreviations: AA – amino acid; Asn – 
asparagine; Glc – glucose; Gln – glutamine; Lac – lactate; PPP – pentose phosphate pathway; Pyr – pyruvate. 
From a systems biology point of view, characterizing the metabolism of a mammalian cell 
involves two main parts: establishing the topology of the metabolic network and in vivo 
flux analysis (Wahrheit et al., 2011a). 
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Table 1.1. Mitochondrial carriers in Baker’s yeast (Saccharomyces cerevisiae), Chinese hamster (Cricetulus griseus) and human (Homo 
sapiens). 1 – from SGD (Christie et al., 2004); 2 – from CHOgenome (Hammond et al., 2012); 3 – from Human Genome Resources (Pruitt et 
al., 2000) . 
Nr 
Mitochondrial 
carrier - 
substrate 
Process S. cerevisiae1 
 
CHO2 
 
Human3 
 
References 
 
1 pyruvate Pyr-c + H+c Pyr-m + H+m 
YGL080W (MPC1) 
YHR162W (MPC2) 
YGR243W (MPC3) 
Mpc1 
Mpc2 
LOC100772695 
LOC103162130 
MPC1 
MPC1L 
MPC2 
 
(Bricker et al., 2012; Herzig 
et al., 2012) 
2 NAD+ - 
YIL006W/ YEL006W  
(YIA6/YEA6) 
- - (Hildyard and Halestrap, 
2003; Todisco et al., 2006) 
3 citrate 
Citc + Malm   Citm + Malc 
Citc + Pepm  Citm + Pepm 
YBR291C (CTP1) Slc25a1 SLC25A1 (CIC) (De Palma et al., 2005; 
Gnoni et al., 2009; Kaplan et 
al., 1995) 
4 oxaloacetate Oaac + H+c  Oaam + H+m YKL120W (OAC1) - - (Palmieri et al., 1999) 
5 
pyrimidine 
nucleotide 
C/U/TTPc + C/U/TDPm  
C/U/TTPm + C/U/TDPc 
YBR192W (RIM2) Slc25a36 
Slc25a33 
SLC25A36 
SLC25A33 
(Di Noia et al., 2014; 
Marobbio et al., 2006) 
6 GTP/GDP 
GDPc + GTPm  GDPm + 
GTPc 
YDL198C (GGC1) - - (Vozza et al., 2004) 
7 dicarboxylate C4c + Pim   C4m + Pic 
YLR348C (DIC1) Slc25a10 
LOC100766192 
SLC25A10 (DIC) (Fiermonte et al., 1998; 
Palmieri et al., 1999; 
Pannone et al., 1998) 
8 thiamine phosphate ThPPc  ThPPm 
YGR096W (TPC1) Slc25a19 SLC25A19 (DNC) (Kang and Samuels, 2008; 
Marobbio et al., 2002) 
9 phosphate Pic  Pim 
YJR077C (MIR1) Slc25a25 
Slc25 A23 
SLC25A25 (APC3) 
SLC25A23 (APC2) 
(del Arco and Satrustegui, 
2004; Dolce et al., 1991; 
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Slc25a3 SLC25A24 (APC1) 
SLC25A3 (PHC) 
Phelps et al., 1991) 
10 
citrate / 
oxoglutarate 
Citm + AKGc  Citc + AKGm 
YMR241W (YHM2) - - (Castegna et al., 2010) 
11 
S-
adenosylmethionine 
SAMc  SAMm 
YNL003C (PET8) Slc25a26 SLC25A26 (SAMC1) (Marobbio et al., 2003) 
12 ADP/ATP ADPc + ATPm  ADPm + ATPc 
YBL030C 
(PET9/AAC3) 
Slc25a4 
Slc25a5 
Slc25a31 
SLC25A4 (ANT1) 
SLC25A5 (ANT2) 
SLC25A6 (ANT3) 
SLC25A31 (ANT4) 
(Houldsworth and Attardi, 
1988; Lawson and Douglas, 
1988) 
13 
aspartate / 
glutamate 
Gluc  Glum 
Gluc + Aspm  Glum + Aspc 
YPR021C (AGC1) Slc25a12 
Slc25a13 
SLC25A12 (AGC1, 
ARALAR1) 
SLC25A13 (AGC2, 
ARALAR2) 
(Cavero et al., 2003; 
Kobayashi et al., 1993) 
14 succinate / fumarate Succ + Fumm  Sucm + Fumc YJR095W (SFC1) - - (Palmieri et al., 1997) 
15 
acylcarnitine, 
basic amino acids 
AcCARc + CARm  AcCARm + 
CARc 
YOR100C (CRC1) Slc25a20 
Slc25a29 
SLC25A20 (CAC) 
SLC25A29 
(Huizing et al., 1997; 
Porcelli et al., 2014; van 
Roermund et al., 1999) 
16 
 
Calcium-binding 
carrier protein 
ATPm/ADPc + Pim  
ATPm/ADPc + Pic 
- (YMC3 in 
P.pastoris) 
SCaMC-1 SLC25A24 (Fiermonte et al., 2004) 
17 
α-ketoglutarate 
/malate 
AKGm + Malc  AKGc + Malm 
- Slc25a11 
LOC100770598 
SLC25A11(OGC) (Iacobazzi et al., 1992) 
18 ornithine Ornc + H+m  Ornm + H+c 
ORT1 Slc25a15 
Slc25a2 
SLC25A15 (ORC1) 
SLC25A2 (ORC2) 
(Fiermonte et al., 2003; 
Palmieri et al., 2000)  
19 glutamate Gluc  Glum 
- Slc25a18 
Slc25a22 
SLC25A18 (GC2) 
SLC25A22 (GC1) 
(Fiermonte et al., 2002) 
20 oxoadipate 
C5-C7 oxodicarboxylatec  
C5-C7 oxodicarboxylatem 
YPL134C (ODC1) Slc25a21 SLC25A21 (ODC) (Fiermonte et al., 2001; 
Palmieri et al., 2001) 
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21 folate - - Slc25a32 SLC25A32 (MFT) (Titus and Moran, 2000) 
22 uncoupling proteins - 
- Slc25a7 
Slc25a8 
Slc25a9 
Slc25a27 
Slc25a14 
SLC25A7 (UCP1) 
SLC25A8 (UCP2) 
SLC25A9 (UCP3) 
SLC25A27 (UCP4) 
SLC25A14 (UCP5) 
(Boss et al., 1997; Cassard et 
al., 1990; Sanchis et al., 
1998) 
Not yet annotated 
YHR002W (LEU5, involved in CoA transport in yeast 
mitochondria) (Prohl et al., 2001) 
MTCH1 (Palmieri, 2013) 
MTCH2 
SLC25A16 (Mitochondrial carrier, Graves disease autoantigen) 
(Zarrilli et al., 1989) 
SLC25A28 (Mitoferrin2) 
SLC25A30 (KMCP1) 
SLC25A33 (PNC1) 
SLC25A34 
SLC25A35 
SLC25A36 (PNC2) 
SLC25A37 
SLC25A38 
SLC25A39 (CGI-69) 
SLC25A40 (MCFP) 
SLC25A41 
SLC25A42 
SLC25A43 
SLC25A44 
SLC25A45 
SLC25A46 
SLC25A47 
SLC25A48 
SLC25A49 
SLC25A50 
SLC25A51 
SLC25A52 
SLC25A53 
Required by metabolism but not yet assigned 
glutamine transporter (Indiveri et al., 1998) 
neutral amino acids carrier (Cybulski and Fisher, 1977) 
 
  
  
9 
 
1. Introduction 
Metabolic network reconstruction aims at building a consistent network of metabolic 
events, i.e. reactions and transport, using biochemical knowledge. Biochemistry books, 
the metabolic network compilation by (Michal and Schomburg, 2012) and online 
databases (Hammond et al., 2012; Zhu et al., 2003) that collect and curate gene 
annotation, gene expression and proteomic data constitute the main starting points for 
building a metabolic network. Bioinformatics software can assist the otherwise 
cumbersome process of network reconstruction making the process automatic (Forth et 
al., 2010; Karp et al., 2010). Popular open source software like COBRA (Schellenberger et 
al., 2011) includes tools for constraint-based genome scale reconstruction and analysis. 
Table 1.2. Isoenzymes from the central carbon metabolism of Mus musculus* and 
their localization in cytosol and/or mitochondria. 
Enzyme 
Compartment 
Cytosol Mitochondria 
Acetyl-Coenzyme A 
acetyltransferase 
Acat2, Acat3 Acat1 
Aconitase Aco1 Aco2 
Branched chain 
aminotransferase 
Bcat1 Bcat2 
Fumarase Fh1** Fh1* 
Glutamic-oxaloacetic 
transaminase 
Got1 Got2 
Glutamic pyruvic 
transaminase 
Gpt Gpt2 
Isocitrate dehydrogenase 
Idh1 (NADP+-
dependent) 
Idh2 (NADP+-dependent), 
Idh3 (NAD+-dependent) 
Lactate dehydrogenase Ldha, Ldhb Ldhd 
Malate dehydrogenase Mdh1 Mdh2 
Malic enzyme 
Me1 (NADP+-
dependent) 
Me2 (NAD+-dependent), 
Me3 (NADP+-dependent) 
Phosphoenolpyruvate 
carboxykinase 
Pck1 Pck2 
Serine 
hydroxymethyltransferase 
Shmt1 Shmt2 
* (Blake et al., 2014) 
**  fumarase is present in the same form in both compartments 
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Genome scale models of the mammalian cell metabolism include cofactor (e.g. NADH, 
NADPH, ATP, etc.) balance, but this can be a potential pitfall because of the lack of 
reliable respiration measurements, limited knowledge about futile cycles and 
uncertainties in the selectivity of enzymes for NAD+ or NADP+ (Wahrheit et al., 2011a). 
Missing links and inconsistencies in the network are corrected by reevaluating the model 
based on experimental observations. Once a consistent metabolic network was 
constructed, it can be used to determine the material flow from substrates to products by 
applying flux analysis methods. Genome scale models are modeled mathematically by 
converting them into stoichiometry matrices, where the rows correspond to the 
components, and the columns represent the reactions. Stoichiometry based modeling 
involves methods for flux balance analysis (Varma and Palsson, 1994; Xie and Wang, 1996; 
Zupke and Stephanopoulos, 1995), elementary mode analysis (Schuster et al., 2000), 
extreme pathway analysis (Wiback et al., 2003) or other constraint-based modeling that 
can include e.g. thermodynamics (Henry et al., 2007) or kinetics. Such methods can be 
used to understand cellular objectives, to obtain a feasible solution space for the 
metabolic fluxes under specific conditions or to simulate possible mutants/inhibitions in 
silico. All such models rely on the assumption of metabolic steady state, which means 
that: (1) intracompartmental concentrations do not change over time and (2) only one 
metabolic state of the cell is characterized. 
1.3.   13C-based metabolic flux analysis 
Detailed metabolic flux analysis needs powerful tools to tackle complex networks as those 
of mammalian cells. Alternative pathways, intercompartmental transport and the 
presence of isoenzymes introduce new degrees of freedom in the network that weaken 
the resolution power of flux balance approaches. Flux balance analysis (FBA) methods 
rely on considering cofactor and electron balances. This can generate errors due to the 
uncertainty of cofactor preference of certain enzymes. Also, it is difficult to include 
oxidative phosphorylation uncoupling, futile cycles or electron leaking through the 
mitochondrial membrane. For answering questions regarding compartmentation, 
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metabolite exchange or channeling, while at the same time avoiding the use of cofactor 
and electron balances, 13C metabolic flux analysis (13CMFA) is currently method of choice. 
The principle of using 13C substrate labeling is that, following the distribution of carbon in 
the metabolic network, the labeling pattern of intra- or extracellular metabolites contains 
information about the metabolic flux distribution. For a molecule, there are 2n possible 
arrangements of labeled and non-labeled carbon atoms, called carbon isotopomers, in 
which n is the number of carbon atoms in the molecule. A network is then built to trace 
the distribution of carbon from substrate(s) to metabolites and more specifically, to those 
for which the labeling pattern was sampled. Simulation of the 13C distribution throughout 
a metabolic network at steady state involves carbon-transfer rules and mass balances to 
compute the label distributions in the readout metabolites (Schmidt et al., 1997; 
Wahrheit et al., 2011a; Wiechert and de Graaf, 1997; Zupke and Stephanopoulos, 1994). For 
a typical reaction A + B  C, the isotopomer distribution vector of C (IDVC) will be 
mapped from the isotopomer distribution vector of A (IDVA) and B (IDVB) using the 
isotopomer mapping matrices that maps A to C (IMMAC) and B to C (IMMBC) and 
element-wise multiplication : 
   BCBACAC IDVIMMIDVIMMIDV      (1.1) 
Known parameters, such as uptake fluxes vu,i (eq. 1.2) and biomass fluxes vbio,i (eq. 1.3), are 
determined by analyzing the extracellular metabolite concentrations (pools) Ci and 
biomass composition, then relating them to the cell number X, specific growth rate  
Xdt
dX 1
 and the cell volume Vcell: 
cell
i
iu
VXdt
dC
v
11
,        (1.2) 
cell
Xiibio
VXdt
dX
Yv
11
/,       (1.3) 
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The intracellular fluxes v constitute the null space of the stoichiometric matric S (eq. 1.4), 
that can be further divided to include the measured fluxes vm: 
0
0


eemm vSvS
vS
    (1.4) 
where Sm – stoichiometric matrix corresponding to measured fluxes, Se – stoichiometric 
matrix corresponding to estimated fluxes, ve – estimated fluxes. In addition to the 
condition of metabolic steady state, in compartmented systems it is also necessary to 
assume that the volume ratio between compartments does not change. The mass balance 
in the three volumes for metabolite A in Fig. 1.2 can therefore be written as: 
Aextra:   cellcultureuptakeAinA
extraA
VVXvQ
dt
dC
 ,,
,
      (1.5) 
Acyt:  transportAcytprodAcytconsAuptakeA vvvv ,,,,,,0        (1.6) 
Amit:  mitprodAmitconsAtransportA vvv ,,,,,0        (1.7) 
where: CA,extra – concentration of A in the media, [mmol  L-1]; QA,in – total feed of A in 
the culture media, [mmol  h-1]; v – fluxes of uptake, consumption (cons), production (prod) 
and transport between compartments, [mmol  (L cell)-1  h-1]; X – cell density, [cells  
L-1]; Vculture – cultivation volume, [L]; Vcell – cell volume, [L cell]. 
A problem is then constructed that estimates the free parameters Φ by fitting the 
simulated labeling patterns to labeling data retrieved from GC-MS (mass isotopomers) or 
13C-NMR (positional enrichment) (Schmidt et al., 1999; Wittmann and Heinzle, 1999) 
using an optimization algorithm that minimizes the quadratic deviation estimator (f) 
computed as the weighted sum of square differences between measured and computed 
MIDs (1.8). 
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








 

..
1
2
exp
exp
1
)(min
measnr
i ii
sim
ii
errorMID
MIDMID
f  , Φ ≥ 0   (1.8) 
In 13CMFA, the free parameters are the net and reversible fluxes at metabolic steady state. 
Classical 13CMFA uses the isotopomer distributions sampled at labeling steady state. 
Estimated flux distributions rely on several factors: (1) amount and quality of 
experimental data involving extracellular fluxes and labeling, (2) degree of complexity 
and correctness of the metabolic network, (3) numerical methods and performance of 
optimization algorithms. Sensitivity analysis or statistical methods e.g. Monte Carlo are 
then used to assess the influence of experimental errors and establish the confidence 
intervals for the estimated parameters (Antoniewicz et al., 2006; Wittmann and Heinzle, 
2002; Yang et al., 2008). Experimental design can guide the choice of substrate labeling 
and the layout of an optimal set of measurements (Chang et al., 2008; Metallo et al., 
2009). Software packages for 13CMFA are available and can vary in their user-friendliness, 
open/closed source type, flexibility and the algorithms used for isotopomer balancing and 
parameter estimation (Millard et al., 2014; Quek et al., 2009b; Srour et al., 2011; Zamboni 
et al., 2005). 
Representative 13CMFA applications for mammalian cells include the characterization of 
hybridoma cells metabolism and a comparison to flux analysis without using 13C labeling 
(Bonarius et al., 1998), unraveling compartmentation of pyruvate metabolism in 
pancreatic beta-cells (Lu et al., 2002), assessing the subtoxic effects of drugs on 
cardiomyocites (Strigun et al., 2012), probing the metabolism of an inducible expression 
system in Chinese hamster ovary cells (Sheikholeslami et al., 2013) or  using lactate 
labeling to characterize the metabolism of HEK cells (Henry et al., 2011). Efforts were 
made to establish cultivation media and techniques that help to maintain the metabolic 
steady state long enough until isotopic steady state is reached (Deshpande et al., 2009). 
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1.4. Non-stationary 13C metabolic flux analysis 
Ensuring metabolic steady state until isotopic steady state is reached is a mathematical 
necessity for applying 13CMFA, but it can prove difficult in mammalian cell cultures. The 
required time scale is usually too large to maintain a stable metabolism. Substrates 
become depleted in the media and toxic products like lactate or ammonia accumulate, 
leading to significant changes in the metabolism and sometimes even to cell death. Also, 
exchange of metabolites with the media influences the intracellular labeling while 
increasing considerably the time needed to reach isotopic steady state. Although 
computationally and experimentally much more intensive than classical 13CMFA, non-
stationary 13CMFA (Inst-13CMFA) has the potential to overcome these difficulties by using 
the isotopomer dynamics at a short time scale, when the metabolism remains at steady 
state (Antoniewicz et al., 2007; Noh et al., 2007). For applying Inst-13CMFA, the 
experimental isotopomer distributions are sampled over time and a mathematical model 
simulates the dynamics of isotopomers by integrating the carbon balance equations (eq. 
1.9) starting from the moment when the labeled substrate was fed. For the system of 
reactions shown in (Fig. 1.4), the dynamic isotopomer balance depends on the 
intracompartmental concentration of D (CD, [mmol  (L cell)-1]), on the fluxes producing 
D (vD,1 and vD,2, [mmol  (L cell)-1  h-1]) and the fluxes consuming D (vD,out, [mmol  (L 
cell)-1  h-1]): 
      DoutDCDCDBDBADAD
D
D IDVvIDVIMMvIDVIMMIDVIMMv
dt
dIDV
C   ,21,   (1.9) 
where IDV – isotopomer distribution vector, IMM – isotopomer mapping matrix. 
Following the substrate label switch, the isotopomer distribution of D changes gradually 
from non-labeled to labeled (Fig. 1.3), at a rate proportional to the vD,out / PoolD  ratio.  
In addition to extracellular fluxes and transient intracellular isotopomer distributions, 
Inst-13CMFA (Fig. 1.5) also requires that at least some key intracellular concentrations are 
sampled experimentally (Noh and Wiechert, 2006). One major advantage is that Inst-
13CMFA permits the estimation of unknown intracompartmental, perhaps difficult to 
measure concentrations. 
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Figure 1.4. Example of a dynamical labeling experiment. Metabolite D is produced by two enzyme-
catalyzed reactions from metabolites A and B in one reaction and from C in the second. The isotopomers of 
D corresponding to the labeling in A, B and C, IDVD,xxxxxx, are formed at rates proportional to the fluxes vD,1 
and vD,2 and inversely proportional with the intracompartmental pool of D. 
The sampling time points and the labeled substrate or combination of substrates can be 
optimally chosen by applying experimental design strategies (Noh and Wiechert, 2006; 
Yang et al., 2014). Several software packages became recently available to tackle the 
numerical complexity of estimating metabolic fluxes using Inst-13CMFA, of which some 
were published (Antoniewicz, 2013b; Kajihata et al., 2014; Young, 2014) and others are 
commercially available, like 13CFlux (https://www.13cflux.net/). Metabolic networks and 
flux maps are most comprehensible in graphical representation, for which visualization 
software was developed, like Omix (Noh et al., 2015). 
Due to the complex experimental requirements, there are few published applications of 
Inst-13CMFA. Using the transient labeling in intracellular metabolites lead to an extended 
topology and better characterization of methanol metabolism in Pichia pastoris compared 
to studies that used 13C labeling in proteinogenic amino acids (Jorda et al., 2014; Jorda et 
al., 2013). 
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Figure 1.5. Experimental and simulation scheme of non-stationary 13C metabolic flux analysis. (A) In 
the labeling experiment (A1), a naturally labeled Substrate 1 is replaced with a 13C-labeled substrate. Labeled 
metabolites are sampled from the intra- and extracellular media, and then analyzed using mass 
spectrometry (A2) to determine the mass isotopomer distributions (A3). (B) Cultivation in non-labeled 
media (B1) provides the extracellular media and cells for cultivation profiling (B2) that determined the 
extracellular fluxes in the metabolic network (B3). (C) The metabolic network, mass distribution vectors 
(MDVs) and extracellular fluxes are data input for non-stationary 13C metabolic flux analysis (Inst-13CMFA) 
software that estimates the free parameters (fluxes, reversibilities and intracompartmental pools) by 
optimizing the fitting of the simulated MDVs. Once the estimation is considered successful, the confidence 
intervals of parameters are computed and sensitivity analysis is performed. 
Plants use CO2 as the only carbon source, making steady-state 13CMFA inapplicable but 
opening the door to many interesting applications of Inst-13CMFA, as  characterizing the 
leaf metabolism in Arabidopsis thaliana (Ma et al., 2014) or establishing subcellular 
compartmentation in various plant cells (Allen et al., 2007). Production of 
biopharmaceuticals using mammalian cells benefits greatly from a detailed 
understanding of the metabolism of relevant cell lines. Comprehensive flux maps were 
achieved with 13CMFA and multiple labeled substrates in CHO cells (Ahn and 
  
17 
 
1. Introduction 
Antoniewicz, 2011) or extracellular labeling obtained after feeding [U-13C] glucose to 
CHO-K1 cells in batch culture (Nicolae et al., 2014). Detailed metabolic aspects in cancer-
like cells (Murphy et al., 2013) could be resolved at high resolution using isotopically 
nonstationary 13C flux analysis. Transient 13C labeling was also applied to study the 
neuronal metabolism in vivo (Gruetter, 2002) and the influence of hypoglycemia (Amaral 
et al., 2011). 
1.5. Dynamic metabolic flux analysis  
Despite the high resolution of 13CMFA at determining the metabolic fluxes, sometimes the 
focus is to characterize mammalian metabolism over a longer time span. Capturing the 
dynamic change in metabolic fluxes in batch or fed-bath cultivations  could help 
understanding the metabolic shifts in mammalian cell cultures (Niklas et al., 2011c) and 
the limiting effect of glutamine availability for CHO cells (Wahrheit et al., 2014a). Two 
main mathematical approaches exist for dealing with flux dynamics: one is to separate the 
flux timeline in phases for which the metabolism is considered to be at steady state 
(Antoniewicz, 2013a; Leighty and Antoniewicz, 2011) and another is to compute 
continuous flux values by fitting the extracellular concentrations with specific functions 
or with splines (Lequeux et al., 2010; Niklas et al., 2011c; Wahrheit et al., 2014a; Willemsen 
et al., 2015). Regardless of the approach, the extracellular fluxes are determined by fitting 
the extracellular concentrations and growth curve, determining the rates by numerical 
derivation and applying eq. 1.2 and 1.3, then the intracellular fluxes are computed using a 
stoichiometric model. Because the numerical derivation of splines and the experimental 
determination of concentrations are considerable sources of errors, Monte Carlo can be 
used to determine the standard deviations of the computed fluxes (Niklas et al., 2011c). 
 
1.6. Elementary mode analysis 
A very useful method for analyzing the topology of reaction networks, elementary mode 
analysis (EMA) decomposes the fluxes at steady state into elementary modes (Schuster et 
al., 2000) (Fig. 1.6). These are a set of vectors derived from the stoichiometric matrix, that 
have the following properties: (1) for a given network, there is an unique set of elementary 
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modes; (2) each elementary modes consists of the minimum number of reactions needed 
to exist as a functional metabolic unit, and cannot function if any reaction is removed and 
(3) the elementary modes are the set of all possible pathways that satisfy the previous 
condition (Papin et al., 2004). The metabolic fluxes at a given steady state can be 
expressed as a linear combination of the elementary fluxes. EMA provides a tool for 
stoichiometry-based approaches to characterize the structure of the metabolic network in 
mammalian cells (Orman et al., 2011) and evaluate the weight of each flux or to correlate 
the influence the uptake of a certain substrate has on the products. However, the 
decomposition of a flux distribution is usually not unique for large networks, and it can 
be made only by minimizing an objective function (Zhao and Kurata, 2009). Human 
blood cell network was a target for many pathways analysis studies to describe energy 
metabolism or to relate circulatory dysfunctions to enzymes (Cakir et al., 2004; Wiback 
and Palsson, 2002). Macroscopic reaction modes for CHO cells connecting substrates and 
products were constructed based on network decomposition in elementary modes 
(Provost et al., 2006). 
 
1.7. The Chinese hamster ovary cell line 
Both theoretical studies and bioproduction using mammalian cells require stable cells 
lines that can be cultivated in reproducible conditions. The Chinese hamster ovary (CHO) 
cell line was obtained by Puck in 1957 (Puck, 1985) from a female Chinese hamster 
(Cricetulus griseus). Nowadays, CHO are considered the mammalian equivalent of E. coli 
and are ideal model mammalian systems or for recombinant expressing heterologous 
proteins owing to: (1) their stable gene expression, (2) high yields of protein production, 
(3) the ability to produce glycosylated proteins compatible with humans, (4) powerful 
gene amplification systems, such as dihydrofolate reductase or glutamine synthetase-
mediated gene amplification and (5) their ability to grow in serum-free media and 
suspension conditions found in large industrial bioreactors.  
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Figure 1.6. An example of elementary mode decomposition of a reaction network. EM – elementary mode. 
The red arrows represent each elementary mode. Adapted from (Papin et al., 2004) 
CHO are therefore the main production cell line for biopharmaceuticals, responsible for 
nearly 70% of all recombinant therapeutic production (Jayapal et al., 2007; Kim et al., 
2012). Considering the economical and scientific importance of CHO cells, there has been 
sustained effort in the field of systems biology to characterize the CHO cells (Table 1.3). 
Their genome was published in 2011 (Xu et al., 2011), sequenced from sorted chromosomes 
(Brinkrolf et al., 2013) and is available online at www.chogenome.org (Hammond et al., 
2012), a database that is continuously updated to include new annotations. Combining 
genome annotation using homology with omics studies that focused on unraveling the 
transcriptome (Becker et al., 2011; Hackl et al., 2011) and proteome (Baycin-Hizal et al., 
2012) constitutes the foundation for the CHO systems biology era (Kildegaard et al., 2013). 
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Table 1.3. Timeline of “omics” and metabolic studies of the CHO cell line. Abbreviations: CHO – 
Chinese hamster ovary; GS – glutamine synthetase; mAb – monoclonal antibody; PPP – pentose phosphate 
pathway; SHMT – serinehydroxymethyltransferase. 
“omics” studies of CHO 
cells 
YEAR Metabolic studies of CHO cells 
Cell line, 
culture type 
Development of the CHO cell 
line (Puck, 1985). 
1957   
Mitochondria isolation in 
CHO cells (Madden and 
Storrie, 1987). 
1987  
 
 1996  Partitioning of serine and glycine metabolism 
was studied using [1-13C]- or [2-13C]glycine. 
Mitochondrial SHMT is the primary pathway 
for serine into glycine interconversion 
(Narkewicz et al., 1996). 
CHO K1 
CHO glyA 
(lacks mSHMT 
activity) 
 1999 
 
FIRST METABOLIC MODEL OF CHO 
 A simplified model of the central carbon 
metabolism of CHO was used to study the 
consistency of mass balances when CHO cell 
are grown in complex media (Nyberg et al., 
1999). 
γ-CHO, 
continuous 
 2001 
 
 Metabolic flux redistribution in glutamate-
based media. Regulation of glucose feed rate 
promotes efficient use of glucose and nitrogen 
source and lowers production of byproducts 
(Altamirano et al., 2001b).  
CHO TF 70R, 
suspension 
continuous 
 Decoupling cell growth and product 
formation by generating a process with a 
growth phase and a stationary (producing) 
phase (Altamirano et al., 2001a). 
CHO TF 70R, 
suspension 
batch 
Two-dimensional 
electrophoresis map of CHO-
K1 cell line proteins (Hayduk 
et al., 2004). 
2004 
 
 
 
 2005 
 
 Metabolism of CHO cells at low glucose 
concentration analyzed by determining 
intracellular metabolites. Amino acid 
catabolism and intracellular concentrations 
increased at reduced glucose availability (Lu et 
CHO 
producing 
erythropoietin, 
monolayer 
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al., 2005). 
 2006 
 
 Macroscopic bioreaction model of CHO cell 
culture generated using elementary modes for 
each culture phase (Provost et al., 2006). 
CHO-320, 
suspension 
batch 
 Metabolic characterization of recombinant 
CHO cells expressing glutamine synthetase 
(GS) in the medium with or without glutamine 
(Zhang et al., 2006). 
CHO-GS 
producing a 
recombinant 
protein, 
monolayer 
Genomic platform for CHO 
cells containing 28,000 CHO 
transcripts obtained using 
Sanger-based sequencing 
(Kantardjieff et al., 2009). 
2009 
 
 
 
 2010 
 
 Flux analysis of an underdetermined network 
of CHO generates flux ranges (Zamorano et al., 
2010). 
CHO-320, 
suspension 
batch 
 Metabolic flux analysis of CHO cell 
metabolism in the late non-growth phase 
evidences a high PPP and low lactate 
production (Sengupta et al., 2010). 
CHO-GS SF18, 
suspension 
batch 
 Metabolic flux analysis of CHO cells in 
perfusion culture using 13C-labeled glucose 
(Goudar et al., 2010). 
n.s., perfusion 
 CHO genome published 
(Xu et al., 2011). 
 Transcriptome unraveled 
by next-generation 
sequencing (Becker et al., 
2011) 
 Next-generation 
sequencing of miRNA 
transcriptome (Hackl et al., 
2011) 
 Metabolite profiling of 
CHO cells and identification 
of nutrient bottlenecks 
(Sellick et al., 2011a) 
2011 
 
 MFA of CHO cells at growth and non-growth 
phases using [1,2-13C]glucose. Exponential 
phase: high glycolysis, lactate production, 
anaplerosis from pyruvate to oxaloacetate and 
from glutamate to α-ketoglutarate, and 
cataplerosis though malic enzyme. Stationary 
phase: reduced glycolysis, lactate uptake, PPP 
flux, and reduced rate of anaplerosis (Ahn and 
Antoniewicz, 2011). 
CHO-K1, 
monolayer 
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 Proteomic analysis of CHO 
cells included the cellular 
proteome, secretome, and 
glycoproteome. A total of 
6164 grouped proteins were 
identified from both 
glycoproteome and proteome 
(Baycin-Hizal et al., 2012). 
 Chinese hamster ovary 
database is made available as 
an online resource 
(Hammond et al., 2012). 
 Identification of the 
extracellular protein 
secretome in CHO cells 
(Slade et al., 2012). 
2012 
 
 Dynamic metabolic model of CHO cell 
culture based on decomposition provides sets 
of macroscopic bioreactions (Zamorano et al., 
2012). 
CHO-320, 
suspension 
batch 
 CHO-K1 genome sequenced 
from sorted chromosomes 
(Brinkrolf et al., 2013). 
 Comparison of the 
Cricetulus griseulus genome 
with that of six CHO cell 
lines highlights differences in 
genes related to 
bioproduction (Lewis et al., 
2013). 
2013 
 
 Kinetic model of CHO central carbon 
metabolism using Michaelis-Menten was used 
for studying the effect of sodium butyrate on 
CHO cells metabolism (Ghorbaniaghdam et 
al., 2013). 
CHO 
producing t-
PA 
 
 Flux balance analysis of Chinese hamster 
ovary cells before and after a metabolic switch 
from production to consumption showed that 
cells consuming lactate have a higher energy 
efficiency lactate producing cells (Martinez et 
al., 2013). 
CHO-XL99, 
suspension 
batch 
 Metabolic ﬂux distributions of GS-CHO cell 
clones based on exometabolome proﬁling 
reveals that asparagine is the main source of 
nitrogen (Carinhas et al., 2013). 
CHOK1SV 
(producing 
IgG4 mAb), 
suspension 
batch 
 13CMFA of a high expressing recombinant 
CHO cell line in fed-batch productions applied 
to determine changes in central metabolism 
that accompany growth and mAb production 
(Dean and Reddy, 2013). 
CHO 
producing 
mAb, 
suspension 
batch 
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 Parallel labeling using [1,2-13C]glucose and 
[U-13C]glutamine in parallel produced detailed 
flux maps of CHO cells (Ahn and Antoniewicz, 
2013). 
CHO-K1, 
monolayer 
 Steady state 13CMFA applied to characterize 
CHO cell metabolism during four separate 
phases of a culture showed that a highly 
oxidative state of metabolism corresponds with 
peak antibody production (Templeton et al., 
2013). 
mAb-
producing 
CHO cell line, 
fed-batch 
 Comparative study of the intracellular flux 
distribution with and w/o the induction of 
recombinant protein synthesis studied using 
extracellular labeling showed that protein 
expression is correlated with changes in 
pathways related to ATP and NADPH 
formation (Sheikholeslami et al., 2013) 
CHO 
producing 
anti-CD20 
mAb, 
suspension 
batch 
140 synthetic promoters for 
CHO engineering (Brown et 
al., 2014). 
2014 
 
 Profiling of extracellular metabolites coupled 
with an analysis of intracellular distributions 
using 1‐13C‐pyruvate was used to trace 
metabolic rearrangements in different 
scenarios of asparagine and serine availability 
(Duarte et al., 2014). 
CHOK1SV 
(producing 
IgG4 mAb), 
suspension 
batch 
 13CMFA used to examine the effects of 
glutamine feeding on the metabolism and 
recombinant protein productivity of induced 
CHO cells. High TCA cycle at low glutamine 
levels and increased lactate production at high 
glutamine levels (Sheikholeslami et al., 2014) 
CHO 
producing 
mAb using a 
cumate gene-
switch, fed-
batch 
 Inst-13CMFA in CHO cells using only 
extracellular labeling showed that at 
exponential phase the metabolism ensures fast 
growth and mitigates oxidative stress. 
Compartmentation is used to control 
NAD(P)H availability and synthesis/catabolism 
of amino acids (Nicolae et al., 2014). 
CHO-K1, 
suspension 
batch 
 Glutamine feeding influence on CHO growth 
studied using dynamic metabolic flux analysis 
(Wahrheit et al., 2014a). 
CHO-K1, 
batch, fed-
batch 
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 2015  FBA applied to a large scale model and 
multivariate analysis to quantify intracellular 
metabolic fluxes of antibody-producing GS-
CHO cells supplemented with different lots of 
wheat hydrolysates (Lee et al., 2015). 
CHO-GS 
producing 
mAb 
 
In a typical culture of CHO cells, during the exponential growth phase, the CHO 
metabolism is characterized by a high glycolytic flux combined with a high lactate 
secretion flux. For protein production purposes, this state is highly inefficient due to low 
TCA cycle activity, glucose and media waste and the accumulation of lactate that alters 
the pH in the culture media. Later, depending on substrate availability, the culture can 
switch from producing to taking up lactate. This phase is characterized by slow growth 
but a high rate of protein production. The metabolism is responsible for handling the 
available substrates and supply the precursors related to growth and production. By 
reviewing the studies presented in Table 1.3, it is revealed that a deep understanding of 
the CHO cells metabolism is tightly correlated to improving recombinant protein 
production. 
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Compartmentation plays a key role in managing metabolites, and constitutes the major 
aspect to control the metabolism of eukaryotic cells. Dysfunctions in the mitochondrial 
metabolism are related to many widespread diseases. The aging process and many 
neurodegenerative diseases are correlated with changes in the mitochondria. Strain 
improvement for production of biopharmaceuticals relies on redirecting carbon and 
energy in the metabolic network. Mitochondria are at the core of the energy metabolism 
and are a partial location of the central carbon metabolism. Understanding 
compartmentation relates to gaining knowledge directed at engineering mammalian cell 
lines for optimized production or at designing novel treatments for diseases. Models of 
metabolism that include reaction compartmentation and mitochondrial transporter 
regulation are essential for describing the processes in the eukaryotic metabolism in a 
systemic manner. Consequently, both medicine and bioproduction would benefit greatly 
from a deeper understanding of the compartmentation of cellular processes. 
 This thesis sets the goal to understand better the compartmentation of the eukaryotic 
metabolism by applying a systems biology approach. To this goal, more mathematical 
modeling tools are developed that include compartmentation in the framework of the 
central carbon metabolism of mammalian cell. Through model building and model 
validation cycles, the task is to simultaneously determine details about the topology of 
compartmentation together with metabolic fluxes between the mitochondria and cytosol, 
all considered in the larger frame of the mammalian central carbon metabolism. The 
CHO-K1 cell line is used as a model mammalian system. In the chapters of this work are 
described the mathematical models in correlation to the specific knowledge that can be 
extracted by combining modeling with suitable experiments. 
Chapter 2: Building and calibrating an Inst-13CMFA modeling platform using data from a 
labeling experiment in a continuous culture of Saccharomyces cerevisiae. 
Chapter 3: Inst-13CMFA applied to a controlled batch culture of CHO-K1 cells aims to 
confirm that intracellular fluxes and reversibilities can be computed in a complex 
metabolic network by using only the labeling in extracellular metabolites. Experimental 
  
26 
 
1. Introduction 
labeling is fitted to the one computed using a model that simulates carbon and 
metabolite balance in both intra- and extracellular environments under the assumption 
of exponential growth. 
Chapter 4: Taking Inst-13CMFA one step further, it was applied to a shake flask culture of 
CHO-K1 cells fed in parallel with [U-13C6] glucose and [U-13C5] glutamine. The goal is to 
perform the most detailed metabolic flux analysis to date with respect to 
compartmentation and to uncover details related to mitochondrial traffic and reaction 
compartmentation. 
Chapter 5: Elementary mode analysis was applied to a model of the mitochondria to 
establish the contribution of enzymes and transporters to the mitochondrial metabolism. 
This was investigated by feeding several key substrates to selectively permeabilized CHO-
K1 cells. By analyzing the flux values from each feeding experiment and the modes that 
achieve the conversion of substrates into observed products, it can be possible to 
determine key bottlenecks, regulatory effects and pathway activities in the mitochondria.
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Chapter 2 
2. Platform for non-stationary 13C metabolic flux analysis 
2.1. Introduction 
As mentioned in Chapter 1, there are situation when steady state 13CMFA is not 
applicable. Besides the practical aspects related to maintaining a stable metabolism 
throughout the duration of the labeling experiment, there are also situations determined 
by the structure of the carbon network that cannot be resolved using steady state 13CMFA. 
Methods for quick quenching and sampling intracellular of metabolites allow exploring of 
the information content of dynamic carbon labeling experiments. The goal of using any 
MFA method is to estimate intracellular fluxes. In order to reach this goal, Inst-13CMFA 
requires a complex software platform that handles heterogeneous types of data 
(extracellular fluxes, biomass composition, and mass isotopomer distributions), is capable 
of simulating the dynamic carbon balance model in a numerically stable manner, 
provides options for customization, enables checkpoints and offers a user-friendly 
interface where the simulations and parameter estimation are done efficiently.  
2.2. Theoretical aspects that require Inst-13CMFA 
2.2.1. Inst-13CMFA to study compartmentation 
Due to compartmentation of metabolites and/or metabolic reactions, the labeling of 
certain metabolites can be different in the cytosol and mitochondria when using a labeled 
substrate. Activity of compartmented enzymes such as, e.g., mitochondrial malic enzyme 
and pyruvate carboxylase or cytosolic phosphoenolpyruvate carboxykinase, will 
differentiate the mitochondrial/cytosolic labeling patterns of the involved pools, i.e. 
malate, oxaloacetate and pyruvate. If inter-compartmental exchange occurs with high 
fluxes, transported metabolites will have similar labeling patterns in both compartments. 
Observing the proposed network, there are cases (Fig. 2.1) when alternative pathways 
cannot be distinguished even by using labeling. 
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One case (Fig. 2.1 a) is when there are several reaction pathways which connect one 
metabolite to a product, and they all transform the carbon backbone in the same manner. 
An example is the case for pyruvate dehydrogenase and pyruvate decarboxylase pathways 
leading both to mitochondrial acetyl-CoA. The second case (Fig. 2.1 b) is where a sampled 
metabolite (e.g. alanine, aspartate) originates from more precursor pools. By balancing 
metabolic fluxes and carbon it is mathematically impossible to determine compartment 
exchange fluxes and alternative synthesis pathways using only extracellular fluxes and 
steady state labeling patterns. An example of such a situation is the compartmentation of 
aminotransferases, which exist both in the cytosol and mitochondria and whose activity 
does no change the carbon backbone. 
 
Fig 2.1. Model describing alternative synthesis pathways indistinguishable using labeling. (a) Alternative 
pathways which change the carbon backbone in the same way. (b) Compartmented identical reactions 
coupled with inter-compartmental exchange. The sampled metabolite originates via two pathways (vsyn,1 and 
vsyn,2) from a precursor compartmented in two pools (1 and 2). Reversible precursor transport is active (v1, 
v1_) and pool draining into other metabolic reactions is considered measurable (vout,1, vout,2). Also 
input/output fluxes and labeling pattern are experimentally available. 
2.2.2. Reversibility 
It has already been shown that reversibility affects steady state labeling in several 
pathways (Follstad and Stephanopoulos, 1998). As Noh et al. (Noh and Wiechert, 2011) 
revealed by simulation, reversible fluxes affect the 13C dynamics through the metabolic 
network. A backflow from a large pool into a small pool modifies the labeling dynamics of 
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both metabolites considerably, as it can be seen in Fig. 2.2. The labeling dynamics of A is 
slower if there is a reverse flux from a large pool B. Because many metabolic reactions 
take place close to equilibrium, reversibility changes label dynamics in the system 
without changing the isotopic steady state. Ignoring reversibility will therefore bias the 
estimation of intracompartmental concentrations. The steady state values depend only on 
the magnitude and ratio of metabolic fluxes (Fig. 2.2). 
 
Figure 2.2. Summed fractional labeling (SFL) dynamics in a hypothetical reaction system. The label (SFL0) 
is introduced at time=0 and A and B become labeled at rates depending on the flux/pool ratio and 
reversibility. (1) there is no reversibility between A and B; (2) there is a high reversibility between A and B 
2.3. Platform structure 
A platform for simulating Inst-13CMFA experiments and for estimating parameters was 
built in Matlab®. At the core of the platform (Fig. 2.3) there is a system of differential 
equations for balancing the carbon in the metabolic network, which represents 
fundamentally the mathematical model of the dynamic carbon distribution through the 
metabolic network, from the labeled substrate to the sampled intra- or extracellular 
readout metabolites. Several procedures and functions were coded to:  
(1) generate atom mapping matrices from carbon transfer rules; 
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(2) analyze the stoichiometric matrix, determine the degrees of freedom and select free 
fluxes; 
(3) compute intracellular fluxes for determined stoichiometric systems; 
(4) simulate the dynamic of isotopomers given a set of parameters; 
(5) compute the weighed sum of square differences (SSQD) from simulated and input 
MIDs (eq. 1.5); 
(6) determine the free parameters by minimizing the SSQD using numerical 
optimization; 
(7) perform sensitivity analysis; 
(8) plot the MID dynamics and sensitivity maps; 
(9) export the results in .csv or Microsoft Excel® form. 
 
Figure 2.3. Scheme of the modeling platform for simulation and parameter estimation using non-stationary 
13C metabolic flux analysis. The main program handles the carbon transfer rules, procedures for balancing, 
data handling and optimization algorithms selection and/or customization, and also the simulation of the 
carbon balance through the metabolic network model. Data inputs: extracellular fluxes, intracellular 
concentrations and labeling. Combining data from more labeling experiments is possible. The user can 
input options related to the simulation and parameter estimation parameters.   
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2.4. Platform testing 
The software platform for simulating non-stationary 13C labeling experiments was tested 
using a metabolic network of S. cerevisiae (Fig. 2.4) developed based on genome 
annotation data retrieved from KEGG and SGD databases (Christie et al., 2004; Kanehisa 
et al., 2014). 
  
Figure 2.4. Central carbon metabolism of S. cerevisiae, using glucose as substrate.  Reversible reactions are 
indicated by double arrows. Extracellular metabolites are shown in boxes and the sampled isotopomer mass 
distributions are highlighted with gray. Biomass fluxes are not shown.  The oxaloacetate (OAA) pool is 
lumped with the malate (MAL) pool, as well as fumarate (FUM) with succinate (SUC). Pyruvate (PYR), 
oxaloacetate/malate and acetyl-coenzyme A (AcoA) are compartmented into the cytosol (cyt) and 
mitochondria (mit). Abbreviations: ACA – acetaldehyde; ACE – acetate; AKG – α-ketoglutarate; ALA – alanine; ARG – 
arginine; ASP – aspartate; CYS – cysteine; DHAP – dihydroxyacetone-phosphate; E4P – erythrose-4-phosphate; EtOH – ethanol; F6P – 
fructose-6-phosphate; G6P – glucose-6-phosphate; GAP – glyceraldehyde-3-phosphate; GLC – glucose; GLU – glutamate; GLY – 
glycine; GOX – glyoxylate; ICI/CIT – isocitrate/citrate; ILE – isoleucine;  LAC – lactate; LEU – leucine; LYS – lysine; MAL – malate; MET 
– methionine; OAA – oxaloacetate; ORN – ornithine; PEP – phosphoenolpyruvate ; PG – phosphoglycerate; PRO – proline; PYR – 
pyruvate; R5P – ribulose-5-phosphate; S7P – sedoheptulose-7-phosphate; SER – serine; THR – threonine; VAL – valine. 
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Extracellular fluxes and transient mass isotopomer data from an experiment feeding [U-
13C6]glucose and 50% [1-13C]glucose to a continuous culture of  S. cerevisiae were obtained 
from (Hans, 2003). Although several parameter estimations and metabolic network 
modifications were attempted, the best fit failed to satisfy the χ-squared test for model 
verification. Therefore, reliable parameter values could not be computed. However, the 
comprehensive data set was useful to test the functionality of the platform represented in 
Fig. 2.3. The model accurately described the labeling of intracellular alanine (Fig. 2.5), but 
it had difficulties to fit the amino acids whose labeling exhibited overshooting (Fig. 2.6), 
in particular the dynamics of the m+1 mass isotopomer of arginine and the steady state of 
the m+1 mass isotopomer of serine. 
 
Figure 2.5. Dynamic distribution of intracellular alanine mass isotopomers from a carbon labeling 
experiment using a mixture of 50% [U-13C6]glucose and 50% [1-13C]glucose. Labeled substrate was fed to a 
continuous culture of S. cerevisiae until the labeling eventually reached a steady state in the proteinogenic 
amino acids (●). Intracellular metabolites were sampled by rapid quenching and then their labeling pattern 
was analyzed by GC-MS. A dynamic model carbon distribution in the S. cerevisiae central carbon 
metabolism was used to simulate the theoretical mass distributions (continuous line) which fitted best the 
experimental data (  ). 
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A model including the vacuole for storage of arginine was not successful for fitting the 
experimental overshooting, although it was able to simulate the qualitative behavior. 
Concerning serine labeling, the isotopomer model is not able to simulate a double 
overshooting (Fig. 2.6 d). It is very likely that the amino acids are cycled between protein 
synthesis and degradation (Belle et al., 2006) and that this process is also 
compartmented, as shown for yeast vacuoles (Horst et al., 1999). 
The dataset was useful to calibrate the modeling platform and to test the performance of 
numerical algorithms for integration of differential equations and for optimization. In 
this respect, an integration algorithm for stiff systems of differential equations (Shampine 
and Reichelt, 1997) proved to be the fastest and the most stable from those tested. 
Random sets of fluxes that satisfy the numerical constraints imposed on the model by 
biochemistry (e.g. reaction direction) were generated using simulated annealing. The 
fastest converging optimization method was an internally reflective sequential quadratic 
programming optimization algorithm (Han, 1977). This algorithm accepts boundary and 
linear inequality constraints. A model simulation need approximatively 10 seconds on a 
2.3 GHz QuadCore CPU, and the optimization algorithm performed around 2000 model 
runs before converging to a local minimum. 
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Figure 2.6. Nonlinear behavior of amino acids labeling dynamics manifested by certain mass isotopomers 
of metabolites from S. cerevisiae central carbon metabolism when a mixture of 50% [U-13C6]glucose and 50% 
[1-13C]glucose was fed to a continuous culture. Glutamate m+1(a) and m+2 (b), arginine m+1 (c) and serine 
m+1 (d) behavior was modeled for the experimental conditions using estimated values for intracellular 
fluxes and concentrations.  
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Chapter 3 
3. Non-stationary 13C metabolic flux analysis of CHO cells 
in batch culture*1 
 
Abstract 
Mapping the intracellular fluxes for established mammalian cell lines is important for 
scientific and economic reasons. However, this is being hampered by the complexity of 
metabolic networks, particularly concerning compartmentation. 
Intracellular fluxes of the CHO-K1 cell line central carbon metabolism were successfully 
determined for a complex network using non-stationary 13C metabolic flux analysis. MIDs 
of extracellular metabolites were determined using [U-13C6] glucose. Compartmentation 
and transport reversibility proved essential to successfully reproduce the dynamics of the 
labeling patterns. Alanine and pyruvate reversibility changed dynamically even if their net 
production fluxes remained constant. Cytosolic phosphoenolpyruvate carboxykinase, 
mitochondrial malic enzyme and pyruvate carboxylase fluxes were successfully 
determined. Glycolytic pyruvate channeling to lactate was modeled. In the exponential 
growth phase, alanine, glycine and glutamate were excreted, and glutamine, aspartate, 
asparagine and serine were taken up. All these amino acids except asparagine were 
exchanged reversibly with the media. High fluxes were determined in the pentose 
phosphate pathway and the TCA cycle. The latter was fueled mainly by glucose but also 
by amino acid catabolism. 
The CHO-K1 central metabolism in controlled batch culture is robust. It has the purpose 
to ensure fast growth on a mixture of substrates and also to mitigate oxidative stress. It 
achieves this by using compartmentation to control NADPH and NADH availability and 
by simultaneous synthesis and catabolism of amino acids. 
 
*1This chapter was published as: Nicolae, A., Wahrheit, J., Bahnemann, J., Zeng, A. P., Heinzle, E., 2014. Non-
stationary 13C metabolic flux analysis of Chinese hamster ovary cells in batch culture using extracellular 
labeling highlights metabolic reversibility and compartmentation. BMC Syst Biol. 8, 50. 
All experimental work described herein was carried out by Judith Wahrheit and Janina Bahnemann.  
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3.1. Introduction 
Economic importance and ease of cultivation make CHO cells a desirable candidate for 
metabolic studies in eukaryotic systems. Alongside with being the most important 
mammalian cell line for producing biopharmaceuticals (Butler and Meneses-Acosta, 2012; 
Kim et al., 2012; Walsh, 2010), CHO cells are able to grow in suspension cultures using 
chemically defined media (Deshpande et al., 2009), use multiple carbon sources 
simultaneously and maintain a stable metabolism for long periods in batch cultivations. 
This has led to a wealth of studies aimed at exploring CHO metabolism. After the 
decoding of the CHO-K1 cell line genome (Brinkrolf et al., 2013; Xu et al., 2011) and 
transcriptome (Becker et al., 2011), it can be expected that such studies will increase both 
in number and complexity. Metabolic flux analysis (MFA) of CHO cell cultures evolved 
from flux balancing analysis (Altamirano et al., 2001b) to more complex metabolic or 
isotopomer dynamic models (Ahn and Antoniewicz, 2012). Newer studies rely on 13C-MFA 
applied by fitting the summed fractional labeling (Ahn and Antoniewicz, 2011) or by 
fitting steady-state labeling data (Templeton et al., 2013) resulted from using in parallel 
more labeled substrates for determining the intracellular fluxes at metabolic steady state 
in different growth phases. However, the labeling patterns of the intracellular metabolites 
or of amino acids from hydrolyzed proteins that are usually needed for non-stationary 
13C-MFA are obtained through a tedious methodology (Zamboni, 2011; Zamboni et al., 
2009) and are susceptible to errors stemming mostly from the quenching/extraction 
phase (Dietmair et al., 2010; Wahrheit and Heinzle, 2013). In the absence of metabolite 
exchange with the media, intracellular labeling would reach steady state relatively fast, in 
the order of minutes for glycolytic intermediates and few hours for TCA cycle 
metabolites, as it was determined in Pichia pastoris (Jorda et al., 2013). In mammalian 
cells, exchange with the extracellular pools (Murphy et al., 2013) delays the intracellular 
isotopic steady state usually beyond the possibility to maintain metabolic steady state. 
Due to the large extracellular pools of amino acids, their exchange will transfer the time 
constant of the extracellular labeling process, which is in the order of days, to the 
intracellular labeling. One option is to use isotopic non-stationary metabolic flux analysis 
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(Inst-13CMFA) applied at short time scales (Noh et al., 2007), but this approach has the 
drawback of requiring accurate determination of intracellular concentrations of 
metabolites (Noh and Wiechert, 2006). 
Metabolite and reaction compartmentation is important for a realistic representation of 
the mammalian cell metabolism, but determining it raises supplementary demands from 
the experimental and modeling procedures, as reviewed in (Wahrheit et al., 2011a). In the 
exponential growth phase, a typical culture of CHO is characterized by high uptake rates 
of glucose and glutamine, the Warburg effect and the exchange of non-essential amino 
acids with the extracellular media (Deshpande et al., 2009; Provost et al., 2006). We can 
expect that by feeding a 13C labeled substrate, some of the extracellular metabolites will 
exhibit labeling patterns that can then be detected using GC-MS. As these metabolites 
will be enriched in 13C dynamically, non-stationary 13C metabolic flux analysis (Inst-
13CMFA) applied to extracellular and intracellular isotopomers (Noack et al., 2010; Noh et 
al., 2006; Schmidt et al., 1997) provides a suitable framework to determine the 
intracellular fluxes. Extracellular pools have a large time scale for labeling (hours) 
compared to the intracellular pools (seconds/minutes), thus removing the need to sample 
intracellular pools provided that the labeling information in the extracellular metabolites 
is sufficient. 
It is shown in this chapter that by using only the labeling patterns of extracellular 
metabolites produced by feeding [U-13C6]glucose as the only labeled substrate, 
intracellular fluxes can be successfully determined in a complex, compartmented 
metabolic network of the CHO-K1 cell line. In parallel, the aim is to prove that a 
simplified, non-compartmented model is not sufficient for describing the metabolism. 
The importance of considering reversibility when dealing with non-stationary isotopomer 
models is also underlined. 
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3.2. Materials and Methods 
3.2.1. Cell culture and experimental set-up 
The CHO-K1 cell line was kindly provided by the Institute of Cell Culture Technology 
(University Bielefeld, AG Noll, Germany). The cells were growing in suspension under 
serum and protein free conditions in the chemically defined medium TC-42 (TeutoCell 
AG, Bielefeld, Germany) supplemented with 4 mM L-glutamine (PAA, Germany). 
Precultures were cultivated in 125 mL baffled Erlenmeyer flasks (Corning Inc., Germany) 
at an initial cell density of 0.4  106 cells/mL and a working volume of 50 mL on a 
shaking device (225 rpm) at 37°C and 5% CO2 in a humid atmosphere. For the main 
cultivation, cells were harvested during the exponential growth phase at a viability of ≥ 
98% and resuspended in TC-42 medium with 100% [U-13C6] glucose (99%, Euriso-Top, 
Saarbrücken, Germany). The main cultivation was performed in a Vario1000 bioreactor 
(Medorex e.K., Nörten-Hardenberg, Germany) at batch mode with a starting culture 
volume of 200 mL. The bioreactor was inoculated at a cell density of 0.4  106 cells/mL. 
The cultivation temperature was kept constant at 37 °C and the impeller (3-blade marine 
propeller) speed was set to 300 rpm. During the cultivation, the pH value was controlled 
at 7.2 by gassing with CO2 and by using 0.5 M sodium carbonate solution. Dissolved 
oxygen was maintained at 30% of the saturation concentration. Samples were taken three 
times a day. Cell density and viability were determined by cell counting using the Trypan 
blue exclusion method. Supernatants were transferred into fresh tubes and stored at -
20°C until further analysis. The average cell diameter was determined using an automated 
cell counter (Invitrogen, Darmstadt, Germany) in a separate experiment. This experiment 
was performed in a shaking incubator (2 inches orbit, 185 rpm, 37°C, 5% CO2 supply) 
using 250 mL baffled Erlenmeyer flasks (Corning Inc., Germany), an initial cell density of 
0.4  106 cells/mL, a working volume of 100 mL and using the same medium TC-42 
medium (TeutoCell, Bielefeld, Germany) supplemented with 4 mM glutamine. 
Differences of cell diameters during the cultivation were maximum 5% and not taken into 
account. Cell volume was computed assuming the cells are spherical using a diameter of 
10.6 µm. Glutamine degradation kinetics were determined experimentally in a cell-free 
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setup identical to the one employed for cell volume estimation. The determined 
glutamine degradation rate constant was kdGLN = 0.0033 h-1. 
3.2.2. Quantification of metabolites 
Quantification of glucose, organic acids and amino acids via HPLC was carried out as 
described previously by Strigun et al. (Strigun et al., 2011). 
3.2.3. Analysis of isotopomer labeling patterns 
3.2.3.1. Sample preparation 
For determination of labeling patterns of lactate and amino acids, 50 µl of supernatants 
were lyophilized, resolved in 50 μl N,N-dimethylformamide (0,1 % pyridine) and 
incubated at 80°C for 30 min. 50 µl N-methyl-N-t-butyldimethylsilyl-trifluoro-acetamide 
(MBDSTFA) was added followed by another incubation at 80°C for 30 min for 
derivatization of metabolites into corresponding dimethyl-t-butylsilyl derivatives. For 
determination of the labeling pattern of pyruvate, lyophilized supernatants were resolved 
in 50 µl pyridine containing 20 mg/ml methoxyamine hydrochloride and 50 µl MSTFA 
(Macherey-Nagel, Düren, Deutschland) and incubated at 80°C for 30 min for 
derivatization into the methoxyamine-trimethylsilyl derivative. Derivatized samples were 
centrifuged at 13000 x g for 5 min at 4 °C and supernatants transferred into fresh glass 
vials with micro inlets. 
3.2.3.2. GC-MS measurements 
Extracellular 13C-labeling dynamics were analyzed by gas chromatography mass 
spectrometry (GC-MS). The GC-MS measurements were carried out on a GC (HP 6890, 
Hewlett Packard, Paolo Alto, CA, USA) equipped with an HP5MS capillary column (5% 
phenyl-methyl-siloxane diphenylpolysiloxane, 30 m × 0.25 mm × 0.25 μm, Agilent 
Technologies, Waldbronn, Germany), electron impact ionization at 70 eV, and a 
quadrupole detector (Agilent Technologies). The injection volume was 1 µl (7683B 
Autosampler, Agilent, Waldbronn, Germany; PTV-Injektor, Gerstel, Mühlheim a. d. Ruhr, 
Germany). Helium was used as carrier gas at a flow rate of 1.1 ml/min for analysis of 
lactate and amino acids or 0.7 ml/min for pyruvate analysis. The following temperature 
gradient was applied for lactate and amino acid analysis: 135°C for 7 min, 10°C/min up to 
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162°C, 7°C/min up to 170°C, 10°C/min up to 325°C, 325°C for 2.5 min; inlet temperature: 
140°C and heating with 720°C/min up to 320°C; interface temperature 320°C; quadrupole 
temperature 150°C. The temperature gradient for pyruvate analysis was as follows: 70°C 
for 1 min, 1°C/min up to 75°C, 5°C/min up to 315°C, 25°C/min up to 340°C, 340°C for 5 min; 
inlet temperature: 70°C and heating with 360°C/min up to 360°C; interface temperature 
320°C; quadrupole temperature 280°C. 
3.2.3.3.Data analysis 
After identification of metabolites in the scan mode using the NIST data bank, 
quantification of labeling enrichment was done in SIM (single ion monitoring) mode in 
two technical replicates using the following unique fragments (m/z) containing the 
complete carbon skeleton of metabolites: pyruvate 174, lactate 261, alanine 260, glycine 
246, serine 390, aspartate 418, glutamate 432, glutamine 431. Mass isotopomer 
distributions were corrected for naturally occurring isotopes using the method of Yang et 
al.(Yang et al., 2009). 
3.2.4. Metabolic network models 
Two metabolic networks were established based on experimental observations related to 
metabolite uptake and production and extracellular labeling. Both networks included: 
glycolysis; TCA cycle; anaplerotic reactions; synthesis of fatty acids, proteins and 
carbohydrates for biomass production; amino acid production and degradation. 
Transport from the extracellular media was reversible in both models for all metabolites 
with the exception of glucose, asparagine and essential amino acids. Mitochondrial 
transport of malate, α-ketoglutarate, alanine, and reactions of transaminase, malate and 
lactate dehydrogenase were also reversible. The first model shown in Fig. 3.1 A considers 
the intracellular space without compartmentation. In the second model (Fig. 3.1 B), the 
mitochondrial reactions and pools are separated from the cytosol. Both models start from 
the annotation of the genomes of CHO-K1 and Mus musculus (Hammond et al., 2012; 
Kanehisa et al., 2014; Zhu et al., 2003). Enzyme localization was established using 
information from the MGI database and data from J. Wahrheit (Wahrheit et al., 2014b) 
who measured compartmented enzyme activity using a method adapted from Niklas et al. 
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(Niklas et al., 2011a). Mitochondrial transport of alanine was included to explain the 
existence of alanine aminotransferases in both compartments. Metabolite pools were 
lumped where it did not influence the simulated labeling dynamics. Pentose phosphate 
pathway was reduced to one reaction where one carbon atom is lost for each G6P 
molecule and 5/3 molecules of PG are produced. Glycolysis was lumped to three fluxes 
transforming G6P into PYRcyt. 
 
Figure 3.1. Compartmented (A) and non-compartmented (B) networks of the CHO-K1 central 
metabolism used for simulations. Irreversibility is indicated by simple arrows, and reversibility by 
double arrows. The reactions depicted in B are listed in detail in the Supplem. Table S3.1 together with 
fluxes and reversibilities determined. Subscripts meaning: ex – extracellular; c – cytosolic; m – 
mitochondrial. Abbreviations: AA –amino acids; AcoA – acetyl CoA; AKG – α-ketoglutarate; ALA – 
alanine; ASN – asparagine; ASP – aspartate; CIT/ICI – citrate/isocitrate; G6P – glucose 6-phosphate; 
GLC – glucose; GLN – glutamine; GLU – glutamate; GLY – glycine; MAL – malate; OAA – oxaloacetate; 
PEP – phosphoenolpyruvate ; PG – phosphoglycerate; PYR – pyruvate; SER – serine. 
Isocitrate and citrate were condensed into one pool. Succinate, fumarate and malate were 
condensed into one pool. Two cytosolic pyruvate pools were used to describe metabolic 
channeling to lactate. Non-essential amino acids catabolism was lumped to three fluxes 
fueling the malate, acetyl-CoA and glutamate pool respectively. No carbon mapping was 
required in this case as essential amino acids are unlabeled. Glutaminase activity was 
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mitochondrial (Xu et al., 2011) and glutamine synthetase was cytosolic (Hayward et al., 
1986). Fatty acids, protein and storage carbohydrates composition of the cell was taken 
from Altamirano et al. (Altamirano et al., 2001b). 
In total, the compartmented model consisted of 60 fluxes and 25 metabolites and the 
non-compartmented model of 42 fluxes and 16 metabolites. The complete flux list for the 
two models, together with the carbon transfer rules, is provided in the Supplem. Table 
S3.1. 
3.2.5. Non-stationary-13CMFA methodology 
Isotopic non-stationary metabolic flux analysis (Inst-13CMFA) comprises: (1) metabolic 
steady-state balancing of intracellular metabolites for determining extracellular rates; (2) 
dynamic extracellular metabolite and isotopomer balance and (3) dynamic balances of 
intra-compartmental isotopomers. 
3.2.5.1. Metabolite balancing 
Net extracellular rates vM_ex were determined for each extracellular metabolite M_ex for 
the batch cultivation situation, under the assumption of metabolic steady state, by fitting 
the cell density X(t) and extracellular concentrations of metabolites CM_ex to an 
exponential growth model with specific growth rate μ (eq. 3.1.a,b) and constant 
extracellular rates. Glutamine balance included first order degradation in the culture 
media (eq. 3.1.c). 
dX/dt  = μ∙X(t)       (3.1.a) 
dCM_ex/dt = vM_ex∙X(t)       (3.1.b) 
dCGLN/dt = vGLN∙X(t) – kdGLN∙CGLN(t)     (3.1.c) 
 
At intracellular metabolic steady state, the n metabolic fluxes that connect the m 
metabolites are constant and satisfy the material balance: 
𝑮 ∙ 𝒗 = 0                    (3.2.a) 
vj = φj,   j = 1..Rmeas     (3.2.b) 
αi ≤ vi ≤ βi, i = 1..n     (3.2.c)  
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where G is the m  n stoichiometric matrix and its null space v is the vector of net 
metabolic fluxes which are constrained by Rmeas measured fluxes φj (eq. 3.2.b) and n 
inequalities (eq. 3.2.c) determined by flux direction. To reduce the number of parameters, 
the free fluxes were extracted from the network as described (Yang et al., 2008) to 
produce a determined stoichiometric system. 
All biomass fluxes were computed considering the biomass composition listed in Suppl. 
Table S1.1 and Suppl. Table S1.2. 
3.2.5.2. Intracellular and extracellular carbon balance 
The Inst- 13CMFA framework developed in (Noh and Wiechert, 2006; Schmidt et al., 1997) 
was adapted to the case of batch culture cultivation. Isotopomer balances for extracellular 
(eq. 3.3) and intracellular (eq. 3.4) metabolites were solved together with the extracellular 
mass balances (eq. 1.a,b,c). 
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with IDVM_ex, IDVM_cyt, IDVM_in, are the isotopomer distribution vectors of the 
extracellular, cytosolic and mitochondrial fractions of metabolite M. IDVM_in,j is the jth 
reaction contribution to isotopomers of metabolite M, computed using isotopomer 
mapping matrices as described by Schmidt (Schmidt et al., 1997). Xconc is the cell 
volumetric concentration expressed in L cell / L media. CM_ex is the extracellular 
concentration of M, in exMv _ is the production flux of M expressed in mmol  (L cell)
-1  h-1, 
out
exMv _ is the uptake flux, vj is one of the RM fluxes entering the intracompartmental pool of 
M, CM_in, and 
out
inMv _  is the flux exiting the pool. The metabolite and isotopomer balances 
from equations 1,2 and 4 are then solved simultaneously to obtain the time course of the 
mass isotopomer distributions. Isotopomer balancing employs absolute fluxes that can be 
computed from the net fluxes by introducing a reversibility parameter: 
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j
reverse
j
j
v
v
rev
,
                                                          (3.5) 
where vj is the net flux and vj, forward and vj, reverse are the forward and respectively the 
reverse exchange fluxes, with vj, forward – vj,reverse = vj; vj, forward ≥0 and vj,reverse ≥0. 
The contribution of reaction j was computed using isotopomer mapping matrices 
(Schmidt et al., 1997) that trace carbon from the substrate to the reaction products. The 
initial mass distribution of all metabolites was computed considering the naturally 
occurring 13C fraction (1.1%) and the 99% atom purity of the employed 13C labeled 
substrate. 
3.2.5.3. Parameter estimation 
The simulated time course of extracellular mass isotopomer distributions (MID) was 
compared with the experimental values. The objective function to be minimized is 
expressed as the weighted sum of square differences between the experimentally 
determined and simulated MIDs: 
   exp1exp MIDMIDMIDMIDSSQD simMID
Tsim                        (3.6) 
where SSQD is the objective function, MIDsim is the simulated MID, MIDexp is the 
measured MID and ΣMID is the measurement covariance matrix. The optimal solution was 
accepted when it satisfied the χ-squared test for model verification with 95% probability, 
and N-p degrees of freedom, where N is the number of sampled points (size of MIDexp) 
and p is the number of free parameters. To reduce the bias in the objective function 
generated by very small standard deviations, a minimum threshold of 0.005 was imposed. 
Accurate confidence intervals and sensitivity analysis of fluxes were computed according 
to (Antoniewicz et al., 2006). All the code was programmed and simulated in Matlab 
[MATLAB and Simulink Release 2013a, The MathWorks, Inc., Natick, Massachusetts, 
United States]. 
3.3.  Results and discussion 
3.3.1. Cell growth and extracellular fluxes 
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The cells exhibited exponential growth for 72 h (Fig. 3. 2) until glutamine became 
exhausted and a shift in metabolism was observed (data not shown). Estimated specific 
growth rate as fitted to eq. 3.1.a was µ = 0.0401 h-1. Uptake and production of most 
metabolites was balanced, i.e. they were proportional to growth for the main carbon 
sources and produced metabolites (Fig. 3.2) and for other amino acids (Supplem. Fig. S 
3.1).This means that metabolic steady state was maintained during the first 72 h of 
cultivation. Glucose constituted the main carbon source (Table 3.1), providing 65% of the 
total carbon entering the central carbon metabolism, with an uptake flux of 371 mmol  
(L cell)-1  h-1. Note that all fluxes are related to the cell volume specified by L cell. 39% of 
the glucose was converted to lactate. The observed pyruvate production rate was 3.3 
mmol  (L cell)-1  h-1. 
Table 3.1. Carbon sources for the central metabolism of the CHO-K1 cell line in batch culture 
during the exponential growth phase. The contribution of AA1, AA2 and AA3 amino acid groups 
considers only catabolism. Abbreviations: AA1: amino acids catabolized to AcoA (isoleucine, leucine, lysine, 
phenylalanine, tyrosine); AA2: amino acids catabolized to four-carbon dicarboxylic acids (isoleucine, 
methionine, phenylalanine, threonine, tyrosine, valine); AA3: amino acids catabolized to glutamate 
(arginine, histidine, proline); AcoA: acetyl coenzyme A; AKG: α-ketoglutarate; ASN: asparagine; ASP: 
aspartate; OAA: oxaloacetate.  
* Excluding requirements for protein synthesis 
Metabolite 
Target 
intracellular 
metabolite 
Uptake flux 
[mmol  (L cell)-1 
 h-1] 
Uptake flux 
[Cmmol  (L cell)-1 
 h-1] 
Percentage of 
the total 
carbon-flux 
Glucose Pyruvate 371.0 2226.2 64.9 
Glutamine AKG 66.4 331.9 9.7 
AA1* AcoA 92.6 185.2 5.4 
AA2* Malate 49.6 198.4 5.8 
AA3* AKG 11.6 58.2 1.7 
ASP/ASN OAA 68.1 272.3 7.9 
Serine 
Pyruvate, 
glycine 
48.3 146.4 4.3 
TOTAL - - 3428.53 100 
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The glutamine uptake flux determined by fitting eq. (3.1.c) to the glutamine 
concentration over time was 66.4 mmol  (L cell)-1  h-1, 16% smaller compared to the 
case when degradation was ignored. Glutamine uptake contributed with 10% to the total 
carbon pool. 
 
Figure 3.2. Culture profile of the CHO-K1 cells for the first 72 h during the exponential growth 
phase. Experimental values are shown with circles and calculated values are represented by solid lines. 
The rest of the carbon feeding the central carbon metabolism, i.e. 25%, was obtained from 
amino acids catabolism. 
Alanine, glycine and glutamate were produced (Fig. 3.3), while the other amino acids 
were taken up in excess of the quantity required for biomass synthesis. As a consequence 
of amino acids catabolism, a flux of 92.6 mmol  (L cell)-1  h-1 fueled the mitochondrial 
acetyl-CoA pool from the degradation of isoleucine, leucine, lysine, phenylalanine and 
tyrosine, while a flux of 39.1 mmol  (L cell)-1  h-1 cytosolic AcoA was directed towards 
fatty acids synthesis. The catabolism of excess isoleucine, methionine, phenylalanine, 
threonine, tyrosine and valine that remained after protein synthesis produced 49.6 mmol 
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 (L cell)-1  h-1 succinate and fumarate (lumped into one pool of four carbon di-
carboxylic acids, here represented as MAL in Fig. 3.1). 
Metabolite dilution by growth was neglected due to negligible influence on the total mass 
balance. 
3.3.2. Non-stationary labeling experiment 
The MID of extracellular pyruvate, lactate, alanine, glutamate, glutamine, aspartate, 
serine and glycine was sampled at 1, 18, 24, 42, 48, 66 and 72 h. During the exponential 
growth phase of 72 h none of the labeling reached steady state as shown in Fig. 3.4. 
Lactate and pyruvate exhibited similar labeling dynamics, however with different MIDs 
towards the end of the growth. This is surprising since lactate is obtained from pyruvate 
through the lactate dehydrogenase reaction. The predominant lactate fraction, i.e. M+3, 
increased to 0.85 and the pyruvate M+3 fraction stabilized at 0.81, pointing towards 
glycolytic channeling to lactate achieved by the localized cooperation of glycolytic 
enzymes as observed in rapidly proliferating cells (Mazurek et al., 2001; Vander Heiden et 
al., 2010). From the produced amino acids, alanine, also derived from pyruvate, had a high 
M+3 fraction. Glutamate and glycine M+2 fractions increased slowly, with most of the 
change happening in the last 24 h due to the high number of producing cells present in 
the media., Extracellular aspartate, glutamine and serine were found to be labeled 
although they exhibited a net uptake. Glutamine fractional labeling, mostly the M+2 
isotopomer, increased sharply at the end of the phase, when very little glutamine 
remained in the media and the contribution of secreted glutamine played a large role to 
the labeling state. 
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Figure 3.3 Compartmentation of the CHO-K1 metabolism and the fate of extracellular 
metabolites.Net fluxes are indicated on the gray arrows in units of mmol product/ (L cell  h), and 
reversibility parameter defined as reverse flux/net flux is shown in the square brackets (n.d. = not 
determined. The thickness of the gray arrows is proportional to the forward flux (=reverse flux + net flux), 
and shown qualitatively for the fluxes with variable reversibility. Net flux direction is shown by the black 
arrow heads. Amino acids catabolism is represented as the sum of the differences between amino acid 
uptake flux and flux required for protein production, reported to the metabolite derived from catabolism. 
Subscripts meaning: ex – extracellular; c – cytosolic; m – mitochondrial. Abbreviations: AAex1 – isoleucine, 
leucine, lysine, phenylalanine, tyrosine catabolized to acetyl-CoA; AAex2 -  isoleucine, methionine, 
phenylalanine, threonine, tyrosine, valine catabolized to fumarate and succinate; AAex3 – arginine, histidine, 
proline catabolized to glutamate; AcoA – acetyl CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; 
CIT/ICI – citrate/isocitrate; GLN – glutamine; GLU – glutamate; GLY – glycine; MAL – malate; PYR – 
pyruvate; SER – serine.  
  
49 
 
3. Non-stationary 13CMFA of CHO cells in batch culture  
3.3.3. Isotopomer fitting 
Both the non-compartmented and compartmented isotopomer network models (Fig. 3.1) 
were fitted to the experimental mass distributions with the goal of determining unknown 
fluxes and reversibilities. The 7 sampling time points of the 8 metabolites produced a 
total number of 252 experimental MIDs.  
Convergence to the optimal solution is difficult in isotopomer models (Srour et al., 2011) 
and the parameter space of the objective function is marked by a multitude of local 
minima (Chen et al., 2007), making gradient-based algorithms unreliable. Consequently, 
a global optimization scheme was applied that had the following steps: (1) generate an 
initial random population of (40 x p) parameter sets that satisfy constraints using a 
simulated annealing-based algorithm, (2) submit the population to a 50-generations 
genetic algorithm optimization, and (3) refine the best solution using a trust region 
reflective algorithm. Convergence to the optimal solution was verified by repeating the 
optimization scheme. One simulation took about 3 s, and the optimization procedure 
required about 40 h on a 2.3 GHz QuadCore CPU. All the numerical integration and 
optimization algorithms are found in Matlab toolboxes.  
There were initial difficulties in fitting pyruvate and alanine labeling dynamics. As it was 
shown that reversibility greatly affects labeling dynamics (Noh and Wiechert, 2011), it was 
assumed that the transport reversibility parameter changes in time, even if the net fluxes 
remain constant. The decrease with time of pyruvate transport reversibility was 
mechanistically expressed using a hyperbolic function


time
rev
rev PYRPYR
0
, where pyruvate 
transport reversibility revPYR decreases from a starting value
0
PYRrev . To avoid division by 
zero, a negligible correction factor ε was introduced. Alanine transport into the cell 
intensifies as extracellular alanine becomes exponentially more abundant. Transport 
reversibility was expressed in this case as )exp( timerev ALA   , where α and β are 
parameters to be determined. 
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Figure 3.4 Non-stationary 13C labeling experiment. Experimental mass isotopomer distributions 
(symbols) with their standard deviations vs. simulated (line) mass isotopomer distributions of labeled 
extracellular metabolites. The plots A-C represent results from using the non-compartmented 
metabolic network specified in Figure 3.1 A. For the other eight plots (D-K), the compartmented model 
from Figure 3.1 B was simulated. 
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The 24 free parameters of the non-compartmented model (Fig. 3.1 A) consisted of 5 fluxes, 
18 reversibilities and the CO2 pool. At convergence, the model failed to fit the data with 
the minimized SSQD of 1572, larger than χ2 (0.95, 252-24) = 264.2. Pyruvate, lactate, 
alanine and glutamate labeling were fit poorly even when transport reversibility was 
variable (Fig. 3.4). In consequence, the non-compartmented model was rejected. The low 
labeling content of pyruvate, alanine and lactate simulated with the non-compartmented 
model is explained by the lumping of the cytosolic and mitochondrial pyruvate pools. 
More than 30% of the carbon feeding the TCA cycle is not labeled, therefore it would be 
expected that the cataplerotic reactions catalyzed by phosphoenolpyruvate carboxykinase 
and malic enzyme will produce a large quantity of unlabeled pyruvate, which contradicts 
the experimental observations. 
The compartmented model, consisting of 11 free fluxes and other 27 free parameters 
(reversibilities) depicted in Fig. 3.1 B, fitted the data successfully with the minimized 
SSQD = 249.0 slightly smaller than χ2(0.95, 252-38) = 249.13. The poorer fit of the 66 and 
72 h time points for lactate and 72 h for alanine can be explained by the metabolic shift 
towards the end of the growth phase. Exponential growth will add a larger contribution in 
the objective function to the labeling towards the end of the exponential phase compared 
to the beginning of the experiment because the rates of 13C accumulation in the 
extracellular media are much larger at high cell densities. This is best evidenced in Fig. 3.4 
where glutamine, aspartate, serine and glycine do not become noticeably labeled until 40 
h after the introduction of the labeled substrate. 
3.3.4. Metabolic fluxes in the CHO-K1 cell line 
Glucose was converted to phosphoglycerate mostly by bypassing glycolysis (Fig. 3.5) 
through the pentose phosphate pathway (PPP). The estimated PPP flux was 80% of the 
total molar glucose input flux, a high activity contrasting with results obtained by Ahn 
and Antoniewicz for adherently growing CHO cells (Ahn and Antoniewicz, 2011) but 
observed for hybridoma (Bonarius et al., 1996) and cancer cells (Bensaad et al., 2006). A 
wide range of PPP activities, between 0-160 % of the glucose input flux, was determined 
for a highly-productive CHO line in fed-batch cultivation conditions at different growth 
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phases (Templeton et al., 2013). The large quantities of cytosolic NADPH produced 
through PPP drive fatty acids synthesis and mitigate oxidative stress by reducing reactive 
oxygen species (Anastasiou et al., 2011; Schafer et al., 2009; Sengupta et al., 2010; Tuttle et 
al., 2000; Vizan et al., 2009), as it has also been proposed by Templeton et al. (2013). 
Overflow to lactate comprised 39% of the pyruvate produced from glycolysis. From the 
rest of the cytosolic pyruvate, 42.7 mmol  (L cell)-1  h-1 were converted to alanine, but 
most of it was transported into the mitochondria and converted to AcoA. The channeling 
flux from phosphoenolpyruvate to lactate was 122.7 mmol  (L cell)-1  h-1, accounting 
for 42% of the total lactate being produced. The low reversibility of exchange between the 
two cytosolic pyruvate pools (Fig. 3.5) means that the channeled cytosolic pyruvate is 
practically separated from the cytosolic bulk pool. However, lactate was produced from 
both cytosolic pyruvate pools, indicating that glycolytic channeling is not the only lactate 
source in the cell. One possible explanation is that multi-enzyme complexes associated to 
membrane transporters, as characterized by Campanella et al. (2005), create a micro-
compartmented environment in the cytosol. Glycolytic enzymes are partly associated and 
partly soluble, resulting in a mixed response in the lactate labeling. 
The carbon flux in the TCA cycle originated mainly from acetyl-CoA derived from 
glycolytic pyruvate transported into the mitochondria (Fig. 3.5), with significant 
contributions from glutamine and essential amino acids catabolism. Such high activity of 
the TCA cycle and high connectivity with the glycolysis is in contrast with some previous 
reports of lower activity during exponential growth phase (Ahn and Antoniewicz, 2011; 
Quek et al., 2009a; Zamorano et al., 2010) but similar to (Goudar et al., 2010; Sengupta et 
al., 2010; Sheikholeslami et al., 2013). The differences can be assigned mainly to the use of 
different cell lines and cultivation conditions like media composition, aeration mode, pH 
control and culture type e.g. suspension or immobilized, batch or fed-batch. The lower 
lactate/glucose molar ratio of 0.78 reported herein means more pyruvate is available for 
use in the TCA cycle, thus making for a more efficient metabolism. Gluconeogenesis was 
active through phosphoenolpyruvate carboxykinase with 10% of the total flux entering the 
phosphoenolpyruvate pool, a fact explained qualitatively by the presence of M+2 lactate 
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and pyruvate. In the absence of gluconeogenesis, only the M and M+3 mass isotopomers 
of these metabolites would be present after feeding fully labeled glucose. Malic enzyme 
activity was negligible in the cytosol, and this is in agreement with compartmented 
enzyme activity observed by Wahrheit et al. (2014b). This observation reaffirms that PPP 
was the main source of cytosolic NADPH. Mitochondrial malic enzyme was highly active, 
producing one third of the total mitochondrial pyruvate. However, a part of the 
mitochondrial pyruvate was recycled back into the TCA cycle via pyruvate carboxylase. 
Mitochondrial malate net transport flux was small and reversible. This explained the lack 
of M+1 labeling in lactate, alanine and pyruvate that would have been otherwise linked to 
the M+2 malate isotopomers that are expected to be obtained in the TCA cycle. As a 
consequence, the M+2 labeling in these metabolites relies on mitochondrial transport of 
citrate and on the activity of citrate lyase producing cytosolic acetyl-CoA and 
oxaloacetate, which is then further converted to phosphoenolpyruvate. 
About one third of the total serine was produced from phosphoglycerate, using cytosolic 
glutamate for transamination. Serine was exchanged with the media, thus explaining 
extracellular labeling of serine. Half of the serine was not used for protein synthesis but 
was reversibly converted to glycine and C1 units to sustain the high anabolic activity. 
Glycine was then secreted. The remaining excess of serine was converted to pyruvate. 
Alanine was synthesized mainly from cytosolic pyruvate in a highly reversible reaction. 
Connectivity between cytosolic and mitochondrial alanine pools and the direction of the 
mitochondrial alanine aminotransferase flux could not be determined. However, the 
transport flux of alanine to/from mitochondria was confined between -11.6 to 13.6 mmol 
 L cell-1  h-1, i.e. ±25% of the alanine production flux. The flux of 68.1 mmol  L cell-1 
 h-1 from asparagine and aspartate uptake to oxaloacetate was split through aspartate 
aminotransferases between cytosolic and mitochondrial oxaloacetate with a 3/1 ratio, but 
no other details could be inferred due to the low labeling level in extracellular aspartate.  
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Figure 3.5. Estimated net intracellular fluxes in the CHO-K1 central metabolism qualitatively 
shown by the arrow thickness and their 95% confidence intervals (number interval) together with 
reversibility confidence intervals (square brackets), expressed in mmol  (L cell)-1  h-1. n.d. – not 
determined. 
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Isocitrate dehydrogenase (IDH) activity in the cytosol could not be reliably determined. 
This is due to lack of information in directly connected metabolites citrate and α-
ketoglutarate, but also because it affects the labeling pattern in the same way as the 
mitochondrial isozyme. As a result, the fluxes in the mitochondrial/cytosolic citrate and 
α-ketoglutarate loop could not be determined. Nevertheless, a net activity towards 
producing the high glutamate flux needed for cytosolic transamination reactions implies 
that α-ketoglutarate is either produced in the cytosol by IDH or transported from the 
mitochondria into the cytosol. Mitochondrial glutamate pool was fed by transporting 
cytosolic glutamate into the mitochondria and by glutamine through glutaminase activity 
at comparable rates. In the mitochondria, glutamate was then converted to α-
ketoglutarate and fed into the TCA cycle through mitochondrial GDH. In the cytosol, the 
glutamate produced from α-ketoglutarate in the various transaminase reactions was 
partially converted to glutamine, which was then exchanged with the media, leading to 
the presence of labeled glutamine in the media. In conclusion, simultaneous degradation 
and synthesis pathways for glutamine involve glutamine uptake, transport into the 
mitochondria and conversion to glutamate, glutamate dehydrogenation to α-
ketoglutarate, α-ketoglutarate transport to the cytosol or citrate transport and citrate 
conversion to α-ketoglutarate through cytosolic IDH activity, conversion of α-
ketoglutarate to cytosolic glutamate, and cytosolic glutamine synthesis. 
3.3.5. Transport reversibility 
A very important part in modeling the extracellular labeling was considering the 
reversible exchange between the intracellular pools and the extracellular media, a 
phenomenon which affects the dynamics of the labeling process. All sampled extracellular 
non-essential amino acids except asparagine and proline, either produced or taken up, 
were exchanged with the culture media (Fig. 3.3). Even if the production flux of alanine 
remained constant throughout the cultivation, the fitting remained poor for alanine when 
considering a constant reversibility factor. There, the reversibility was estimated to 
increase with time. The function )0.0359exp(0.154 timerev ALA   was used to compute the 
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forward and reverse exchange fluxes (eq. 3.5), with both parameters being determined 
with a narrow confidence interval (Supplem. Table S3.1). Time is computed in hours. This 
successfully explained the dynamics of alanine labeling. The time constant of the 
reversibility function is a value close to the specific growth rate, pointing to the fact that 
alanine re-uptake is correlated to the extracellular concentration. Serine secretion flux, as 
computed with eq. 5, was up to 35 times higher than the net uptake flux. Glycine re-
uptake flux was 4.6 times the net production flux. Aspartate, glutamate and glutamine 
exchange fluxes were in the same order with the net uptake/production flux, as expressed 
by the estimated reversibility parameter values of about 1. The confidence intervals for the 
transport reversibility parameters are larger than those for fluxes because at high 
reversibilities the labeling becomes less sensitive to small changes in reversibility. 
Pyruvate transport reversibility is described by the function 
01.0
2700


time
revPYR , where time 
is specified in hours. The hyperbolic function implies that at the beginning of the 
cultivation, the intense exchange of pyruvate (Garcia et al., 1994) eliminates the 
difference between the labeling of the intracellular and extracellular pools. Pyruvate re-
uptake decreases because pyruvate concentration changes slightly (Fig. 3.1) while lactate 
accumulates in the media to reach high concentrations and competes with pyruvate for 
the monocarboxylate transporters (Halestrap and Price, 1999; Morris and Felmlee, 2008). 
Lactate transport reversibility parameter could not be estimated because at the beginning 
of the cultivation there is no lactate present in the media that could dilute the 
intracellular pool and affect the labeling dynamics. 
3.3.6. Confidence intervals calculation and sensitivity analysis 
Most of the fluxes depicted in Fig. 3.5 were determined with narrow confidence intervals. 
Interval boundaries are not symmetrical due to the non-linear characteristics of the 
mathematical model. Determining both the flux and exchange in alternative pathways 
was not possible in the case of high reversibility e.g. for determining the 
compartmentation of alanine metabolism involving reversible transaminase reactions. 
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The sensitivity coefficients provided quantitative information about the impact of the 
measured fluxes on the estimated flux values (Fig. 3.6 A). Sensitivity analysis also 
evidenced correlations between external fluxes and network pathways when [U-13C6] 
glucose is used. In this case, the MIDs of metabolites will depend on the interplay 
between the multitude of non-labeled carbon sources and the glucose feed, as opposed to 
organisms that use only one carbon source (Sellick et al., 2011a). The determination of 
anaplerotic fluxes relied on the supply of four carbon metabolites from amino acid 
catabolism. 
Changes in the glutamine uptake flux (Fig. 3.6 A) affected most fluxes to a large extent. 
Nevertheless, the high influence was mainly computational, as any increase of the flux 
caused depletion of glutamine at the end of the cultivation and dramatically different 
labeling patterns. Glucose uptake flux affected the estimation of the PPP and TCA cycle 
fluxes. Errors in measuring glucose concentration over time will propagate in the values 
of these fluxes, as the glucose uptake flux determines the fraction of 13C entering the cell. 
Glucose-6-phopshate loses one 13C through oxPPP, therefore estimating the split between 
glycolysis and oxPPP depends highly on determining correctly all carbon sources. This 
explains the high sensitivity of the glycolysis/oxPPP split to all extracellular fluxes. 
Unexpected correlations were observed for the glycine production flux that influenced 
most anaplerotic and aminotransferase fluxes. Glycine is produced at the expense of 
serine, which is in turn produced from 3-phosphoglycerate, also converting glutamate to 
α-ketoglutarate during transamination, and simultaneously converted to pyruvate, thus 
affecting the availability of both cytosolic pyruvate and glutamate. 
Local sensitivity of the SSQD to free parameters computed as the normalized mean 
deviation of the objective function to variations in the estimated parameters shown in 
Fig. 3.6 B evidenced the determinable parameters and the redundant parameters. The 
notoriously difficult to determine anaplerotic fluxes of the phosphoenolpyruvate 
carboxykinase enzyme and mitochondrial malic enzyme induced a noticeable sensitivity 
in the objective function.   
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Figure 3.6.  Sensitivity analysis to measured fluxes and to parameters. (A) Sensitivity of free fluxes to 
extracellular fluxes, computed for the compartmented network of CHO-K1 with [U-13C6] glucose as 
substrate, 
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*
, where SSQ* is the optimized value of the objective function (eq. 3.6), and pi* is 
the estimated value of parameter i. The rates vi correspond to the rates in the network from Supplem. Table 
S3.1. Abbreviations: subscripts: c: cytosolic, ex: extracellular, m: mitochondrial; ALA: alanine; AcoA: acetyl 
coenzyme A; AKG: α-ketoglutarate; ASN: asparagine; ASP: aspartate; CIT: citrate; G6P: glucose 6-
phosphate; GLC: glucose; GLN: glutamine; GLU: glutamate; GLY: glycine; LAC: lactate; MAL: malate; OAA: 
oxaloacetate; PEP: phosphoenolpyruvate; PG: phosphoglycerate; PYR: pyruvate; SER: serine. 
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The increased network connectivity, obtained by coupling alanine or aspartate 
deamination to conversion of α-ketoglutarate to glutamate, contributed to this fact. 
Oppositely, most intracellular reversibilities did not influence the parameter estimation 
results. This can be easily inferred from the fact that while reaction reversibility affects 
the dynamics of intracellular isotopomers, it does not mirror in the extracellular labeling 
apart from the reactions altering the carbon backbone. Also, in the situation where high 
values of the reversibilities resulted from estimation, local perturbations around these 
values will not influence the MIDs.  
3.4. Conclusions 
In the present chapter it was shown that intracellular fluxes of the CHO-K1 cell line 
central carbon metabolism in batch culture can be determined for a complex network by 
making use solely of the mass isotopomers of extracellular metabolites resulted from 
feeding [U-13C6] glucose as the only labeled substrate. To this end, non-stationary 13C 
metabolic flux analysis proved an effective tool for unraveling important details of the 
CHO-K1 metabolism. Pathway compartmentation, e.g. of anaplerotic reactions and amino 
acid metabolism had to be considered for describing the mass isotopomer distribution. It 
can be reckoned that this fact plays an essential role in controlling the availability of 
NADH and NADPH in mitochondria and cytosol, but also in facilitating amino acid 
catabolism. A cancer-like high activity of the pentose phosphate pathway produced 
reducing NADPH partly to counteract the oxidative stress generated by the mitochondrial 
respiration and partly to fuel fatty acids biosynthesis. Cultivation conditions and different 
cells lines generate a wide range of metabolic fluxes, when considering previous studies 
concerned with the metabolism of CHO cells. Cytosolic pyruvate transport is reversible 
thousand-fold compared to the net production flux, indicating that although it is not a 
carbon source, pyruvate creates an extracellular environment (O'Donnell-Tormey et al., 
1987) most probably by functioning as a balancing system for cytosolic NADH (Bucher et 
al., 1972). Considering that metabolite exchange with the media played a very important 
role in determining the intracellular fluxes, it is expected that future 13CMFA studies of 
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mammalian cells metabolism will include this essential aspect. Compartmentation 
controls the simultaneous degradation and production of non-essential amino acids. 
Most likely, the CHO-K1 cells maintain the exponential growth phase under batch 
conditions by using a well-connected multi-pool system involving metabolite and 
reaction compartmentation, exchange with the media and inter-compartment exchange 
for controlling the metabolite and cofactor pools. Further studies on localizing enzyme 
and transporter activity together with sampling intra-compartmental concentrations 
would bring valuable contributions at elucidating the function of such cycling pathways. 
Accurate enzyme kinetics and thermodynamics (Henry et al., 2007) in mammalian cells 
would complement the modeling using Inst-13CMFA with information about reaction 
direction and reversibility. The knowledge gained through Inst-13CMFA depicts the CHO-
K1 central metabolism as a robust, highly interconnected network that ensures fast 
growth and mitigates stress generated by reactive oxygen species and the accumulation of 
lactate in the culture media.  
Due to the economic importance of CHO cells, efficient production processes leading to 
high product quality with minimum effort are of utmost importance. In-depth knowledge 
about CHO metabolism is expected to provide valuable assistance in identifying targets 
for metabolic engineering and guiding the design of feeding strategies leading to the 
development of efficient production processes. Overexpression, silencing or knockout of 
the specific glycolytic enzymes that associate with channeling glucose to lactate could 
either be used to study the control of the Warburg effect in cancer cells or for improving 
glucose utilization. However, as it was shown that compartmentation is important in 
managing metabolites, mitochondrial transporters are likely to constitute important 
targets for genetic modifications. Inter-compartmental transport of metabolites is a key 
factor in connecting the cytosol and the mitochondria energetically and it can be 
reckoned that modifying the genetic expression of transporters will have significant, 
perhaps surprising effects on the overall metabolism.  
The proposed methodology of sampling the MID only in extracellular metabolites for 
determining intracellular fluxes using Inst-13CMFA has the potential of broader 
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applications, as it circumvents the need to extract intracellular metabolites and it is non-
invasive to cells. The information contained in the extracellular mass isotopomers has a 
higher resolution compared to the summed fractional labeling used previously. This is 
sufficient for resolving a complex metabolic network when more metabolites are 
produced and/or exchanged with the culture media. Therefore, future applications in the 
study of mammalian metabolism at physiological and pathological conditions, especially 
related to compartmentation, as reviewed in (Gutierrez-Aguilar and Baines, 2013), and 
oxidative stress, e.g. in cancer, neurodegenerative disorders and ageing are to be 
expected. Knowledge about the metabolism at the compartment level will be essential for 
identifying therapeutic targets and understanding disease mechanisms. Similarly, the 
method could be applied to other enzymatic systems or prokaryotic cells where extended 
metabolite exchange with the media occurs. 
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Supplementary data 3 
Supplem. Fig. S3.1. Complete culture profile of CHO-K1 cells during the 
exponential growth phase. The lines represent the fitted concentration profiles to the 
experimental values (dots) and in the boxes are the determined extracellular rates 
[mmol/(L cell  h )] together with the 95% confidence intervals. Glutamine uptake was 
determined by considering a spontaneous degradation rate of 0.0033 h-1. The exponential 
growth phase is shown in the last plot. 
Supplem. Table S3. 1. List of reactions in the non-compartmented central carbon 
metabolism of CHO-K1 (Table 1). List of metabolic reactions, fluxes and 
reversibilities in the compartmented central carbon metabolism of CHO-K1 cells 
(Table 2). Carbon transfer rules are provided in the parentheses after each reaction. 
Reversible reactions are designated by double arrows. Reversibility is computed as the 
ratio between the reverse flux and the net flux. 
Supplem. Table S3.2. Experimental and simulated mass isotopomer distributions 
of extracellular metabolites and used standard deviations 
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Chapter 4 
4. High resolution 13C metabolic flux analysis in CHO cells*2 
Abstract 
The metabolism of mammalian cells is characterized by compartmentation, metabolite 
exchange and channeling. Mass isotopomer distributions were determined from two 
parallel labeling experiments using [U-13C6]glucose and [U-13C5]glutamine as substrates in 
a CHO-K1 suspension culture. Using extra- and intracellular labeling dynamics non-
stationary 13C metabolic flux analysis (INST-13CMFA) was applied to resolve the metabolic 
fluxes in a complex metabolic network that included mitochondrial transport, metabolite 
compartmentation and channeling. Fluxes, reversibilities and intracompartmental 
concentrations were determined within narrow confidence intervals. The metabolism was 
characterized by pentose phosphate pathway activity of 90% and lactate production of 
75% of the glucose uptake, low TCA cycle, low cataplerotic fluxes, and simultaneous 
catabolism and production of non-essential amino acids. Mitochondrial glutamate was 
converted to α-ketoglutarate by aminotransferases while glutamate dehydrogenase flux 
was negligible. Malate and glutamate were cycled via several transporters between cytosol 
and mitochondria. Cytosolic NADH was partially transported into the mitochondria 
using the malate-aspartate shuttle and partially regenerated by cytosolic lactate 
dehydrogenase. The labeling dynamics of lactate and pyruvate indicate various 
metabolite channeling effects in the cytosol and the mitochondria as well as the existence 
of a mitochondrial lactate pool that serves most likely as intramitochondrial redox buffer. 
INST-13CMFA combined with targeted parallel labeling experiments allowed to unravel 
great details of mammalian metabolism. Using this strategy, a comprehensive description 
of metabolic compartmentation including detailed insights in the C3 and C5 metabolism 
of CHO suspension cells was possible for the first time. 
*2A part of this chapter was submitted as an article to Metabolic Engineering Journal (February 2015). All 
experimental work described herein was carried out by Judith Wahrheit. 
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4.1. Introduction 
In the context of a fast-developing biopharmaceutical industry (Birch and Racher, 2006; 
Walsh, 2010) and a continuous need to understand disease mechanisms at the molecular 
level, in-depth knowledge of mammalian cell metabolism is crucial. This requires a 
systems biology approach that integrates “omics” information to determine the metabolic 
network structure and function by using adequate computational tools. The major 
current challenge in metabolic flux analysis (MFA) of mammalian cells is to untangle the 
details related to compartmentation (Wahrheit et al., 2011a). Dysfunctions in metabolite 
management between compartments in mammalian cells can lead to a multitude of 
diseases (Balaban, 2010; Calvo et al., 2006; Duchen, 2004; Nassir and Ibdah, 2014; 
Palmieri, 2008). In addition, metabolite channeling (Jandt et al., 2013; Malaisse et al., 
2004; Zhang, 2011), association of enzymes (Campanella et al., 2005), and 
microcompartmentation (Holthuis and Ungermann, 2013) are forms in which the 
eukaryotic metabolism is controlled by the cellular microstructure, but are only little 
understood. 
Metabolic flux analysis of mammalian cells can rely just on flux balancing (Altamirano et 
al., 2001b; Bonarius et al., 1996; Sidorenko et al., 2008) or use also 13C-labeling information 
to resolve more complex metabolic networks (Amaral et al., 2011; Bonarius et al., 2001; 
Goudar et al., 2010; Niklas et al., 2011b). Non-stationary 13C metabolic flux analysis (INST-
13CMFA) allows a detailed characterization of metabolic network function (Noh et al., 
2006; Noh and Wiechert, 2006). By using the dynamics of mass isotopomer distributions 
(MIDs) it is possible to obtain detailed information about metabolic fluxes, reversibility 
and intracompartmental concentrations (Noh et al., 2007; Noh and Wiechert, 2011; 
Schmidt et al., 1997). However, the experimental and computational costs of this method 
are substantially higher when compared to other MFA methods (Fig. 4.1). INST-13CMFA 
also allows the estimation of intracompartmental concentrations by using only the 
labeling dynamics of selected metabolites (Wiechert and Noh, 2005). As a tool for 
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detailed metabolic flux analysis, INST-13CMFA proved to achieve the best resolution in 
resolving fluxes for cultured B-cells (Murphy et al., 2013). In eukaryotic cells, it was 
applied to study the metabolism of Pichia pastoris (Jorda et al., 2014), of hepatic cells 
(Hofmann et al., 2008; Maier et al., 2008) and of neurons (Amaral et al., 2011). I previously 
applied INST-13CMFA using the extracellular MIDs of metabolites from a reactor batch 
culture of CHO-K1 suspension cells where [U-13C6] glucose was used as labeled substrate 
to determine the fluxes in a compartmented metabolic network as well as metabolite 
exchange with the media (Nicolae et al., 2014). 
CHO cells are the main production cell line for biopharmaceuticals (Kim et al., 2012) and 
considered as the “mammalian equivalent of E. coli” given their relevance as mammalian 
model system (Jayapal et al., 2007). Economic importance made CHO cells a target for 
various MFA studies (Ahn and Antoniewicz, 2011; Altamirano et al., 2001a; Altamirano et 
al., 2001b; Duarte et al., 2014; Goudar et al., 2010; Nicolae et al., 2014; Nolan and Lee, 2010; 
Provost et al., 2006; Sengupta et al., 2010; Sheikholeslami et al., 2013; Templeton et al., 
2013; Wahrheit et al., 2014a). The most detailed MFA studies used parallel labeling 
experiments and steady-state labeling to characterize the growth and the non-growth 
phases in monolayer CHO-K1 cells (Ahn and Antoniewicz, 2011), [1-13C] glucose for 
analyzing an inducible expression system engineered into a CHO cell line 
(Sheikholeslami et al., 2013) or to characterize the metabolic shifts during antibody 
production in highly-productive CHO cell line (Templeton et al., 2013). Nevertheless, all 
previous studies did not succeed in untangling the traffic between mitochondria and 
cytosol, as these models did not fully take into consideration mitochondrial transport and 
metabolite compartmentation. 
In the present work the CHO-K1 metabolism was studied by applying two labeled 
substrates, [U-13C6] glucose and [U-13C5] glutamine, to a shake flask batch culture of CHO-
K1 suspension cells. The dynamics of intra- and extracellular MIDs was used to estimate 
the intracellular fluxes, reversibilities and intracompartmental concentrations by applying 
INST-13CMFA. Such method produces a high-resolution analysis of the mammalian cell 
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metabolism, as it allows a detailed exploration of metabolic compartmentation, 
mitochondrial transport and metabolic channeling. The metabolic network resolved 
herein offers a new perspective of the complex CHO-K1 cells metabolism in particular and 
more generally on the intricate system of metabolic fluxes in mammalian cells. 
 
Figure 4.1. Experimental requirements for metabolic flux analysis tools. 
4.2. Materials and methods 
4.2.1. Cell culture 
The CHO-K1 cell line was kindly provided by the Institute of Cell Culture Technology of 
the University Bielefeld (Germany). The cells were grown in suspension culture under 
serum and protein free conditions in the chemically defined, protein-free TC-42 medium 
(TeutoCell, Bielefeld, Germany), supplemented with 6 mM L-glutamine (Sigma-Aldrich, 
Steinheim, Germany) from a 240 mM stock solution in dH2O. Cultivation of the CHO-K1 
cells was performed in baffled shake flasks (250 ml, Corning, New York, USA) in a shaking 
incubator (Innova 4230, New Brunswick Scientific, Edison, NJ, USA) at 135 rpm (2 inches 
orbit), 37°C and 5% CO2. 
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4.2.2. Experimental set-up of labeling experiments 
The pre-culture was carried out in a 250 ml baffled shake flask (Corning Inc., Germany) at 
an initial cell density of 4  105 cells/ml and a working volume of 100 ml. For the tracer 
experiments, cells were harvested during the exponential growth phase and resuspended 
in TC-42 medium with 100% [U-13C6] glucose (99%, Euriso-Top, Saarbrücken, Germany) 
or with 100% [U-13C5]glutamine (99%, Cambridge Isotope Laboratories, Andover, MA, 
USA). Four parallel tracer experiments were performed, two replicates with fully labeled 
glucose and two replicates with fully labeled glutamine, respectively. The main cultures 
were inoculated at a start cell density of 2  106 cells/ml in a start volume of 120 ml 
medium. 
Extracellular samples of 0.5 ml were taken from all four cultivations every 6 h for cell 
counting, determination of extracellular metabolite concentrations and extracellular 
labeling dynamics. 50 µl of the sample was diluted with PBS and mixed with Trypan Blue 
for determination of cell density, cell viability and average cell diameter using an 
automated cell counter (Invitrogen, Darmstadt, Germany). The sample was centrifuged 
(10,000 rpm, 5 min, Biofuge pico, Heraeus Instruments, Hanau, Germany), 300 µl of the 
supernatant transferred to fresh tubes and stored at -20°C for further analysis. The rest of 
the sample was used for pH determination (MP 220 pH Meter, Mettler-Toledo, Giessen, 
Germany). 
Intracellular samples of 5 ml were taken alternately from the two replicates after 2 min, 10 
min, 20 min, 30 min, 1h, 2 h, 4 h, 6 h, 12 h, 18 h, 24 h, 30 h, 36 h, 42 h and 48 h. Quenching 
and extraction for determination of intracellular metabolites was performed as described 
in detail recently (Wahrheit and Heinzle, 2013; Wahrheit and Heinzle, 2014a). In brief, a 
sample of 5 ml cell suspension was quenched in 45 ml ice-cold 0.9% sodium chloride 
solution and centrifuged for 1 min at 2000  g in a pre-cooled centrifuge at 0°C. The 
supernatant was carefully decanted followed immediately by suction of residual liquid 
using a vacuum pump without touching the cell pellet. Washing was performed by 
carefully rinsing the cell pellet with 50 ml ice-cold 0.9% sodium chloride solution without 
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resuspending the cells. After repeating the centrifugation step and removal of the 
supernatant, the cell pellet was frozen in liquid nitrogen. Intracellular metabolites were 
extracted twice in 100% methanol and once in water by repeated freeze-thaw cycles as 
described previously (Wahrheit and Heinzle, 2014b) and similar to (Sellick et al., 2011b). 
Extracts were dried in a centrifugal evaporator. 
4.2.3. Quantification of extracellular metabolites 
Quantification of glucose, organic acids and amino acids via HPLC was carried out as 
described previously by Strigun et al. (Strigun et al., 2011). 
4.2.4. Analysis of isotopomer labelling patterns 
4.2.4.1. Sample preparation 
For determination of extracellular labeling dynamics, 50 µl of supernatants were 
lyophilized, resolved in 50 μl N,N-dimethylformamide (0.1 % pyridine) and incubated at 
80°C for 30 min. 50 µl N-methyl-N-t-butyldimethylsilyl-trifluoro-acetamide (MBDSTFA) 
was added followed by another incubation at 80°C for 30 min for derivatization of 
extracellular metabolites into corresponding dimethyl-t-butylsilyl derivatives. Dried cell 
extracts were resolved in 50 µl pyridine containing 20 mg/ml methoxylamine and 50 µl 
MSTFA (Macherey-Nagel, Düren, Deutschland) and incubated at 80°C for 30 min for 
derivatization of intracellular metabolites into corresponding methoxyamine-
trimethylsilyl derivatives. Derivatized samples were centrifuged at 13000  g for 5 min at 
4 °C and the supernatants transferred into fresh glass vials with micro inlets. 
4.2.4.2. GC-MS measurements 
Extra- and intracellular 13C-labeling dynamics were analyzed by gas chromatography mass 
spectrometry (GC-MS). The GC-MS measurements were carried out on a GC (HP 6890, 
Hewlett Packard, Paolo Alto, CA, USA) equipped with an HP5MS capillary column (5% 
phenyl-methyl-siloxane diphenylpolysiloxane, 30 m × 0.25 mm × 0.25 μm, Agilent 
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Technologies, Waldbronn, Germany), electron impact ionization at 70 eV, and a 
quadrupole detector (Agilent Technologies). The injection volume was 1 µl (7683B 
Autosampler, Agilent, Waldbronn, Germany; PTV-Injektor, Gerstel, Mühlheim a. d. Ruhr, 
Germany).  
Helium was used as carrier gas at a flow rate of 1.1 ml/min for analysis of extracellular 
metabolites or 0.7 ml/min for analysis of intracellular metabolites. The following 
temperature gradient was applied for analysis of extracellular metabolites: 135°C for 7 
min, 10°C/min up to 162°C, 7°C/min up to 170°C, 10°C/min up to 325°C, 325°C for 2.5 min; 
inlet temperature: 140°C and heating with 720°C/min up to 320°C; interface temperature 
320°C; quadrupole temperature 150°C. The temperature gradient for analysis of 
intracellular metabolites was as follows: 70°C for 1 min, 1°C/min up to 75°C, 5°C/min up to 
315°C, 25°C/min up to 340°C, 340°C for 5 min; inlet temperature: 70°C and heating with 
360°C/min up to 360°C; interface temperature 320°C; quadrupole temperature 280°C. 
4.2.4.3. Data analysis 
After identification of metabolites in the scan mode using the NIST data bank, 
quantification of labeling enrichment was done in SIM (selected ion monitoring) mode in 
at least two technical replicates. Unique fragments (m/z) containing the whole carbon 
backbone were chosen for secreted extracellular metabolites and selected intracellular 
metabolites of the central metabolism. Following fragments of extracellular metabolites 
(MBDSTFA derivatization) were analyzed: lactate 261, alanine 260, glycine 246, serine 
390, aspartate 418, glutamate 432, glutamine 431. Identified fragments in cell extracts 
(MSTFA derivatization) were as follows: pyruvate 174, lactate 219, alanine 218, fumarate 
245, malate 335, citrate 465, α-ketoglutarate 304, glycine 276, serine 278, aspartate 334, 
glutamate 348. Mass isotopomer distributions were corrected for naturally occurring 
isotopes using the method of Yang et al. (Yang et al., 2009). 
4.2.5. Dynamic metabolic flux analysis 
The continuous time course of the metabolic fluxes was computed similar to Niklas et al. 
(2011) following the steps: (1) interpolation of the extracellular concentrations of 
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metabolites and the cell density with a continuously derivable function, (2) computing 
the extracellular rates, and (3) computing intracellular fluxes based on a stoichiometric 
model. Cell density was interpolated using an exponential growth model. Extracellular 
concentrations of metabolites were interpolated using SLM (Shape Language Modeling), 
a user-developed fitting tool that uses customized splines (MATLAB 2012b, The 
Mathworks, Natick, MA, USA). To avoid overfitting and biological nonsense, all fitted 
values were constrained to positive values, not more than three splines per curve were 
used and, except where observed to be otherwise e.g. visual observation of metabolite 
production followed by uptake or vice versa, all fitting curves were constrained to be 
monotonous.  
Water evaporation was taken into account by correcting the concentration values prior to 
interpolation using the experimentally determined evaporation rate. Both the evaporation 
rate and glutamine degradation kinetics were determined experimentally in a cell-free 
setup identical to the one employed during the cultivation. Extracellular fluxes were 
calculated in units of mmol  (L cell)-1  h-1 using the numerically differentiated 
concentration slopes 
dt
dCi : 
cell
i
iu
VXdt
dC
v
11
,       (4.1) 
and by considering the spontaneous degradation of glutamine: 
cell
GLNGLNGLN
GLNu
VX
CkddtdC
v


,      (4.2) 
where vu,i is the uptake rate of metabolite i, Ci is the fitted extracellular concentration, 
kdGLN is the first order degradation constant of glutamine, X is the fitted cell density [cells 
 L-1] and Vcell is the volume of one cell [L]. Biomass fluxes were calculated using the 
time-dependent growth rate: 
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cell
Xiibio
VXdt
dX
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/,      (4.3) 
where vbio,i is the biomass rate for metabolite i and Yi/X is the biomass yield coefficient. 
All biomass fluxes were computed considering the biomass composition listed in Suppl. 
Table S1.1 and Suppl. Table S1.2. 
The stoichiometric model of the CHO-K1 metabolism was built based on pathway data 
presented by (Ahn and Antoniewicz, 2012) and adapted to accommodate experimental 
observations (Fig. 4.2). It comprises the main pathways in the central carbon metabolism: 
biomass production using proteins, fatty acids and carbohydrates; glycolysis, pentose 
phosphate pathway (PPP), tricarboxylic acid (TCA) cycle, and amino acids syntheses; and 
catabolism (Suppl. Table S4.1). Aminotransferase reactions were always coupled with the 
conversion of α-ketoglutarate to glutamate. The stoichiometric model was simplified in 
the following way: compartmentation was neglected, anaplerotic reactions were lumped 
into one flux connecting phosphoenolpyruvate with oxaloacetate; and serine production 
and degradation reactions were modeled as one reversible flux between serine and 
pyruvate. The intracellular fluxes were calculated using the external fluxes according to 
network stoichiometry: 
)()( mmcc vGGinvv        (4.4) 
where vc and vm are the arrays of intracellular and extracellular fluxes, Gc and Gm are the 
corresponding stoichiometric matrices. The Gc matrix must be invertible. Consequently, 
the stoichiometric model was modified as described above. Following all listed 
simplifications, the PPP flux could still not be calculated directly but was fixed in order to 
obtain an invertible Gc. The PPP was therefore set at 5% of the total glucose input flux, a 
value that suffices for DNA and RNA synthesis requirements and also limits the carbon 
loss in the reaction catalyzed by phosphogluconate dehydrogenase. 
Numerical derivation is an important source of errors. In dynamic flux analysis, this issue 
can lead to computing fluxes lacking biological sense (e.g. a reversed TCA cycle). Noise 
amplification by derivation is mitigated by considering the measurement errors in the 
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computed flux values. Monte Carlo was applied to sample 1500 sets of extracellular 
concentrations using the average measured values perturbed normally with the standard 
deviations. Each set was then interpolated with piecewise splines and the metabolic fluxes 
were computed at the interpolation time points. Average flux values and flux standard 
deviations were calculated using the resulting flux sets. 
 
Figure 4.2. Simplified metabolic network of the CHO-K1 cell line central carbon metabolism. Subscripts: ex 
– extracellular. Abbreviations: AA1 – isoleucine, methionine, threonine, valine; AA2 – isoleucine, leucine, 
lysine, phenylalanine, tyrosine; AA3 – arginine, proline; AcoA – acetyl-coenzyme A; AKG – α-ketoglutarate; 
ALA – alanine, ASN – asparagine; ASP – aspartate; C3 – phosphoenolpyruvate / pyruvate; C4 – malate / 
oxaloacetate; CIT – citrate; G6P – glucose-6-phosphate; GLC – glucose; GLN – glutamine; GLU – glutamate; 
GLY – glycine; LAC – lactate; PG – phopshopglycerate; PYR – pyruvate; SER – serine. 
4.2.6. Metabolic network for non-stationary 13C MFA 
A detailed metabolic network of the CHO-K1 cell line was constructed using the 
annotated CHO genome database (Hammond et al., 2012), the Mus musculus genome 
(Zhu et al., 2003) and the KEGG Pathway database (Kanehisa et al., 2014). Information 
about enzyme compartmentation, mitochondrial transporters and metabolic channeling 
was included when available.  The network included compartmentation of cytosolic and 
mitochondrial alanine and aspartate aminotransferases, cytosolic glutamine synthesis and 
mitochondrial glutaminase, cytosolic and mitochondrial isocitrate dehydrogenase. 
Concerning mitochondrial carriers, the following were considered: irreversible pyruvate 
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carrier (confirmed by own mitochondrial studies, unpublished data), reversible 
dicarboxylate carrier, irreversible citrate carrier, reversible α-ketoglutarate carrier, 
reversible glutamate carrier, reversible aspartate-glutamate carrier, reversible alanine 
transport and irreversible glutamine transport into the mitochondria. In addition, the 
network was modified using enzyme activity localization determined by Wahrheit et al. 
(2014b). The pathways producing macromolecules e.g. carbohydrates, proteins, fatty 
acids, nucleic acids were included as sink fluxes for precursor metabolites. The catabolism 
of amino acids was lumped into fluxes feeding target metabolite pools. For the detailed 
reaction list and the carbon transfer rules see (Supplem. Table S 4.2). 
4.2.7. Flux space analysis 
Constraints imposed by extracellular fluxes and reaction direction limit the possible flux 
space. Convex analysis applied to calculating the flux polytope could be computationally 
cumbersome. This fact was circumvented by using Monte Carlo sampling to generate the 
flux space (Wiback et al., 2004). A total of 10000 flux sets was generated within the 
designated constraints and using the stoichiometry of the detailed model. The boundaries 
of the flux space were further used as constraints for the non-stationary 13C MFA.  
4.2.8. Non-stationary-13CMFA 
Metabolite and carbon balancing for both intracellular and extracellular metabolites was 
applied for simulating the mass isotopomer distribution (MID) of selected metabolites 
over time. The mathematical modeling procedure of non-stationary 13C metabolic flux 
analysis (INST-13CMFA) is the same as described and applied by Nicolae et al. (2014). In 
the present study intracellular MIDs were available therefore intracompartmental 
concentrations of metabolites with sampled MIDs could be estimated. The sampled MID 
of a metabolite is the average of the mitochondrial and cytosolic values, weighed by the 
intracompartmental concentrations of that metabolite. The total mitochondrial volume 
was set to be 20% of the total cell volume, as estimated from STED microscopy (personal 
communication, Uwe Jandt), higher than reported for HeLa cells and a different cell line 
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of CHO cells (Gandhi and Samuels, 2011; Ross and Mel, 1972) but comparable to the 
average for mammalian cells or rat liver (Else and Hulbert, 1985; Weibel et al., 1969). 
Exact 3D data are, however, still lacking. For all the metabolites that were included in the 
model but for which the MIDs were not sampled, the intracompartmental pool values 
took negligible values of 0.1 mmol/L cell. The accepted standard deviation of extracellular 
MIDs in the objective function was 0.01 and of intracellular MIDs it was 0.03.   
4.3. Results and Discussion 
4.3.1. Cell growth and extracellular metabolite concentrations 
Growth and extracellular metabolite concentrations were determined from four biological 
replicates. The CHO-K1 cells maintained exponential growth for the whole cultivation 
period of 48 h (Fig. 4.3). The parallel cultivations were reproducible as is evident from the 
low standard deviations in (Fig. 4.3,Fig. 4.4 and Supplem. Table 4.4). The estimated 
specific growth rate was μ = 0.034 h-1 (Fig. 4.3). Glucose, glutamine, pyruvate, serine, 
asparagine, aspartate and essential amino acids were taken up (Fig. 4.4). Lactate, alanine, 
glutamate and glycine were produced throughout the cultivation period. By the end of 
the 48 h cultivation, 60% of the glucose was converted to lactate. Although the specific 
growth rate was constant, the specific uptake and production rates generally decreased 
over the 48h, the most marked trend being observed for lactate production (Fig. 4.4). 
However, no switch from production to uptake or vice-versa was observed. 
 
Figure 4.3. Growth profile of the CHO-K1 cells in 250 ml baffled shake flask with a working volume of 120 
mL and the determined specific growth rate µ. The values represent the average of 4 parallel cultivations 
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Figure 4.4. Cell density (cells / mL) and extracellular metabolites concentrations (µmol / L) for a 48 h 
cultivation of CHO-K1 cells in 250 ml baffled shake flask with a working volume of 120 mL. The lines 
represent the piecewise spline interpolations and the red bars are the standard deviation computed from 4 
parallel cultivations 
4.3.2. Labeling experiment 
Extracellular MIDs were determined from two biological replicates. For determination of 
the time courses for intracellular labeling dynamics, MIDs were obtained alternatively 
from two parallel cultivations for each labeled substrate. In the experiment where [U-13C6] 
glucose was used, the sampled metabolites became labeled gradually, and no steady state 
was reached after 48 h (Fig. 4.5 A). The general trend was an increase of the labeled 
fraction, the exception being intracellular lactate, whose M3 mass fraction decreased after 
36 h. The mass isotopomer with the highest proportion for pyruvate, lactate and alanine 
was M+3, while for metabolites related to the TCA cycle e.g. citrate, α-ketoglutarate, 
fumarate and malate, it was the M2. Lactate and alanine pools were labeled differently 
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intra- and extracellularly. This evidence supports the hypothesis of metabolic 
compartmentation of these two metabolites. Partitioning of lactate dehydrogenase 
activity, either by channeling (Jandt et al., 2013; Malaisse et al., 2004; Perez-Bercoff et al., 
2011) or in cellular compartments (Baba and Sharma, 1971; Brooks et al., 1999; Gladden, 
2004; Hashimoto and Brooks, 2008; Lemire et al., 2008; Philp et al., 2005; Sagrista and 
Bozal, 1987) can also be inferred by comparing the intracellular labeling of pyruvate and 
lactate. During the first 24 h, intracellular pyruvate and lactate follow similar labeling 
patterns. At 18 h after inoculation, a switch in the partitioning of lactate dehydrogenase 
was evident from diverging labeling patterns of intracellular pyruvate and lactate.  
In the first 2 h, the labeling in pyruvate exhibited a sharp overshooting of the M+3 
fraction, that was manifested later also in lactate (Fig. 4.5 B). A similar overshooting 
behavior was observed in the M+4 isotopomer of malate, and it transmitted to aspartate.  
When [U-13C5] glutamine was used as the 13C label source, no labeling was observed in 
serine and glycine, indicating there is no gluconeogenesis. Pyruvate and lactate displayed 
a sharp overshooting in the first 2 h in all mass isotopomers (Fig. 4.5 B). However, after 12 
h, the labeling of pyruvate and lactate returned close to the natural labeling state, 
indicating the absence of fluxes that connect glutamine to pyruvate. The M+4 fraction in 
aspartate, fumarate and malate increased until 18 h, and then it decreased in favor of the 
non-labeled fraction. This is most likely the result of a metabolic shift occurring around 
18 h after inoculation. The shift is mirrored in glutamine and glutamate labeling, where 
the non-labeled fraction increased steadily after 24 h. The metabolic shift consists most 
likely of a decrease in the ratio between glutaminolysis and glycolysis in contributing to 
the TCA cycle. The specific uptake and production rates were therefore computed for the 
period of 0-18 h by fitting the model of exponential balanced growth in batch culture to 
the sampled extracellular concentrations (Fig. 4.4).  
Aspartate, fumarate and malate had similar labeling patterns on both labeled substrates, 
suggesting a high degree of connection and exchange between these metabolites. The 
MID curves that exhibited overshooting returned to a smooth behavior after 2 h on both 
labeled substrates. Overshooting can be assigned to a stress response of the cells to media 
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change at the beginning of the culture (Wellen and Thompson, 2010). The stress response 
is characterized by very high metabolic rates that quickly convert the fed substrates after 
being resuspended to replenish the depleted intracellular pools. Once these pools were 
replenished, the metabolism followed a steady state behavior as can be seen in (Fig. 4.4). 
Since there is no observable difference in the cell number and extracellular 
concentrations in the first two hours, assessing the extracellular fluxes during this brief 
period and proving the existence of metabolic steady state required for metabolic flux 
analysis tools is not possible. 
4.3.3. Dynamic metabolic flux analysis 
Flux changes throughout the 48 h cultivation period reflected the observation in the 
MIDs, namely that a shift in metabolism occurs after 18 h (Fig. 4.6). Glucose uptake flux 
decreased markedly and the relatively high standard deviation in glucose concentration 
measurement (Fig. 4.4) propagated in the computed fluxes. The initial slope of the 
interpolation curves is a significant source of uncertainty in the flux values computed in 
the first 10 h, as it can be observed by the high values of estimated standard deviations 
(Fig. 4.6.A). The metabolic shift occurring after approx. 20 h is marked by a decrease in 
the lactate production rate compared to the main extracellular fluxes: glucose uptake 
(Fig. 4.6.B), glutamine uptake (Fig. 4.6.D) and alanine production (Fig. 4.6.E). 
Remarkably, the specific growth rate remained constant despite decreasing uptake rates 
of carbon sources. It can therefore be inferred that the cells are programmed for 
maximizing growth regardless of the availability of carbon sources. It is also very likely 
that the uptake and processing rates of glucose and glutamine depend on their 
extracellular concentrations. Owing to the sharply decreasing uptake rates of carbon 
sources, after 20 h from the inoculation, the carbon sources were deployed almost 
exclusively for sustaining growth and metabolite secretion. This led to an arrest of the 
TCA cycle (Fig. 4.6 A), which can explain the switch observed in lactate and pyruvate 
labeling (Fig. 4.5 A). 
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Figure 4.5. (A) Experimentally 
determined mass isotopomer 
distributions of intracellular and 
extracellular (subscript ex) 
metabolites during the 48 h of 
the labeling experiment using [U-
13C6] glucose and [U-13C5] 
glutamine as substrates. (B) The 
first 5 h of the labeling 
experiment using [U-13C6] glucose 
and [U-13C5] glutamine as 
substrates showing the 
overshooting behavior in 
intracellular pyruvate (PYR), 
lactate (LAC), malate (MAL) and 
aspartate (ASP). Abbreviations: 
AKG – α-ketoglutarate; ALA – 
alanine; ASN – asparagine; ASP – 
aspartate; CIT – citrate; FUM – 
fumarate; GLN – glutamine; GLU 
– glutamate; GLY – glycine; Lac – 
lactate; MAL – malate; PYR – 
pyruvate; SER – serine. 
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Figure 4.6. (A) Dynamics of fluxes in the metabolic network of CHO-K1 cells. The fluxes (black lines, mmol 
 L cell-1  h-1) and their standard deviations (red bars) were determined from 1500 Monte Carlo 
simulations that fitted with piecewise splines normally perturbed extracellular. Dynamics of flux ratio 
between (B) lactate secretion and glucose uptake, (C) glutamine uptake and glucose uptake, (D) glutamine 
uptake and lactate secretion and (E) alanine secretion and lactate secretion. Subscripts: ex – extracellular. 
Abbreviations: AKG – α-ketoglutarate; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT – citrate; 
FUM – fumarate; GLN – glutamine; GLU – glutamate; GLY – glycine; Lac – lactate; MAL – malate; PYR – 
pyruvate; SER – serine 
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4.3.4. Flux space 
The flux space for the detailed network of the CHO-K1 cell was computed using as 
constraint the extracellular fluxes computed for the first 18 h of cultivation and default 
boundary constraints for the free fluxes. Many fluxes were limited only by the default 
boundaries (Fig. 4.7). This outcome is not surprising considering the large number of 
degrees of freedom in the flux space i.e. 13. Fluxes in glycolysis and TCA cycle were 
limited by substrate uptake, i.e. glucose and glutamine. Pentose phosphate pathway 
consumes one carbon atom, making its flux inversely proportional to the flux in the TCA 
cycle. Interestingly, in the majority of cases the estimated fluxes did not match the fluxes 
with the highest frequency of occurrence in the flux space. Most of the fluxes estimated 
using 13C labeling data lie near the boundaries of the flux space.  
4.3.5. Fitting of MIDs and model re-adaptation 
For applying INST-13CMFA, it was considered that the cells were at metabolic steady state 
between 2-18 h after the beginning of the labeling experiments (Deshpande et al., 2009; 
Noh et al., 2006). This is a valid assumption for most metabolites, as it was shown by 
fitting the extracellular concentrations to an exponential growth using constant yield 
coefficients (Fig. 4.4). The MIDs of 15 extracellular and intracellular metabolites, 5 time 
points for [U-13C6] glucose and 4 time points for [U-13C5] glutamine were sampled, totaling 
675 experimental MID points (Fig. 4.8, Supplem. Table 4.3). Because of the highly noisy 
data, the MIDs of intracellular alanine and α-ketoglutarate were excluded from the 
objective function. After several trials in which no successful fitting was obtained, the 
initial model was modified to include: (1) two pools of cytosolic pyruvate, of which one is 
channeled to lactate that is then directly secreted, (2) two pools of mitochondrial 
pyruvate, of which one is converted to acetyl-CoA via pyruvate dehydrogenase, (3) a pool 
of mitochondrial lactate, (4) cytosolic synthesis of glutamine and (5) serine degradation 
to pyruvate. 
The parameter estimation was conducted using two strategies in parallel: one used a 
genetic optimization algorithm as described earlier (Nicolae et al., 2014), and the other 
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used the following procedure: (1) generate 1000 random initial points that satisfy 
constraints, (2) use the point that produced the smallest value of the objective function as 
the starting point of a gradient-based algorithm and (3) find the minimum using the trust 
region reflective algorithm. The second optimization strategy was repeated 30 times, and 
it provided the best fit of the MIDs. One simulation took about 6.5 s, and the 
optimization procedure required about 6 days on a 2.3 GHz QuadCore CPU. A total of 64 
parameters were estimated, of which 13 were free fluxes, 29 were flux reversibilities, 20 
were intracompartmental pools and 2 additional parameters that expressed the non-
labeled CO2 flux entering the cytosol and the mitochondria. This flux was needed to 
evaluate the labeling dynamics of CO2 used by carboxylation reactions. 
The best fit (Fig. 4.8) resulted in a minimized weighted sum of square differences value of 
665, which is smaller than the criteria for fitting χ2(0.95, 675-64) = 670. Most of the MIDs 
of metabolites were reasonably well fitted, with the exception of lactate when [U-13C6] 
glucose was used. Because the labeling of extracellular lactate is different from the 
labeling of intracellular lactate (Fig. 4.8), new cytosolic pyruvate pools from which lactate 
can derive were included in the model. While this assumption produced a much better 
approximation of lactate labeling, it is still possible that other metabolic configurations 
involving more sophisticated channeling and compartmentation are responsible for the 
observed labeling pattern in lactate. 
Confidence intervals were computed accordingly to (Antoniewicz et al., 2006) and were 
very narrow for most estimated parameters (Suppl. Table S4.2). This is a strong indication 
that fitting simultaneously the intracellular MIDs from two parallel labeling experiments 
that used two different labeled substrates validates INST-13CMFA as an effective 
methodology for untangling the details of complex metabolic networks, as it was already 
described by (Murphy et al., 2013). 
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Figure 4.7. Flux space of the metabolic network of CHO-K1 cell representing the flux frequency distribution 
computed by Monte Carlo random sampling of 10000 flux sets that satisfied imposed constraints. The fluxes 
are expressed in [mmol  L cell-1  h-1]. The red line represents the fluxes estimated using INST-13CMFA. 
Subscripts meaning: c – cytosolic; m – mitochondrial; Abbreviations: ACoA – acetyl-CoA; ALA – alanine; 
ASP – aspartate; CIT – citrate; FUM – fumarate; GLC – glucose; G6P – glucose-6-phosphate; PG – 
phosphoglycerate; PEP – phosphoenolpyruvate; GLN – glutamine; GLU – glutamate; MAL – malate; OAA – 
oxaloacetate; PPP – pentose phosphate pathway; PYR – pyruvate; SER – serine; SUC – succinate. 
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Figure 4.8. Mass isotopomer distributions (MIDs) of sampled metabolites during the first 18 h of 
cultivation of CHO-K1 suspension cells with (A) [U-13C6] glucose and (B) [U-13C5] glutamine. The values of 
the extracellular MIDs are the average of two biological replicates and the intracellular MIDs are obtained 
alternatively from two parallel cultivations for each labeled substrate. The continuous lines represent the 
best simulated fit of the MIDs. Subscripts meaning: ex – extracellular. Abbreviations: exp – experimental; 
sim – simulated; ALA – alanine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLN – glutamine; GLU – 
glutamate; GLY – glycine; LAC – lactate; MAL – malate; PYR – pyruvate; SER – serine. 
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4.3.6. Metabolic fluxes, compartmentation and channeling 
Glycolysis was the main carbon source of the CHO-K1 cell metabolism (Fig. 4.9 A). 
Consistent with our previous finding for the CHO-K1 cell line cultivated in a reactor batch 
culture (Nicolae et al., 2014), most of the glucose-6-phosphate was metabolized by the 
oxidative branch of the pentose phosphate pathway (PPP) and not by the upper 
glycolysis. 75% of the glucose was converted to lactate that was then secreted. The 
remaining glucose was converted to pyruvate that was transported to the mitochondria. 
In previous studies of this CHO-K1 cell line, it was found that partial glycolytic 
channeling resulted in two cytosolic pyruvate pools (Nicolae et al., 2014; Wahrheit et al., 
2014b), a phenomenon observed before in CHO cells (Ahn and Antoniewicz, 2013; 
Deshpande, 2008) and also in other mammalian cells (Campanella et al., 2005; Cruz et al., 
2001; Peuhkurinen et al., 1983; Zwingmann et al., 2001). In the present study, the 
channeling effect was less pronounced, as the two cytosolic pyruvate pools were 
estimated to be strongly connected (Fig. 4.9 A). However, active exchange from pyruvate 
towards a second cytosolic dead-end lactate pool had to be included. Also, the exchange 
between the extracellular and intracellular lactate pool was significant. This exchange 
must be considered to describe the MIDs dynamics of intracellular lactate and pyruvate. 
Furthermore, the model was expanded by a mitochondrial lactate pool and channeling of 
mitochondrial pyruvate to describe the difference in labeling between extracellular and 
intracellular lactate. Heterogeneously distributed pyruvate dehydrogenase in the 
mitochondrial matrix as found in fibroblasts (Margineantu et al., 2002) supports the 
assumption that a part of the pyruvate entering the mitochondria is converted to acetyl-
CoA without mixing with the mitochondrial pyruvate pool (Fig. 4.9 B). These results are 
similar to those of Ahn et al. (Ahn and Antoniewicz, 2013). 
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Figure 4.9. (A) Metabolic fluxes of the central carbon metabolism of CHO-K1 cells in the 2 – 18 h period of 
cultivation estimated using non-stationary 13C metabolic flux analysis. (B) Glycolysis and pyruvate 
metabolism compartmentation in CHO-K1 cells. (C) Metabolism of oxaloacetate (OAA), aspartate (ASP) 
and malate (MAL) in CHO-K1 cells. (D) Metabolism of glutamine (GLN), glutamate (GLU), α-ketoglutarate 
(AKG) and citrate (CIT) in CHO-K1 cells. The thickness of the lines is proportional to the net flux values, 
except for the fluxes connecting PYRm1-LACm and PYRc1-LACc1, where they represent the exchange flux (the 
net flux being 0). The full arrows indicate the direction of the net flux, and the empty arrows indicate a 
reversible flux. Subscripts meaning: c – cytosolic; ex – extracellular; m – mitochondrial; Abbreviations: AcoA 
– acetyl-CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLC – 
glucose; G6P – glucose-6-phosphate; PG – phosphoglycerate; PEP – phosphoenolpyruvate; GLN – 
glutamine; GLU – glutamate; GLY – glycine; ICI – isocitrate; ILE – isoleucine; LAC – lactate; LEU – leucine; 
LYS – lysine; MAL – malate; MET – methionine; OAA – oxaloacetate; PHE – phenylalanine; PYR – pyruvate; 
SER – serine; SUC – succinate; THR – threonine; TYR – tyrosine; VAL – valine. 
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Mitochondrial channeling results in two pyruvate pools, observed when [U-13C6] glucose 
is used: one with high 13C fractional labeling produced in the glycolysis that is channeled 
to acetyl-coA, and a second larger one replenished with 12C by cataplerotic reactions. 
Activity of mitochondrial lactate dehydrogenase was already confirmed in various tissues, 
e.g. heart mitochondria (Brooks et al., 1999), breast cancer cells (Hussien and Brooks, 
2011), muscle cells (Hashimoto et al., 2006), liver cells (Brooks et al., 1999; Kline et al., 
1986), astrocytoma (Lemire et al., 2008) and neurons (Hashimoto et al., 2008). 
Mitochondrial metabolism of lactate occurs when lactate is being metabolized as a 
carbon source, due to its high intracellular concentration (Brooks et al., 1999). However, 
in our case, lactate was secreted by the cells and it constituted a dead end metabolite in 
the mitochondria. It can therefore be assumed that the role of lactate in the 
mito0chondria is to function as a buffer for NADH, a mediator of redox states between 
compartments (Gladden, 2004). 
Glycolytic pyruvate and glutamine constituted the main fuels of the TCA cycle as 
previously shown for this cell line (Wahrheit et al., 2014a; Wahrheit et al., 2014b). The 
catabolism of essential amino acids was limited to a small flux feeding the acetyl-CoA 
pool. Otherwise, the uptake of essential amino acids was mostly restricted to the 
requirements for protein synthesis also previously found for this cells line (Wahrheit et 
al., 2014b). 
At the cytosol-mitochondria boundary, most mitochondrial transporters carried 
significant fluxes. The mitochondrial pyruvate carrier (Bricker et al., 2012; Herzig et al., 
2012) was the only connection between glycolysis and the TCA cycle, providing most of 
the mitochondrial pyruvate, as the mitochondrial malic enzyme activity was estimated to 
be very low (Fig. 4.9 B), consistent with enzyme assays (Wahrheit et al., 2014b). The 
aspartate-malate shuttle (Fig. 4.9 C) was constituted by export of mitochondrial aspartate 
via the glutamate-aspartate carrier (Cavero et al., 2003; Lane and Gardner, 2005) and 
import of cytosolic malate in the mitochondria via the malate-α-ketoglutarate carrier. 
Cytosolic aspartate was converted to oxaloacetate by the activity of aspartate 
aminotransferase. Cytosolic malate dehydrogenase converted oxaloacetate to malate and 
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consumed a part of the cytosolic NADH. Another transporter that facilitated the 
transport of malate in the mitochondria was the malate-citrate carrier. Malate was 
transported in exchange for citrate, which was used in the cytosol for fatty acids synthesis 
(Gnoni et al., 2009; Zara et al., 2005). Although malate is transported in the mitochondria 
with a net flux, partial cycling of malate between mitochondria and cytosol occurred. The 
malate carrier exchanged mitochondrial malate for cytosolic phosphate (Fiermonte et al., 
1999; Mizuarai et al., 2005) (Fig. 4.9 C). Phosphoenolpyruvate carboxykinase activity was 
modest but could serve as a starting point of gluconeogenesis. However, complete 
gluconeogenesis did not occur because neither serine nor glycine was labeled when [U-
13C5] glutamine was used as tracer (Fig. 4.8 B). 
Glutamine uptake in the mitochondria was 3.6 times higher than the net glutamine 
uptake from the medium. This is the result of a considerable cytosolic synthesis of 
glutamine from glutamate (Fig. 4.9 D). It was previously observed in CHO-K1 cells that 
the glutamine synthesis pathway is active even at high glutamine consumption rates 
(Nicolae et al., 2014). In the mitochondria, glutamine feeds the TCA cycle via glutamate 
that is converted to α-ketoglutarate not by NADH-producing glutamate dehydrogenase, 
but by transamination reactions. Aspartate was synthesized in the mitochondria, 
exported and re-converted to oxaloacetate in the cytosol. Alanine synthesis was estimated 
to occur mostly in the mitochondria. Glutamate transporter carried a high flux leaving 
the mitochondria (Fig. 4.9 D). Glutamate was procured in the cytosol either via transport 
from the mitochondria or transamination of α-ketoglutarate. Cytosolic glutamate was 
used to fuel glutamine synthesis and as an antiport partner to the aspartate-glutamate 
transporter. Despite the high activity detected in vitro for cytosolic IDH (Wahrheit et al., 
2014b), this did not reflect in the labeling patterns, regardless of the reaction direction 
that was considered. Even setting the labeling of the CO2 pool as a free parameter did not 
result in the estimation of a significant activity. The role of such a high activity of 
cytosolic isocitrate dehydrogenase could be to control variations of the cytosolic NADPH 
content and stress response (Lee et al., 2002).   
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In what concerns compartmentation of NADH and NADPH metabolism (Table 4.1), the 
excess of cytosolic NADH produced in the glycolysis is consumed by lactate 
dehydrogenase and malate dehydrogenase that is part of the malate shuttle. Cytosolic 
NADPH is provided only by the PPP since it was found by MFA that the activity of 
cytosolic malic enzyme was virtually absent. This agrees with earlier data of enzyme 
assays (Wahrheit et al., 2014b). The very low activity of mitochondrial malic enzyme 
means that little or even no mitochondrial NADPH was produced via this route. 
Oxidative stress (Tuttle et al., 2000; Vizan et al., 2009) that can be induced by futile cycles 
of disulfide bond formation and breaking during protein folding is an important 
consumer of NADPH (Tyo et al., 2012). This might indicate cytosolic NADPH supply as a 
limit for recombinant protein production. Enhancing the NADPH producing pathways 
could be a target for genetic modification in industrially relevant CHO strains (Klein et 
al., 2015). A large part of the cytosolic NADPH (21%) is used for fatty acid synthesis. 
Mitochondrial NADPH must be supplied by other reactions, most likely the 
transhydrogenase or NADP-dependent isocitrate dehydrogenase (Ceccarelli et al., 2002; 
Hatefi and Galante, 1977). It was shown by previous enzyme assays that around 90% of 
mitochondrial IDH activity is NADP-dependent (Wahrheit et al., 2014b).  
All aminotransferase reactions and also many of the transport reactions were determined 
to be highly reversible (Suppl. Table S4.2). The shapes of the MID curves are strongly 
influenced by reversibility (Noh and Wiechert, 2011). Transport reversibility explained the 
reduced summed fractional labeling when [U-13C6] glucose was used as a substrate, as the 
intracellular labeling was diluted by the large extracellular pool of non-labeled 
metabolites, consistent with our previous observations (Nicolae et al., 2014).  
Using intracellular labeling and two labeling experiments improved considerably the 
resolution and quality of estimated fluxes (Suppl. Table S4.2) compared to our previous 
study, where the same cell line was used but only extracellular labeling and one labeling 
experiment in a batch reactor cultivation (Nicolae et al., 2014). Now it was possible to 
establish the compartmentation of alanine synthesis and to solve the cytosolic and 
mitochondrial isocitrate – α-ketoglutarate – glutamate cycling. Extracellular fluxes are 
  
89 
 
4. High resolution 13C metabolic flux analysis in CHO cells 
highly dependent on the cultivation conditions as also reported earlier (Nicolae et al., 
2014). Many observations are consistent with the earlier ones made in a bioreactor 
culture: (1) almost complete diversion of glucose-6-phosphate through the PPP, (2) 
absence of cytosolic malic enzyme activity, (3) similar phosphoenolpyruvate-
carboxykinase activities, (4) simultaneous uptake and production of glutamine, (5) 
simultaneous uptake and production of serine and (6) excessive exchange of metabolites 
with the extracellular media. There were however also some significant differences 
compared to the reactor cultivation performed earlier (Nicolae et al., 2014): (1) reduced 
glucose uptake (~80% of the previous), (2) higher lactate production from glucose (75% 
compared to 39%) , (3) smaller TCA cycle flux, (4) reduced catabolism of essential amino 
acids, (5) low mitochondrial malic enzyme activity and (6) reduced uptake of asparagine.  
The metabolic flux map determined is probably the most complex to date for mammalian 
cells with respect to metabolic compartmentation, mainly because known mitochondrial 
transporters were incorporated into the flux model applied. The results of studies that use 
13CMFA to unravel the eukaryotic cell metabolism are highly dependent on the network 
structure. Changes in the network structure, e.g. the existence of other mitochondrial 
transporters, can lead to differences in some estimated fluxes due to non-linearity of 
isotopomer balances. It is therefore difficult to compare our results with previous 13CMFA 
studies of CHO cells. A high activity of the PPP was observed in the early exponential 
growth phase in a previous study that applied INST-13CMFA of CHO cells (Nicolae et al., 
2014). A high PPP was found to be a characteristic of the late non-growth phase (Ahn and 
Antoniewicz, 2011; Sengupta et al., 2010) or late-exponential phase (Templeton et al., 
2013). A high production of NADPH (Table 4.1) is required to counteract the oxidative 
stress induced by reactive oxygen species generated by mitochondrial respiration (Schafer 
et al., 2009; Vizan et al., 2009).  
4.3.7. Estimated intracompartmental pools 
The use of INST-13CMFA and the MIDs of intracellular metabolites required the 
simultaneous estimation of fluxes, reversibilities and intracompartmental concentrations 
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of certain metabolites. Estimated intracompartmental concentrations rely on the 
mitochondrial volume ratio determination. Using the available sampled intracellular 
MIDs (Fig. 4.8), the intracompartmental concentrations of 7 metabolites were estimated 
(Fig. 4.10) and the average intracellular concentration of another 2 (Fig. 4.10 A). 
Interestingly, pyruvate and lactate cytosolic concentrations were very low (Fig. 4.10 A) 
and considerably higher in the mitochondria. Lactate and pyruvate concentration 
distributions and the considered channeling effects explained the difference between 
extracellular and intracellular labeling in lactate when [U-13C6] glucose was used (Fig. 4.8 
A). Association of pyruvate dehydrogenase to the mitochondrial pyruvate transporter 
could explain the transport of pyruvate in the mitochondria against a concentration 
gradient, because the complex can use imported pyruvate to produce acetyl-CoA without 
interfering with the mitochondrial pool. Malate and fumarate had almost identical MID 
dynamics (Fig. 4.8). This makes simultaneous determination of intracompartmental 
concentrations not possible. Fumarate intramitochondrial concentration was set to a low 
value (0.1 mmol/L cell). The estimated malate intracompartmental concentration had an 
upper value of 5.2 mmol/L cell in the mitochondria and 3.9 mmol/L cell in the cytosol, 
and lower values of 2.1 mmol/L cell and 0.8 mmol/L cell respectively. Given that high 
exchange between compartments quickly balances labeling between compartments, the 
exact values of malate concentration for each compartment cannot be determined. The α-
ketoglutarate concentration was high in the cytosol whereas citrate had a high 
concentration in the mitochondria. The high cytosolic α-ketoglutarate concentration 
together with a low cytosolic concentration of citrate might be the reason why the 
observed activity of cytosolic isocitrate dehydrogenase towards α-ketoglutarate synthesis 
was virtually zero as was also found by flux analysis in cancer cells (Metallo et al., 2012). 
Alanine had comparable concentrations in both compartments. Aspartate was 
concentrated in the mitochondria, but only the upper threshold of the cytosolic 
concentration could be estimated. A relatively high intracellular concentration of serine 
and glycine was also determined. The most concentrated metabolite was glutamate, with 
a mitochondrial concentration reaching almost 50 mmol/ L cell, which might explain why 
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glutamate is exported from the mitochondria to the cytosol. However, only the upper 
boundary of the cytosolic concentration of glutamate could be estimated (Fig. 4.10 A). 
Citrate, glutamate and aspartate are exported with net fluxes from the mitochondria 
following the concentration gradient, while α-ketoglutarate is exported against the 
concentration gradient. A high cytosolic α-ketoglutarate concentration might be required 
to assist the various transamination reactions. All metabolites except α-ketoglutarate 
were more concentrated in the mitochondria than in the cytosol. Also, the estimated 
concentrations of amino acids are higher than reported intracellular concentrations for 
CHO cells (Hansen and Emborg, 1994; Lu et al., 2005). By applying INST-13CMFA, the 
average intracompartmental concentrations value might be overestimated as an effect of 
assigning negligible values to concentrations that are not estimated. However, since the 
dynamics of the MIDs depends on the pool size / flux ratio, the intracompartmental 
concentrations cannot be higher than their estimated upper boundary. Parameter 
estimation using INST-13CMFA instead of experimental determination has the advantage 
that the concentrations are estimated in vivo, without the risk of metabolite leakage 
during quenching and extraction (Dietmair et al., 2010; Sellick et al., 2009; Wahrheit and 
Heinzle, 2014a; Wahrheit et al., 2011b). In addition, INST-13CMFA provided a method to 
estimate intracompartmental concentrations of key metabolites of the central carbon 
metabolism, which was not yet achieved experimentally. 
4.3.8. Energy requirement and production 
The energy requirement and production in the CHO-K1 cells was computed based on the 
intracellular fluxes (Fig. 4.9) and reaction stoichiometry (Suppl. Table 4.2). Excluding 
oxidative phosphorylation and mitochondrial ATP transport, the balance for ATP is 
positive in both compartments (Table 4.1). The main source of cytosolic ATP is glycolysis, 
and in the cytosol it is produced in the reaction catalyzed by succinate dehydrogenase, 
along with FADH2. There is a small deficit of cytosolic NADH (i.e. electrons) which could 
be covered by reactions that were not included in the model. The value also falls within 
the standard deviation of the lactate secretion flux (Suppl. Fig. 4.1), which influences 
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directly the flux of the rection catalyzed by lactate dehydrogenase, where NADH is a 
cofactor, and also in the error for estimating the glycolysis flux based on glucose uptake.  
As mentioned in subchapter 4.3.6, the high cytosolic NADPH production (Table 4.1) is 
most likely used to mitigate oxidative stress and to fuel fatty acid synthesis. The oxidation 
of NADH will consume 348.8 mmol  (L cell)-1  h-1 O2. Considering a 1/2.5 ratio of 
NADH/ATP and 1/1.5 for FADH2/ATP for the process of oxidative phosphorylation 
(Hinkle, 2005) and the total consumption of NADH during this process, the total 
estimated production of ATP is 1603.9 mmol  (L cell)-1  h-1, which is obviously much 
higher than the requirements for protein and nucleic acids production. Such a high 
production of ATP clearly points to the existence of futile cycles and various processes 
that consume energy in the CHO-K1 cells and are not related to the central carbon 
metabolism or growth. This reinforces the assumption that the CHO-K1 cells do not have 
as a cell objective optimal use of energy and resources, as bacteria are assumed to have, 
but another cell objective that at the moment one can only speculate about. 
Table 4.1. Cofactor fluxes in the cytosol (c) and mitochondria (m) computed 
based on the instracellular fluxes in CHO-K1 cells for the 0-18h cultivation period 
Cofactor 
*excluding oxidative 
phosphorylation 
Flux  
[mmol  L cell-1  h-1] 
ATPc* 146. 
ATPm* 114.5 
NADHc -33.0 
NADHm 501.6 
NADPHc 467.5 
NADPHm 8.2 
FADH2m 114.5 
GTPc -66.4 
GTPm -23.1 
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Figure 4.10. Cytosolic and mitochondrial concentrations of metabolites estimated using non-stationary 13C 
metabolic flux analysis by assuming a mitochondrial volume ratio of 20%. The error bar represents the 95% 
confidence interval evaluated by refitting the model until the minimized objective function took the value 
of χ2(0.95, nr. experimental points – nr. parameters). Abbreviations: AKG – α-ketoglutarate; ALA – alanine; 
ASP – aspartate; CIT – citrate; GLU – glutamate; GLY – glycine; LAC – lactate; MAL – malate; PYR – 
pyruvate; SER – serine. 
4.4. Concluding Discussion 
The fluxes and reversibility of the probably most complex metabolic network to date were 
estimated by applying INST-13CMFA and using the intracellular and extracellular MID 
dynamics of metabolites obtained from two parallel labeling experiments with [U-13C6] 
glucose and [U-13C5] glutamine as labeled substrates. The labeling of MIDs was used 
during the exponential growth phase in the 2 – 18 h interval when the cells were at 
metabolic steady state. In the first 2 h of the labeling experiment, the MIDs of 
intracellular metabolites indicated a stress response to the cultivation condition. After 18 
h, the metabolic state of the cells changed, visible by a shift in the MIDs of the 
metabolites. Most of the parameters were determined with narrow confidence intervals. 
They included: (1) metabolic fluxes in cycles and alternative pathways, (2) flux 
reversibility and (3) intracompartmental concentrations. This confirms that INST-13CMFA 
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is a powerful method that can resolve the metabolic fluxes in a network that included 
multiple mitochondrial transporters, reaction reversibility, metabolite exchange with the 
media and metabolite channeling. Consistent with our previous estimation for the CHO-
K1 cell line (Nicolae et al., 2014), most of the glucose-6-phosphate was directed to the 
PPP, resulting in a high production of NADPH. Oxidative stress and fatty acid synthesis 
are the two main consumers of the cytosolic NADPH. The activity at the mitochondria – 
cytosol boundary is complex, involving intense metabolite trafficking and cycling. Malate 
and glutamate are both imported and exported via various mitochondrial carriers with 
the purpose of managing NADH distribution in the two compartments and providing 
antiport partners for other metabolites. The anaplerotic and cataplerotic fluxes were 
negligible with phosphoenolpyruvate-carboxykinase being the highest cataplerotic flux. 
The aspartate-malate shuttle consumed cytosolic NADH and produced mitochondrial 
NADH. Aspartate and alanine were synthesized in the mitochondria, and then 
transported to the cytosol. However, this is only a single metabolic state of the CHO-K1 
cells. It was evidenced that there are significant differences between the metabolic fluxes 
in CHO-K1 cells in different cultivation setups (shake flask vs. reactor), even if the two 
cultivations used the same cell line and the same media and the sampling was done 
during the exponential growth phase.  
A most interesting finding was related to the different labeling patterns in intracellular 
and extracellular lactate, which could not be explained by cytosol-mitochondria 
compartmentation. Four pyruvate pools were included, two dead-end lactate pools and 
extracellular lactate production channeling for modeling the observed difference in 
labeling. The results show that a large mitochondrial lactate pool is maintained, most 
likely to control the mitochondrial NADH content. Also, due to channeling of lactate 
production, the cytosolic lactate concentration is very small. Because the fitting of 
intracellular lactate left room for improvement, it is possible that the network 
configuration around the pyruvate nodes consists of more complex micro-
compartmented structures (al-Habori, 1995). Such complexity is both a hindrance and an 
opportunity for INST-13CMFA to characterize metabolic networks. Observed 
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mitochondrial pyruvate channeling could be caused by the partial association between 
the recently discovered pyruvate transporter and pyruvate dehydrogenase. A systems 
biology approach that combines biological knowledge from experiments that unravel the 
spatial structure of the mammalian cell metabolism with realistic mathematical models is 
the strategy to follow when studying metabolic networks. Ideally, such strategy accepts 
feedback for guiding future experiments and creating new modeling paradigms that 
include the spatial organization of the metabolism.   
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Supplementary data 4 
Supplem. Figure 4.1. Cultivation profile of the CHO-K1 cells culture during 48 h in 250 
ml baffled shake flask with a working volume of 120 mL. The represented extracellular 
concentrations are in [µmol / L] and the time is in [h]. The values represent the average 
from 4 parallel cultivations. The curves are the fitted values of extracellular 
concentrations simulating an exponential growth model with balanced growth (metabolic 
steady state) over the first 18 h. 
Supplem. Table S4.1. List of reactions used in the stoichiometric model for dynamic 
metabolic flus analysis. 
Supplem. Table S4.2. List of metabolic reactions, fluxes and reversibilities in the central 
carbon metabolism of CHO-K1 estimated for the first 2 – 18 h cultivation period. Carbon 
transfer rules are given in the parentheses for each reaction. Reversible reactions are 
indicated by double arrows. Reversibility is computed as the ratio between the reverse 
flux and the net flux. The 95% confidence interval was evaluated by refitting the model 
until the minimized objective function took the value of χ2(0.95, nr. experimental points 
– nr. parameters). 
Supplem. Table S4.3. Experimental (exp) and simulated (sim) mass isotopomer 
distributions of extracellular metabolites and standard deviations (SD) used in 
simulations. (_ex – extracellular; _cell – intracellular); 
Supplem. Table S4.4. Extracellular concentrations sampled in a 100 mL shake flask 
culture of CHO-K1 cells. (AVG – average from 4 parallel cultivations; SD – standard 
deviation)
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Chapter 5 
5. Identification of active elementary flux modes in 
mitochondria using selectively permeabilized CHO cells*3 
Abstract 
The mitochondrial metabolism of the economically important Chinese hamster ovary 
(CHO) cells was accessed using selective permeabilization. Key substrates were tested 
without and with addition of ADP. Based on quantified uptake and production rates, it 
was possible to determine the contribution of different elementary flux modes to the 
metabolism of a substrate or substrate combination. ADP stimulated the uptake of most 
metabolites, directly by serving as substrate for the respiratory chain, thus removing the 
inhibitory effect of NADH, or as allosteric effector. Addition of ADP favored substrate 
metabolization to CO2 and did not enhance the production of other metabolites. The 
controlling effect of ADP was more pronounced when metabolites were supplied to the 
first part of the TCA cycle: pyruvate, citrate, α-ketoglutarate and glutamine. In the second 
part of the TCA cycle, the rates were primarily controlled by the concentrations of C4-
dicarboxylates. Without ADP addition, the activity of the pyruvate carboxylase – malate 
dehydrogenase – malic enzyme cycle consumed the ATP produced by oxidative 
phosphorylation, preventing its accumulation and maintaining metabolic steady state 
conditions. Aspartate was taken up only in combination with pyruvate, whose uptake also 
increased, a fact explained by complex regulatory effects. Isocitrate dehydrogenase and α-
ketoglutarate dehydrogenase were identified as the key regulators of the TCA cycle, 
confirming existent knowledge from other cells. It was shown that selectively 
permeabilized cells combined with elementary mode analysis allow in-depth studying of 
the mitochondrial metabolism and regulation. 
*3A version of this chapter was submitted as an article to Metabolic Engineering Journal (November 2014). 
All experimental work described herein was carried out by Judith Wahrheit, Christian Weyler and Yannic 
Nonnenmacher. 
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5.1. Introduction 
Eukaryotic cells are able to tune their complex metabolism through compartmentation. 
This involves confining reactions to designated compartments and controlling the access 
of metabolites through specific transporters. Mitochondria play an important part in the 
organization of the eukaryotic cell metabolism (Wahrheit et al., 2011a). They work as the 
powerhouse of the cell, being responsible for the TCA cycle, oxidative phosphorylation 
and other essential reactions in the central carbon metabolism. Furthermore, 
mitochondria play a key role in the signaling processes leading to apoptosis (Kroemer et 
al., 2007). Mitochondrial dysfunctions are associated with the aging process and with a 
wide range of human diseases (Calvo et al., 2006; Duchen, 2004; Lemasters, 2007; 
Moreno-Sanchez et al., 2014; Nassir and Ibdah, 2014; Raimundo et al., 2011; Thiele et al., 
2005). Metabolite traffic between cytosol and mitochondria is mediated by carriers. These 
carriers, excellently reviewed by Palmieri (Palmieri, 2013), have important roles in 
physiological and pathological processes (Gutierrez-Aguilar and Baines, 2013). Studies 
related to mitochondrial function and metabolism focused on isolated features, like 
respiration and the respiratory chain (Frezza et al., 2007; Kuznetsov et al., 2008) or on the 
function of single mitochondrial transporters. Even after the advent of the systems 
biology era, studies of the mitochondrial metabolic network as a whole remain scarce 
(Balaban, 2006). So far, the most complex studies related to mitochondrial metabolism 
used enzyme kinetics, but their results are limited by insufficient knowledge about 
regulation and parameter values (Wu et al., 2007). Studying the mitochondrial 
metabolism in whole cells is complicated by the overlapping with other cellular reactions 
and by the limited accessibility of the mitochondria. Selective permeabilization using 
digitonin (Kuznetsov et al., 2008) is a simple and efficient way to access mitochondria 
while maintaining their functionality (Bahnemann et al., 2014). 
Because mitochondria are capable of taking up several metabolites, either alone or in 
combination, process them through their metabolic network and secrete resulting 
metabolites, new methods are required for analyzing the data obtained from studies of 
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the mitochondrial metabolism. Elementary Mode Analysis (EMA) (Papin et al., 2004; 
Schuster et al., 2000) based on network stoichiometry generates all minimal subsets of 
reactions that can function as standalone metabolic units. Any observed flux distribution 
can be written as a linear combination of elementary modes. Therefore, the contribution 
of a reaction to the metabolic fluxes can be assessed by determining its participation and 
its flux values in the elementary modes. EMA has been used to study metabolic networks 
(Kaleta et al., 2009; Schwartz and Kanehisa, 2006), discover targets for metabolic 
engineering and drug development (Beuster et al., 2011) and to identify high-yield 
mutants of producer strains (Carlson et al., 2002; Neuner and Heinzle, 2011). The main 
application of EMA remains the microbial metabolism because available genome 
annotations and the relatively small network size allow genome-scale analyses. 
Stoichiometric analysis is however gaining an increasingly important role in studying 
mammalian cells (Orman et al., 2010; Orman et al., 2011; Schiff and Purow, 2009; 
Zamorano et al., 2012). 
CHO cells are the mammalian workhorse in the biotechnology industry, responsible for 
the biggest share of biopharmaceuticals production (Jayapal et al., 2007; Walsh, 2010). 
The wealth of studies using CHO cells as model system has led to them being nicknamed 
the “mammalian equivalent of E. coli” (Puck, 1985). They are characterized by the ability 
to grow in suspension cultures using chemically defined media, can reach high cell 
densities and high product titers of recombinant proteins. The availability of recently 
published CHO genome and other omics data (Becker et al., 2011; Brinkrolf et al., 2013; 
Hackl et al., 2011; Xu et al., 2011) facilitates network studies.  
The application of mitochondria-wide metabolic networks adds a new dimension to the 
analysis of mitochondrial metabolism. It permits access for studying interactions of 
several processes, e.g. transport, metabolite conversion, respiration as well as their 
control. This can be done in a most directed way by using intact mitochondria made 
accessible by selective permeabilization of the cell membrane. EMA was used to study the 
metabolism of CHO-K1 mitochondria made accessible through selective permeabilization. 
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Key substrates were screened for their ability to be metabolized by the permeabilized 
cells, both alone or with addition of ADP. The uptake and production of metabolites was 
then quantified. The observations were used to compute the contribution of 
mitochondrial elementary modes to the metabolic flux distribution in each tested case. 
Therefore, this analysis reaches beyond mere metabolic flux analysis by providing 
additional information, e.g. on the coupling of processes or on the control of metabolic 
pathways. Furthermore, the effect of ADP stimulation was quantified and metabolic 
bottlenecks were evidenced. Overall, it was demonstrated that great opportunities arise 
by applying this methodology to study the mitochondrial metabolism. For future studies 
it can easily be combined with other well-established methods, e.g. respiration analysis. 
5.2. Materials and methods/Experimental 
5.2.1. Cell culture 
Cultivation of the CHO-K1 cells was performed in baffled shake flasks (250 ml, Corning, 
New York, USA) in a shaking incubator (Innova 4230, New Brunswick Scientific, Edison, 
NJ, USA) at 135 rpm (2 inches orbit), 37°C and 5% CO2. The cells were cultivated in 
chemically defined, protein-free TC-42 medium (TeutoCell, Bielefeld, Germany), 
supplemented with 6 mM L-glutamine (Sigma-Aldrich, Steinheim, Germany) from a 
240 mM stock solution in dH2O. The cells were passaged at the latest 72 h after 
inoculation and seeded with a cell density of 4 - 5 × 105 cells/mL. 
5.2.2. Preparation of mitochondrial medium 
The mitochondrial medium used in this study was derived from different media used for 
the assessment of respiration in isolated mitochondria (Madeira, 2012) and optimized 
with respect to osmolarity and ionic strength. The composition of the mitochondrial 
medium was as follows: 9.6 mM K2HPO4, 2.4 mM KH2PO4, 80 mM KCl, 75 mM sorbitol, 
2 mM MgCl2 and 100 µM EGTA. The pH was set to 7.4 with 5 N KOH. The individual 
components have been chosen to minimize interactions with the downstream analytics 
(MALDI-ToF, HPLC).  
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5.2.3. Mitochondrial transport experiments 
The experimental set-up is schematically depicted in Fig. 5.1 and the different tested 
substrates and substrate combinations are listed in Table 5.1. CHO-K1 cells were 
harvested from a culture in the early exponential growth phase (48 - 50 h after 
inoculation) by centrifugation (5 min, 125 × g, Labofuge 400R, Function Line, Heraeus 
Instruments, Hanau, Germany). The supernatant was discarded quantitatively and the 
cells were resuspended in mitochondrial medium. Afterwards, the cell number was 
determined using an automated cell counter (Countess® Automated Cell Counter, 
Invitrogen, Karlsruhe, Germany) and set to 107 cells/mL by adding mitochondrial media. 
Selective permeabilization of the cytosolic membrane was performed by adding 0.01 % 
(w/v) digitonin from a 1% stock solution in dH2O and verified under the microscope using 
the Trypan blue exclusion method. 5 mL of permeabilized cell suspension were 
transferred into a 50 mL filter-tube bioreactor (TPP, Trasadingen, Switzerland) 
containing 5 mL of the respective substrate solution (2-fold concentrated in respiration 
medium). The final cell concentration was 5 × 106 cells/mL, the final concentration of 
tested substrates was 4 mM. Considering that the average cell diameter of the CHO line 
was 10.6 µm, a corresponding cell volume of 6.23 × 10-16 m3 (=0.6 pL) was calculated. 
Cytosolic volume was therefore diluted with a factor of at least about 3200. Afterwards, 
incubation was performed for 150 min in a shaking incubator (Innova 4230, New 
Brunswick Scientific, Edison, NJ, USA) at 135 rpm (2 inches orbit), 37°C and 5 % CO2. 
For experiments without ADP-stimulation, 400 µl samples were taken every 30 min. The 
samples were centrifuged (5 min, 6000 × g, Biofuge pico, Heraeus Instruments, Hanau, 
Germany) and the supernatants were frozen for subsequent analysis. For experiments 
with ADP-stimulation, 100 µL of 100 mM ADP (resolved in respiration medium) were 
added every 30 min. 350 µL samples were taken before and after each addition of ADP. 
The samples were centrifuged (5 min, 6000 × g, Biofuge pico, Heraeus Instruments, 
Hanau, Germany) and the supernatants were frozen at -20°C for subsequent analysis. 
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Metabolites in these samples were identified using MALDI-ToF and quantified using 
HPLC. 
 
Figure 5.1. Experimental set-up for mitochondrial transport studies. CHO cells from the early 
exponential growth phase were harvested and resuspended in mitochondrial medium. Selective plasma 
membrane permeabilization with 0.01% (w/v) digitonin was microscopically verified using Trypan blue 
staining. Permeabilized cells were transferred into filter-tube bioreactors, mixed with a mitochondrial 
substrate and incubated in a shaking reactor for mitochondrial transport studies. Sampling (and ADP 
feeding) was performed every 30 min. 
5.2.4. Analytical determination of organic acids and amino acids 
Quantification of tested substrates and resulting products was performed by different 
established HPLC methods as described previously (Strigun et al., 2011). In the presence of 
ADP, citrate could not be quantified at low concentrations because of an unresolvable 
overlay of metabolite peaks in the chromatogram. Identification of organic acids was 
confirmed by MALDI-TOF MS (matrix-assisted laser desorption/ionization time-of-flight 
mass-spectrometry) analysis.   
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Table 5.1. Substrates and substrate combinations used for metabolization by selectively permeabilized 
CHO-K1 cells.  
without ADP stimulation with ADP stimulation 
 No. Substrate(s)  No. Substrate(s) 
1a pyruvate 1b pyruvate, ADP 
2a pyruvate, aspartate 2b pyruvate, aspartate, ADP 
3a citrate 3b citrate, ADP 
4a α-ketoglutarate 4b α-ketoglutarate, ADP 
5a succinate 5b succinate, ADP 
6a fumarate 6b fumarate, ADP 
7a malate 7b malate, ADP 
8a glutamine 8b glutamine, ADP 
9a glutamate 9b glutamate, ADP 
10a aspartate  - - 
11a serine - - 
Since the analytes were negatively charged, the mass spectrometer (ABI 4800, Applied 
Biosystems, Foster City, USA) was operated in negative ion mode. The used laser is a 
Nd:YAG solid-state laser (neodymium-doped yttrium aluminum garnet) emitting UV 
radiation with a wavelength of 355 nm by third harmonic generation. The laser intensity 
was set to 3700 and the number of shots per spot was 1250. The flight distance of the ions 
was doubled by using the reflector-mode, thus achieving an improved mass accuracy. 
Prior to MALDI-TOF MS measurements, the samples were diluted 1:10 with dH2O. This 
was necessary due to the high content of phosphate in the buffer (12 mM), which might 
disturb the measurement by signal suppression. 30 µL of diluted sample were mixed with 
30 µL of matrix (9 mg/mL 9-aminoacridine in methanol) and 0.5 µL of this mixture were 
spotted on a 384-spot MALDI target (Applied Biosystems, Foster City, USA).  
5.2.5. Mitochondrial network 
The model of the mitochondrial reaction network of the CHO-K1 cells (Fig. 5.2) was 
reconstructed using the published genome annotation (Hammond et al., 2012). The 
connection with the extramitochondrial medium is made through carrier-mediated 
transport for large molecules (e.g. amino acids, organic acids, ATP/ADP) and free 
diffusion for small uncharged molecules i.e. O2, CO2 and NH3. The initially formulated 
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network model was reduced by removing reactions and metabolites that cannot 
contribute to the observed uptake and production. Information about compartmentation 
of enzyme activity as determined by Wahrheit et al. (Wahrheit et al., 2014b) for the same 
cell line was also considered. Accordingly, mitochondrial NADP+-dependent malic 
enzyme (ME) was active and mitochondrial PEP carboxykinase was not active. Carriers 
that transport C4-dicarboxylates did not discriminate between succinate and malate. 
With the exception of α-ketoglutarate, glutamine, oxygen and pyruvate, all other 
metabolites are transported reversibly. NAD(P) + transhydrogenase was added to account 
for transferring electrons from NADPH to NADH. The applied stoichiometry of oxidative 
phosphorylation was 2.5 moles of ATP per mole of NADH and 1.5 moles of ATP per mole 
of FADH2 (Hinkle, 2005). In our model, succinyl-CoA ligase used only ADP, and isocitrate 
dehydrogenase (IDH) isoenzymes and glutamate dehydrogenase (GDH) used only NAD+. 
Phosphate and NH3 transport were not included in the stoichiometric model. The 
contribution of extramitochondrial reactions could be excluded because most of the 
possible reactions involving the added substrates or metabolites exported from the 
mitochondria require either cofactors (NADH, NADPH, etc.) or other reaction partners 
that were not present in the extramitochondrial media. Due to more than 3000-fold 
dilution by the selective permeabilization procedure, these metabolites had 
concentrations too low to be detectable. Also, systems for regenerating cofactors are 
absent. In order to prove these assumptions we demonstrated that pyruvate consumption 
was strictly dependent on mitochondrial activities (Suppl. Fig. S1). Pyruvate consumption 
was completely prevented by inhibition of the mitochondrial pyruvate carrier using α-
cyano-4-hydroxycinnamate. The only possible extramitochondrial reactions are those 
that do not need any other substrates than those sampled in the media, e.g. fumarase that 
only requires water as co-substrate. 
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Figure 5.2. Metabolic network of the CHO-K1 mitochondria built based on genome annotation.   - 
Mitochondrial carrier. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – α-
ketoglutarate; ASP – aspartate; C1 – one-carbon units; CIT – citrate; FUM – fumarate; GLN – glutamine; 
GLU – glutamate; GLY – glycine; MAL – malate; MTHF – 5-methyltetrahydrofolate; OAA – oxaloacetate; 
PYR – pyruvate; SER – serine; SUC – succinate; THF - tetrahydrofolate 
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5.2.6. Elementary mode analysis 
The elementary modes of the mitochondrial network were computed using the EFMtool 
software (Terzer and Stelling, 2008). An algorithm was then used to identify, from all the 
elementary modes, the modes that can contribute to the conversion of each tested 
substrate or substrate combinations. This meant: (1) selecting the modes that take up any 
combination of the tested substrates from Table 5.1 and then (2) selecting the modes that 
exclude production of metabolites that were not observed. All possible modes involving 
CO2 were included, though CO2 itself was not measured. The selection is listed in the 
Suppl. Table S1. An observed flux set v can be expressed as a linear combination of 
elementary modes  



M
j
jj EMv
1
       (5.1) 
where M is the total number of elementary modes described by the column vectors EM 
containing the mode stoichiometry. The size of matrix EM is RM, where R is the 
number of reactions. The weight coefficients αj are usually not unique, as the number of 
elementary modes can exceed the dimension of the flux cone. By simplifying the EM 
matrix using the experimental observations and the selection algorithm, a new matrix 
EM# was defined that contains only the transport reactions results. The size of the new 
matrix will be R# by M#, where R# is the number of transport reactions that contribute to 
the observed extracellular fluxes and M# is the number of modes selected using the 
algorithm. The mode flux α representing the contribution of each mode to the measured 
fluxes was computed when the matrix EM# was invertible:  
vEM  1#       (5. 2) 
In some cases, assumptions were made in order to obtain an invertible EM#. These are 
described in the Results and Discussion section, separately for each tested substrate. 
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5.2.7. Metabolic flux analysis 
Mitochondrial fluxes were computed for each feeding situation (Table 5.1) using the 
stoichiometry of the network from Fig. 5.2, the computed extracellular rates and by 
assuming no pyruvate carboxylase activity in the presence of ADP. The complete 
stoichiometry and the results are given in Supplem. Table S5.2. 
5.3. Results and Discussion 
5.3.1. Mitochondrial uptake and production of metabolites 
In a previous study, a high-throughput respiration screening method was applied to verify 
the uptake and metabolization of a range of potential mitochondrial substrates (Wahrheit 
et al., 2015). The outcome of this screening served as starting point to design further in-
depth mitochondrial studies. 
Here, an extended experimental set-up (Fig. 5.1) was used to investigate the 
mitochondrial metabolism of CHO cells. The mitochondrial metabolism in selectively 
permeabilized cells was stimulated by addition of selected substrates or combinations of 
substrates and quantified mitochondrial uptake and production of metabolites (Table 5.2) 
by fitting the extracellular concentrations over time (Supplem. Fig. S5.2). 
Metabolite uptake and production rates remained constant over time (Supplem. Fig. 
S5.2). This proves that the mitochondria remained intact and functioned at metabolic 
steady state throughout the sampling period. It was already shown by Deshpande et al. 
(Deshpande et al., 2009) that CHO cells can be maintained at metabolic steady state in 
defined media. Mitochondrial uptake of aspartate alone was not observed. However, 
aspartate was taken up when fed in combination with pyruvate. Uptake rates of single 
substrates increased in the order of glutamate, serine, pyruvate, citrate, α-ketoglutarate, 
malate, glutamine, and succinate, with the uptake rate for succinate being 7.3 times (C-
mol/C-mol) higher than that of glutamate (Table 5.2). Addition of ADP stimulated the 
uptake and excretion of metabolites by the mitochondria. With feeding of ADP, uptake 
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rates were all higher, increasing in the order of aspartate, pyruvate, malate, succinate, 
citrate, α-ketoglutarate, and glutamine (Table 2). In this case, the uptake rate of 
glutamine was 4.6 times higher than the uptake of aspartate (C-mole/C-mole). It was 
observed that the highest impact of ADP on stimulating the uptake of citrate and α-
ketoglutarate. ADP addition doubled the uptake of aspartate, from 6.1 to 12.2 fmol / (cell 
 min), but not of pyruvate, that increased only by 3.7 fmol / (cell  min) when both 
substrates were fed in combination. 
In accordance with previous mitochondrial studies using respiration analysis (Wahrheit 
et al., 2015), the following trends were observed: (1) stimulation of mitochondrial 
metabolism by addition of ADP, (2) without addition of ADP the highest respiration and 
uptake was observed on succinate, (3) relatively minor impact of ADP on stimulating the 
metabolization of malate and succinate, (4) relatively higher impact of ADP stimulation 
on the uptake of citrate and glutamine. 
Table 5.2. Uptake and production rates of metabolites by the selectively permeabilized CHO-K1 cells [fmol 
/ (cell  min)] and the computed 95% confidence intervals (C.I.) given in square brackets. n.m. – not 
measured. 
No. Substrate 
Uptake rate 
[95% C.I.] 
Product 
Production rate 
[95% C.I.] 
1a pyruvate 4.6 [3.4, 5.7] CO2 n.m. 
1b pyruvate 
ADP 
14.2 [12.6, 15.9] 
n.m. 
CO2 
ATP 
n.m. 
n.m. 
2a pyruvate 
aspartate 
11.9 [10.2, 13.5] 
6.1 [4.0, 8.2] 
glutamate 
CO2 
3.0 [2.5, 3.6] 
n.m. 
2b pyruvate 
aspartate 
ADP 
15.6 [13.8, 17.3] 
12.2 [6.9, 17.6] 
n.m. 
glutamate 
CO2 
ATP 
6.7 [5.4, 8.0] 
n.m. 
n.m. 
3a citrate 5.6 [3.7, 7.5] CO2 n.m. 
3b citrate 
ADP 
38.0 [25.4, 50.6] 
n.m. 
CO2 
ATP 
n.m. 
n.m. 
4a α-ketoglutarate 12.7 [8.1, 17.3] fumarate 
CO2 
0.48 [0.46, 0.50] 
n.m. 
4b α-ketoglutarate 
ADP 
40.2 [30.8, 49.6] 
n.m. 
fumarate 
CO2 
ATP 
2.5 [2.2, 2.7] 
n.m. 
n.m. 
5a succinate 24.5 [19.1, 29.9] fumarate 
malate 
citrate 
CO2 
2.2 [1.7, 2.8] 
14.5 [11, 17.9] 
1.9 [0.9, 2.8] 
n.m. 
  
109 
 
5. Identification of elementary flux modes in mitochondria 
5b succinate 
ADP 
30.5 [27.1, 33.9] 
n.m. 
fumarate 
malate 
citrate 
CO2 
ATP 
2.1 [1.5, 2.8] 
14.6 [10.7, 18.5] 
n.m. 
n.m. 
n.m. 
6a/7a malate 
fumarate 
14.6 [10.2, 19] 
1.9 [0.9, 2.9] 
citrate 
CO2 
4.9 [3.7, 6.0] 
n.m. 
6b/7b malate 
fumarate 
ADP 
19.7 [14.6, 24.8] 
1.7 [0.9, 2.5] 
n.m. 
citrate 
CO2 
ATP 
n.m. 
n.m. 
n.m. 
8a glutamine 20.0 [17.9, 22.1] glutamate 
aspartate 
CO2 
14.4 [11.4, 17.4] 
3.3 [2.4, 4.2] 
n.m. 
8b glutamine 
ADP 
44.7 [35.7, 53.7] 
n.m. 
glutamate 
aspartate 
CO2 
ATP 
19.0 [15.4, 22.6] 
11.4 [9.98, 12.9] 
n.m. 
n.m. 
9a glutamate 2.69 [1.22, 4.16] aspartate 
CO2 
3.38 [2.61, 4.15] 
n.m. 
9b glutamate 
ADP 
3.99 [-14.2, 22.2] 
n.m. 
aspartate 
CO2 
ATP 
15.5 [13.0, 18.0] 
n.m. 
n.m. 
11a serine 4.5 [2.3, 6.7] glycine 2.6 [2.0, 3.2] 
 
5.3.2. Connection of tested substrates and observed products using elementary 
mode analysis 
The mitochondrial elementary modes that connect tested substrates and observed 
products were selected. A total of 1780 elementary modes were generated by applying the 
EFMTool (Terzer and Stelling, 2008) to the network shown in Fig. 5.2, reduced as 
described in the Materials and Methods section and summarized in Supplem. Table S5.2. 
The partitioning of a substrate metabolism into different modes was calculated (Fig. 5.3), 
which was selected using the criteria specified in Supplem. Table S5.1. The production 
rate of a metabolite from a substrate or a combination of substrates is a linear 
combination of all modes that achieve the conversion. The case presented in Fig. 5.3 
allows to compute the mode fluxes through A, B and C if the uptake of Substrate 1 and 
Substrate 2, as well as the production of Product 1 and Product 2 are measured. However, 
there were situations when the matrix describing the linear system relating mode fluxes 
to external fluxes (eq. 2) was not invertible. The contribution of each mode to the 
metabolism of all substrates was calculated without supplementary assumptions with the 
  
110 
 
5. Identification of elementary flux modes in mitochondria 
following exceptions: (1) when pyruvate and aspartate were used together (Table 5.2), (2) 
when succinate and malate were used with ADP because citrate could not be 
experimentally determined, and (3) when glutamate was used, due to experimental noise. 
Situations that require reuptake of metabolites via antiport were also removed as 
including them would result in futile cycling between mitochondria and the 
extramitochondrial media. The selected modes and their computed contribution to each 
observed flux are given in Supplem. Table S5.3. 
 
Figure 5.3 - Example of establishing the partitioning of Substrate 1 and Substrate 2 into the elementary 
modes (A), (B) and (C) for yielding Product 1 and Product 2. The thickness of the arrows indicates the 
theoretical flux through each elementary mode. 
5.3.3. General characteristics 
While in the majority of cases a full metabolization to CO2 was possible, many substrates 
led to partial TCA cycle activity and to secretion of metabolites. All experiments where 
ADP was supplied exhibited higher uptake rates for all tested substrates. This happens 
mainly because (1) ADP increases the availability of NAD+ via the respiratory chain and 
(2) ADP stimulates pyruvate dehydrogenase, isocitrate dehydrogenase and α-
ketoglutarate dehydrogenase (AKGDH), three key enzymes responsible for controlling 
the TCA cycle (Michal and Schomburg, 2012; Strumilo, 2005). In the modes where ADP is 
not supplied, the pyruvate carboxylase (PCX) – malate dehydrogenase (MDH) – malic 
enzyme (ME) cycle is highly active to consume the excess of ATP produced by oxidative 
phosphorylation. It was shown earlier that ME is active in the mitochondria of the CHO-
K1 cell line (Wahrheit et al., 2014b). PCX was found in the mitochondria of mouse cells 
(Da Cruz et al., 2003; Mootha et al., 2003) and was also evidenced as a necessary flux in 
CHO cells (Goudar et al., 2010; Nicolae et al., 2014; Sheikholeslami et al., 2013; Templeton 
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et al., 2013). Using 13C metabolic flux analysis (Nicolae et al., 2014), a PCX flux equivalent 
to 1.56 fmol / (cell  min) was calculated. The activity in vivo is approx. 150-fold times 
smaller than the maximum activity computed for permeabilized cells in the absence of 
ADP. This fact indicates the regulatory effect of ATP/ADP ratio on the PCX. The PCX – 
MDH – ME cycle is the rate-limiting element in metabolizing substrates in the absence of 
ADP since NAD+ and FAD are not regenerated in the respiratory chain, while 
accumulated ATP and NADH inhibit most enzymes involved in the TCA cycle (Michal 
and Schomburg, 2012). ME was responsible for replenishing pyruvate from malate to 
produce the acetyl-CoA required for initiating the citrate synthase reaction when 
pyruvate was not added. The modes that use the PCX – MDH – ME cycle to consume ATP 
were not considered when computing the mode fluxes with added ADP, although it 
would be theoretically possible for them to contribute to the observations. Using this 
assumption, the cells dispose of the produced ATP only by antiport with ADP. This is a 
valid assumption considering that PCX is strongly inhibited by high ADP concentrations 
(Keech and Utter, 1963; Walter and Stucki, 1970). 
In the mitochondria, glutamate dehydrogenase and isoenzymes of IDH can use both 
NAD+ and NADP+ as cofactors. NADPH produced by NADP+-dependent malic enzyme, 
glutamate dehydrogenase and IDH is oxidized by the transhydrogenase enzyme and 
NADH is produced. The conversion of NADPH is coupled with pumping H+ out of the 
mitochondria thereby contributing to building up the proton gradient across the inner 
mitochondrial membrane. Another pathway for transferring reducing factors from 
NADPH to NADH is by the reverse functioning (towards isocitrate) of the NADP+-
dependent IDH and isocitrate consumption by the NAD+-dependent IDH (Sazanov and 
Jackson, 1994). Also, ATP synthesis can become partially uncoupled from respiration 
through the presence of uncoupling proteins (Boss et al., 2000; Moreno-Sanchez et al., 
2014) or reduced due to proton and electron leakage (Jastroch et al., 2010). This can 
change the stoichiometry of using reducing equivalents to produce ATP, hence of the 
computed activity of the PCX – MDH – ME cycle when ADP is not provided. However, 
uncoupling proteins were not found to be expressed in wild-type CHO cells (Pecqueur et 
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al., 2008) but were shown to play a role in other cells concerning thermogenesis, 
protection against oxidative stress, export of fatty acids or mediation of insulin secretion 
(Mozo et al., 2006). One can therefore assume that the effect of uncoupling is negligible 
for balancing ADP/ATP. 
5.3.4. Pyruvate and aspartate 
Pyruvate fed alone sustained a complete TCA cycle. Upon stimulation with ADP, the 
pyruvate uptake flux increased 3.1 times (Table 5.2). Mitochondrial metabolism of 
pyruvate requires an active mitochondrial pyruvate carrier and all mitochondrial enzymes 
that metabolize pyruvate to CO2 (Figure 5.4 A1, 5.4 B1). When pyruvate and aspartate 
were fed together, the two metabolites had a reciprocal stimulating effect. In a separate 
experiment, aspartate alone was not taken up. The uptake of pyruvate in the presence of 
aspartate increased 2.6 times compared to the uptake of pyruvate alone. A double amount 
of aspartate was taken up per amount of glutamate produced (Table 5.2). Four possible 
elementary modes can be used to explain the observations: (1) uptake of pyruvate to 
produce CO2, (2) co-uptake of pyruvate and aspartate to produce CO2 and one mole of 
glutamate per mole of aspartate, (3) uptake of aspartate to produce CO2 and one mole of 
glutamate per two moles of aspartate and (4) uptake of aspartate to produce only CO2. 
Aspartate uptake through the glutamate-aspartate carrier occurs with equimolar 
secretion of glutamate. Glutamate must be partially re-transported into the mitochondria 
through a different carrier (Fiermonte et al., 2002) to account for the aspartate 
uptake/glutamate secretion rate ratio of 2. Surprisingly, the stoichiometry of the mode 
with co-uptake of pyruvate and aspartate (mode (2)), where aspartate provides one mole 
of oxaloacetate and pyruvate provides one mole of acetyl-CoA to fuel the TCA cycle, does 
not match the observed rates. Therefore, aspartate (Fig. 5.4 A3, B3) and pyruvate (Fig. 5.4 
A2, B2) must be metabolized individually. Although aspartate is only taken up in 
combination with pyruvate, its metabolization happens via modes that exclude pyruvate. 
This is possible by mutual activation of modes, i.e. activation of rate controlling enzymes.  
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Figure 5.4. Fluxes of the mitochondrial elementary modes determined after feeding the permeabilized cells 
pyruvate (A1, B1) and a combination of pyruvate and aspartate (A2, A3, B2, B3). Modes from lines 1 and 2 
metabolize pyruvate to CO2. Modes from line 3 metabolize aspartate to glutamate and CO2. The modes in 
the A-column do not use supplied ADP, and the modes in the B-column contained ADP as substrate. The 
fluxes higher than 60 fmol/ (cells  min) are indicated by numbers on the corresponding arrow. Subscripts: 
m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – α-ketoglutarate; ASP – aspartate; CIT – 
citrate; FUM – fumarate; GLU – glutamate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SUC – 
succinate. 
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The first regulatory step in the conversion of aspartate is aspartate aminotransferase, 
which is controlled by products and substrates following complex kinetics (Cascante and 
Cortes, 1988). This enzyme converts aspartate to oxaloacetate simultaneously with 
converting α-ketoglutarate to glutamate. Glutamate is exchanged when aspartate enters 
the mitochondria (Fig. 5.2). Production of α-ketoglutarate in the TCA cycle is needed to 
sustain the outflow of glutamate (Fig. 5.4 A3). Aspartate accumulation was observed in 
retina cells treated with an inhibitor of the mitochondrial pyruvate carrier (Du et al., 
2013), which suggests that aspartate needs pyruvate for metabolization. Although 
oxaloacetate could exert product inhibition on PCX (Barden et al., 1972), it is consumed 
by MDH to produce malate, while the acetyl-CoA synthesized from pyruvate activates 
PCX (Jitrapakdee and Wallace, 1999), thus favoring the PCX-MDH-ME cycle towards 
hydrolyzing the ATP produced from the intramitochondrial pool of ADP in the 
respiratory chain. ME activity could be another bottleneck in the conversion of pyruvate 
and aspartate in the absence of ADP. It was shown that α-ketoglutarate inhibits 
mitochondrial ME and MDH in brain cells (McKenna et al., 1995). Therefore, ME activity 
depends on the efficiency of α-ketoglutarate removal from the mitochondria as 
glutamate. 
Addition of ADP to the pyruvate-aspartate mixture did not change the pyruvate uptake 
flux, compared to when pyruvate and ADP were used. The most probable limitation in 
this case is pyruvate transport into the mitochondria, which was shown to influence the 
respiration capacity in yeast (Timon-Gomez et al., 2013) and is suspected to regulate 
pyruvate metabolism in cancer cells (Schell and Rutter, 2013). Aspartate uptake flux 
increased although the aspartate/glutamate ratio remained close to 2 (Table 5.2), 
comparable to the case without ADP. This result strengthens the assumption that the 
mode which uses aspartate to produce glutamate and CO2 is responsible for aspartate 
metabolism by the mitochondria.  
Pyruvate catabolism to CO2 is limited to approx. 15 fmol/ (cell  min) in all the three 
cases where other substrates were used together with pyruvate (i.e. ADP, aspartate, 
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aspartate and ADP). In a previous study of CHO-K1 metabolism (Nicolae et al., 2014), the 
in vivo computed rate of pyruvate transport into the mitochondria was 4 fmol/ (cell  
min), which is in the same order of magnitude. This suggests the existence of a tightly 
controlled upper threshold in the mitochondrial pyruvate metabolism achieved using the 
pyruvate transporter and/or allosteric control by the pyruvate dehydrogenase complex. 
5.3.5. Citrate 
It was observed no metabolite production when citrate was used as substrate, also when 
ADP was added. Because citrate is taken up by antiport with C4-carboxylates, these were 
taken up again via the dicarboxylate carrier (Fig. 5.5 A, B) thus explaining their absence in 
the extramitochondrial medium. For this, several mechanisms can be assumed: (1) the 
dicarboxylate carrier can take up dicarboxylates at very low extramitochondrial 
concentrations, (2) reuptake of C4-carboxylates occurs via a mechanism that bypasses 
their dilution into the media by maintaining a high concentration in the inter-membrane 
space, (3) there is a mitochondrial carrier that takes up citrate alone, (4) there is 
cooperation between the citrate (Gnoni et al., 2009) and the dicarboxylic carriers. When 
ADP was added, there was a significant stimulation of citrate metabolization (Fig. 5.5 B), 
citrate being the metabolite taken up with the highest carbon flux and the substrate that 
produced the highest activity of the TCA cycle (Supplem. Table S5.2). 
ADP and citrate have a joint activating effect on IDH, which is a limiting step of the TCA 
cycle as previously found for this cell line by Wahrheit et al. (Wahrheit et al., 2014b). The 
effect is also in qualitative accordance with respiration studies performed on selectively 
permeabilized CHO-K1 cells (Wahrheit et al., 2015), where a high stimulation of 
respiration was observed when citrate was used together with ADP. Citrate is known to 
inhibit citrate synthase (Williamson and Cooper, 1980), which would in this case be a 
bottleneck in the TCA cycle. However, citrate is consumed quickly by enzymes 
downstream the TCA cycle, IDH and AKGH, leading to low citrate and isocitrate 
concentrations and a release of its inhibiting effect.  
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Figure 5.5. Fluxes of the mitochondrial elementary modes that completely oxidize citrate to CO2. 
Mode A does not contain added ADP, and mode B uses ADP as substrate. The fluxes higher than 60 fmol/ 
(cell  min) are indicated by numbers on the corresponding arrow. Subscripts: m – mitochondrial. 
Abbreviations: AcoA – acetyl-CoA; AKG – α-ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; 
OAA – oxaloacetate; PYR – pyruvate; SUC – succinate. 
Citrate and isocitrate uptake by the mitochondria is not a typical physiological event 
described for the metabolism of mammalian cells. In contrast, citrate is usually 
transported from the mitochondria to supply the fatty acid synthesis in the cytosol. 
However, given the high cytosolic IDH activity (Wahrheit et al., 2014b), it is possible that 
in a physiological state the excess of NADPH generated by the pentose phosphate 
pathway (Nicolae et al., 2014) drives the reaction towards consuming α-ketoglutarate. A 
reversed functioning of the IDH (Metallo et al., 2012) has been described before for 
mammalian metabolism. Isocitrate and citrate are then produced from cytosolic α-
ketoglutarate and then taken up by the mitochondria to be used in the TCA cycle. 
5.3.6. α-ketoglutarate 
Similarly to citrate, α-ketoglutarate could sustain a complete TCA cycle (Fig. 5.6 A). And 
similar to citrate, α-ketoglutarate enters the mitochondria using the α-ketoglutarate-
dicarboxylate antiporter (Fig. 5.6 A, B1, B2) and the reuptake of malate via the C4-
dicarboxylate carrier. Malate reuptake is not quantitative, as seen in the presence of a 
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small quantity of fumarate in the extramitochondrial media (Table 5.2, 4a), produced 
most probably by extramitochondrial fumarase activity. Though it was shown for 
astrocytes that α-ketoglutarate inhibits ME (McKenna et al., 1995), this effect was not 
manifested in our experiments, considering the high metabolization rate in the absence 
of ADP and hence the high ME flux (Fig. 5.6 A). This means that in the mitochondria, α-
ketoglutarate concentration was maintained low even when the concentration in the 
media was high. With addition of ADP, the activation of IDH and AKGDH results in a 3-
fold increase in α-ketoglutarate uptake rate.  
 
Figure 5.6. Fluxes of the mitochondrial elementary modes that completely oxidize α-ketoglutarate 
to CO2 in the absence of ADP (A), with added ADP (B1) and the mode that produces extramitochondrial 
fumarate in the presence of ADP (B2). The fluxes higher than 60 fmol/ (cell  min) are indicated by 
numbers on the corresponding arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; 
AKG – α-ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; 
SUC – succinate. 
5.3.7. C4-dicarboxylates 
Succinate and malate were metabolized by the mitochondria with a relatively high rate, 
both with and without addition of ADP. They were transported through the dicarboxylate 
carrier, which requires mitochondrial phosphate antiport (Fiermonte et al., 1998). 
Phosphate is then replenished through another transport system e.g. via the phosphate 
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carrier (Hamel et al., 2004). Extracellular fumarate was converted to malate before being 
taken up in a fast equilibrium reaction, probably by extramitochondrial fumarase activity 
(Supplem. Fig. S5.2). The equilibrium reaction explains the presence of fumarate in the 
media when malate is produced from succinate (Fig. 5.7 A4, B4). 
 
Figure 5.7. Fluxes of the mitochondrial elementary modes that metabolize succinate to CO2 (A1, 
B1), succinate to malate (A2, B2), succinate to citrate and CO2 (A3, B3) and succinate to fumarate 
(A4, B4). The modes in the A-column do not use supplied ADP, and the modes in the B-column contained 
ADP as substrate. The fluxes higher than 60 fmol/ (cell  min) are indicated by numbers on the 
corresponding arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – α-
ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SUC – 
succinate. 
Addition of ADP increased the metabolization rate of succinate to CO2 2.5 times (Fig. 5.7 
A1, B1) and of malate 1.7 times (Fig. 5.8 A1, B1). Succinate was converted to malate with the 
same rate in both non-stimulated (Fig. 5.7 A2) and stimulated (Fig. 5.7 B2) cases. It can be 
inferred that fast pathway kinetics between succinate and malate and reduced activity in 
disposing of malate in the TCA cycle leads to accumulation that favors malate secretion 
instead of full metabolization. Compared to the high metabolization rates observed for 
citrate and α-ketoglutarate, the supply of C4-dicarboxylates resulted in a lower activity of 
the TCA cycle. This implies that the second part of the TCA cycle, involving C4-
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dicarboxylates, is mainly controlled by the concentrations of C4-dicarboxylates and less 
by the availability of cofactors. The metabolic steady state and therefore the 
intramitochondrial C4-dicarboxylates concentrations are maintained by removing the 
excess from the mitochondria via the dicarboxylate carrier. Complete catabolism to CO2 
in the absence of ADP was 17% for succinate and 48% for malate, and with ADP it was 
increased to 33% and 60% respectively. Citrate production from either succinate (Fig. 5.7 
B3) or malate (Fig. 5.8 B2) suggests that high cytosolic concentrations of dicarboxylates 
induce de novo fatty acids synthesis by providing citrate to the cytosol, as it was shown on 
mouse models (Mizuarai et al., 2005). 
Analytical determination of citrate was difficult in the presence of ADP due to an overlay 
of metabolite peaks in the chromatogram. Although the uptake fluxes of C4-
dicarboxylates increased, the modes were computed under the assumption that the 
citrate secretion rate did not increase. This assumption relied on the fact that ADP 
enhances significantly the metabolization of citrate, as it was shown above (Fig. 5.5 B). 
Also, the situation when citrate is produced and then taken up for metabolization to CO2 
is equivalent to a mode that metabolizes C4-dicarboxylates to CO2. It is therefore unlikely 
that citrate will accumulate in the media when ADP is added. 
5.3.8. Glutamine and glutamate 
Mitochondria of permeabilized cells took up glutamine via the glutamine carrier 
(Hassanein et al., 2013; Indiveri et al., 1998) and used it to produce mostly glutamate, with 
a conversion of glutamine to glutamate (computed as the glutamate production flux to 
glutamine uptake flux) of 72% in the absence of ADP (Fig. 5.9 A3). By adding ADP, the 
conversion to glutamate decreased to 42% (Fig. 5.9 B3) although the net production rate 
increased by 32%. The glutamine uptake rate of the permeabilized cells was approx. 50 
times higher than determined in vivo (Nicolae et al., 2014).  
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Figure 5.8. Metabolic fluxes of the mitochondrial elementary modes that metabolize malate to CO2 
(A1, B1) and malate to citrate and CO2 (A2, B2). The modes in the A-column do not use supplied ADP, 
and the modes in the B-column contained ADP as substrate. The fluxes higher than 60 fmol/ (cell  min) 
are indicated by numbers on the corresponding arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA 
– acetyl-CoA; AKG – α-ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; 
PYR – pyruvate; SUC – succinate. 
 
Glutamate leaves the mitochondria through a different transport system than the 
aspartate-glutamate carrier, most likely the glutamate carrier (Fiermonte et al., 2002). 
The glutamate carrier has been shown to operate in the reverse direction, hence by 
removing glutamate from the mitochondria when it is produced in excess. The supply of 
cytosolic glutamate could then be used in vivo for transamination, e.g. the production of 
alanine, and also for glutamine synthesis, as it was described previously (Nicolae et al., 
2014; Wahrheit et al., 2014a). When compared to the glutamine derivate α-ketoglutarate, 
the TCA cycle flux was four times smaller on glutamine than on α-ketoglutarate in the 
absence of ADP and half when ADP was supplied. Glutamine metabolism must therefore 
  
121 
 
5. Identification of elementary flux modes in mitochondria 
be regulated before glutamine reaches the TCA cycle as α-ketoglutarate. Because GDH is 
activated by ADP (Fang et al., 2002), glutamine catabolism to CO2 by a full TCA cycle 
increased significantly in the presence of ADP (Fig. 5.9 A1, B1), indicating that this 
enzyme is the first step in controlling glutamine metabolism. The presence of 
extramitochondrial glutamate also activated the secretion of aspartate (Fig. 5.9 A2, B2), 
reversely as in the case with aspartate feeding (Fig. 5.4 A3, B3), when glutamate was 
produced. Most likely, the aspartate-glutamate carrier equilibrates the mitochondrial 
concentrations of these two amino acids and its response is influenced only by their 
intracompartmental concentrations. 
Glutamate was taken up in modest amounts in the absence of ADP, and aspartate was 
produced in nearly equimolar amounts, considering the confidence intervals of the rates 
computed for glutamate uptake and aspartate production (Table 5.2). Glutamate 
concentration could not be determined reliably when using ADP (Supplem. Fig. S5.1, 9b). 
Nevertheless, an increased production of aspartate was observed, which indicates that 
glutamate uptake increased considerably by adding ADP. This means that the preferred 
uptake system for glutamate is the glutamate-aspartate carrier and not the glutamate 
carrier (Fiermonte et al., 2002). 
5.3.9. Serine 
Serine was taken up by the permeabilized cells in moderate amounts (Table 5.2). 
Consistent with previous studies (Appling, 1991; Barlowe and Appling, 1988; Narkewicz et 
al., 1996), serine is converted by mitochondrial serine hydroxymethyltransferase to 
produce glycine and C1 units, that can subsequently be converted to and secreted as 
formate (not measured) (Fig. 5.2) (Kelley et al., 2002). Only 59% of the glycine that could 
be potentially produced was secreted. The remaining glycine was most likely converted 
by the glycine cleavage system into C1 units and CO2. The NADH produced in the glycine 
cleavage reaction is then consumed by the PCX-MDH-ME cycle to maintain the 
metabolic steady state in the mitochondria. Regeneration of tetrahydrofolate from 
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methyltetrahydrofolate produces NADPH that contributes significantly to the 
mitochondrial metabolism under in vivo conditions (Lewis et al., 2014).  
 
Figure 5.9. Metabolic fluxes of the mitochondrial elementary modes that metabolize glutamine to 
CO2 (A1, B1), glutamine to aspartate and CO2 (A2, B2) and glutamine to glutamate (A3, B3). The 
modes in the A-column do not use supplied ADP, and the modes in the B-column contained ADP as 
substrate. The fluxes higher than 60 fmol/ (cell  min) are indicated by numbers on the corresponding 
arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – α-ketoglutarate; ASP – 
aspartate; CIT – citrate; FUM – fumarate; GLN – glutamine; GLU – glutamate; MAL – malate; OAA – 
oxaloacetate; PYR – pyruvate; SUC – succinate. 
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5.4. Conclusions 
Selectively permeabilized CHO-K1 cells proved to be a useful system for detailed studies 
of the mitochondrial metabolism. The permeabilized cells retain functional mitochondria 
that are able to process at metabolic steady state various single substrates or 
combinations of carbon sources. By using EMA it was evidenced that the mitochondrial 
reactions involved in the TCA cycle, anaplerotic and cataplerotic reactions, amino acid 
metabolism, as well as the oxidative phosphorylation and mitochondrial transport are 
active. Beyond demonstrating the functionality of mitochondrial metabolic pathways, 
EMA was used to support the observations from earlier screening experiments (Wahrheit 
et al., 2015). Additionally, the contributions of separate pathways at processing a certain 
substrate or combination of substrates could be quantified. 
In the absence of ADP, substrate uptake was limited in most cases. Full metabolization to 
CO2 has been observed for pyruvate, citrate, α-ketoglutarate, C4-dicarboxylic acids and 
glutamate. This requires an active PCX-MDH-ME cycle that disposes of the ATP 
generated by oxidative phosphorylation. The PCX-MDH-ME cycle is the limiting step in 
processing substrates, as the accumulation of ATP and NADH inhibits key enzymes 
involved in the TCA cycle. Since uncoupling proteins were not found to be expressed in 
wild-type CHO cells (Pecqueur et al., 2008) uncoupling can be excluded in our 
experiments. 
Stimulation by ADP enhanced respiration and the metabolization to CO2 of most 
substrates, as shown by Wahrheit et al. (2015), with considerable differences for α-
ketoglutarate and citrate and less for C4-dicarboxylic acids. The differences are explained 
by the way in which the enzymes of the TCA cycle are controlled. In the first part of the 
TCA cycle, IDH and AKGDH are positively modulated by substrate and cofactor 
availability. The fluxes of the second part of the TCA cycle involving the inter-conversion 
of C4-dicarboxylates seem to be determined primarily by the concentration of C4-
dicarboxylates. The high concentrations of C4-dicarboxylates could inhibit enzymes that 
do not process them directly. This effect may lead indirectly to a reduced TCA cycle flux. 
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Glutamine metabolism is controlled by GDH and by removing glutamate from the 
mitochondria via the glutamate carrier. The summarized conclusions are organized by 
the feeding experiments that support them in Supplem. Table S5.4. 
A question mark that is left after analyzing our results is related to the regulatory role 
played by the mitochondrial carriers. Little is known about their function to control 
metabolite concentrations for achieving a specific metabolic state in the mitochondria. 
Knowledge about regulation of mitochondrial transporters would improve the 
understanding of the mitochondrial metabolic system. Complex regulatory effects that 
span over more reactions are difficult to establish without further information about 
transporter properties. The discovery and characterization of new mitochondrial carriers 
able to transport the tested substrates and observed products would expand the number 
of elementary modes that are computed. The findings obtained using our approach 
indicate a limiting role of the pyruvate carrier, a high sensitivity of the aspartate-
glutamate antiporter for balancing the content of these amino acids in the mitochondria, 
and a potential cooperation between the citrate and the dicarboxylate carrier. Also, 
determining intracompartmental concentrations under selected feeding conditions would 
be of great value at establishing the control checkpoints in the mitochondrial 
metabolism. Off-gas analysis of O2 and CO2 would add extra constraints to the linear 
system used to calculate the mode fluxes, making possible the resolution of more 
complex modes, where e.g. more substrates are taken up together. Sampling ADP and 
ATP concentrations would enable the quantification of uncoupling effects particularly for 
the study of certain diseases or toxic effects of test compounds. 
Using selectively permeabilized cells and flux analysis methods provides a great system 
for metabolic studies that aim at understanding diseases related to mitochondrial 
dysfunctions or at debottlenecking the metabolic connection between mitochondria and 
cytosol. By removing the background noise of cytosolic reactions, it becomes possible to 
study the effect of transport or enzyme inhibitors and of genetic modifications of the 
mitochondrial enzymes on the mitochondrial metabolism.  
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Supplementary data 5 
Supplem. Figure S5.1. Experimental (o) and fitted (-) extracellular concentrations 
in the experiments with permeabilized CHO-K1 cells. r – production rate [fmol/ (cell 
 min)]. The brackets contain the 95% confidence interval for the rate. 
Supplem. Table S5.1. Selection of the elementary modes that can describe the 
observed metabolite uptake and production. The modes are selected accordingly to 
the following criteria:  u - the metabolite is taken up; p - the metabolite is produced; xu - 
the metabolite is not taken up; xp - the metabolite is not produced; iu - the metabolite is 
or is not taken up; ip - the metabolite is or is not produced. 
Supplem. Table S5.2. Mitochondrial fluxes [fmol / cell  min] in selectively 
permeabilized CHO-K1 cells under various feeding conditions. The fluxes were computed 
using the determined extracellular rates and the stoichiometry indicated by reactions R1-
R50. By addition of ADP it was assumed that the flux R44=0.  
Supplem. Table S5.3. Stoichiometry of the modes selected using the Table S1 and 
the contribution to each mode to the total flux in each feeding experiment using 
selectively permeabilized CHO-K1 cells [fmol / cell  min]. 
Supplem. Table S5.4. Conclusions on mitochondrial enzymes and transporters 
activity and about regulation of the mitochondrial metabolism resulted by applying 
elementary mode analysis to the observations from feeding experiments with selectively 
permeabilized CHO-K1 cells. The gray areas indicate the experiments on which each 
corresponding conclusion was based. 
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Chapter 6 
6. Conclusions and outlook 
In the present work, systems biology tools were developed and applied using CHO-K1 as a 
model mammalian system to study metabolic compartmentation between mitochondria 
and cytosol. The focus was to use mathematical modeling first to reveal details about the 
topology of compartmented metabolic networks in eukaryotes and second, what role 
plays compartmentation at controlling metabolic fluxes and metabolite availability in the 
larger scheme of cellular metabolism. 
The systems biology tools that were applied are (1) non-stationary 13C metabolic flux 
analysis (Inst-13CMFA), (2) dynamic metabolic flux analysis (dyMFA) and (3) elementary 
mode analysis (EMA). A software platform for Inst-13CMFA was developed and tested first 
on S. cerevisiae. The model was then extended to include the dynamics of extracellular 
isotopomers by including growth, changes in the extracellular concentrations and 
metabolite exchange with the media. The mass isotopomers of extracellular metabolites 
in a batch culture of CHO-K1 cells was sufficient to compute the metabolic fluxes for a 
detailed, compartmented network. Even though some metabolites are taken up with net 
fluxes, they were found labeled in the extracellular media. Sometimes, like in the case of 
pyruvate, they were exchanged with a very high flux. This means that the media is not 
only a source of substrates for the cells, but it is also an important environment, playing 
the role of another compartment. 
By applying what was named “high resolution Inst-13CMFA”, which is Inst-13CMFA using 
both intra- and extracellular labeling from parallel labeling experiments using different 
labeled substrates, it resulted that the metabolism of CHO-K1 cells is not only 
compartmented, but also most likely spatially structured. Enzyme association and 
metabolite channeling create microenvironments that separate metabolite pools in the 
same compartment. Pyruvate channeling was determined in both cytosol and 
mitochondria. In the cytosol, a possible association of glycolytic enzymes to the cell 
  
127 
 
6. Conclusions and outlook 
membrane produced secreted lactate labeled differently than the cytosolic pool. The 
assumption of glycolytic pyruvate-to-secreted lactate channeling is also supported by the 
very low cytosolic concentrations that were estimated for these organic acids. 
CHO-K1 cells growing in the exponential phase require high amounts of NADPH to be 
consumed by fatty acids synthesis and to mitigate the oxidative stress related to high 
mitochondrial respiration and protein folding and unfolding futile cycles (Klein et al., 
2015). The main source of cytosolic NADPH is a high PPP activity, similar to cancer cells. 
No or little cytosolic activity of ME and IDH was estimated using Inst-13CMFA, these two 
enzymes being the only other possible sources of NADPH. Cytosolic ME activity was not 
detected experimentally (Wahrheit et al., 2014b) nor simulated, but high cytosolic activity 
of IDH determined by (Wahrheit et al., 2014b) did not reflect in flux estimations. It is 
possible that cytosolic IDH has more a protective role than as a NADPH 
producer/consumer (Lee et al., 2002). Although the in vivo activities of mitochondrial ME 
and PCX were modest, their activity together with that of MDH formed a futile cycle 
which ran at high flux. This cycle has the purpose to recycle ADP from ATP when ADP is 
not provided together with the metabolized mitochondrial substrate. The flux values are 
the maximum possible when in the mode flux calculation it is considered that uncoupling 
and proton leakage do not occur. 
Inst-13CMFA revealed that some pathways for synthesis and degradation of non-essential 
amino acids occur simultaneously, but in different compartments. Key metabolites, e.g. 
malate and glutamate, are cycled via several mitochondrial carriers between 
mitochondria and cytosol. A dynamic control of the cytosolic and mitochondrial NADH 
pools could be a reason for this observation, as these two metabolites are part of the 
aspartate-malate shuttle. The aspartate-glutamate mitochondrial carrier contributes to 
the shuttle activity by controlling the content of these two amino acids in the 
compartments, as it resulted from studies using selectively permeabilized cells. 
Selectively permeabilized cells consumed substrates at considerably higher rates than 
those estimated in vivo. An exception is uptake of pyruvate by the mitochondria, which 
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was comparable in both cases. Mitochondrial uptake of pyruvate combined with the 
activity of the PDH complex is most likely the bottleneck in the split of pyruvate between 
glycolysis and the TCA cycle.  Because of its complex regulation pattern, PDH was already 
indicated as bottleneck reaction in the pyruvate metabolism of cancer cells (Israel and 
Schwartz, 2011). However, as it was shown in Chapter 5, the control of metabolism does 
not operate through individual reactions. The example of aspartate being taken up by 
mitochondria only in the presence of aspartate is an important indication of systemic 
interactions. Enzyme co-regulation, transporter cooperation and metabolite 
inhibition/stimulation effects are all advocates for employing systemic characterizations 
of mammalian cells instead of gene-focused or reaction-focused approaches. This is 
especially important when the goal is to understand the causes/effects of a disease or to 
optimize the cell for production of biopharmaceuticals. 
Labeling experiments where exchange with the media occurs must consider the influence 
of the extracellular labeling. As this process becomes dynamic due to changes in the 
extracellular concentrations and cell growth, only a dynamic model can accurately 
describe the labeling state of the cell. In this context, Inst-13CMFA proved to be an 
effective tool for estimating metabolic fluxes considering the narrow confidence intervals 
that were computed. Experiments using selectively permeabilized cells provided direct 
access to the mitochondrial metabolism and contributed to establishing the topology of 
the mitochondrial metabolism. This led to revealing not only the activity of certain 
enzymes or transporters, but the activity of whole mitochondrial pathways. The key 
highlights of the methods that were described in this thesis are:  
● INST-13CMFA using only extracellular labeling: can be applied industrially, useful to 
reveal compartmented fluxes, can be used to estimate the fluxes of metabolite exchange 
with the media. 
● High resolution INST-13CMFA: estimate metabolic fluxes in a complex network with 
small confidence intervals, estimate reaction reversibility, estimate fluxes and exchange 
  
129 
 
6. Conclusions and outlook 
at the cytosol/mitochondria boundary, estimate intracompartmental concentrations, 
can be used to uncover details about metabolite channeling. 
● Dynamic metabolic flux analysis: determine metabolic switches, correlate switches 
with changes in metabolite availability and with cell growth. 
● EMA applied to analyze feeding experiments using selectively permeabilized cells: 
reveal the activity of whole mitochondrial pathways (including transporters), reveal 
regulatory effects observed by using more mitochondrial substrates. 
Mammalian metabolism is a complex system that is tightly controlled at several levels. In 
this framework, compartmentation allows the cells to maintain stable states, e.g. 
exponential growth, under highly dynamic extracellular conditions where substrates are 
depleted and secreted products accumulate. For this reasons, the methods that were 
employed herein would be greatly complemented by larger scale models, which are able 
to simulate growth in a comprehensive manner. Genome scale initiatives have already 
been set in place for plant cells (de Oliveira Dal'Molin and Nielsen, 2013), the human 
genome reconstruction is already available owing to a concerted scientific effort (Mo et 
al., 2007; Thiele et al., 2013), based on which a mouse reconstruction was also built 
(Sigurdsson et al., 2010). Given the immense economic importance of this cell line, it is to 
be expected that a genome scale model of the CHO cell line will soon be available (Borth, 
2014; Kaas et al., 2014). However, if genome scale models are to be used for fluxomics, the 
same problems related to alternative pathways and cycles will be encountered. Such 
fluxes cannot be solved by flux balancing. To minimize this uncertainty, a future option 
for comprehensive genome-scale fluxomics is combining genome scale models with 
13CMFA. The labeling information can be used in the objective function that constrains 
the flux space. Genome scale atom networks could then be built to describe the atom 
mapping throughout the whole network. Mathematical frameworks that condensate 
atoms into metabolic units, similar to the elementary metabolite units introduced by 
Antoniewicz et al. (Antoniewicz et al., 2007), could greatly reduce the computational 
costs and make such applications feasible. 
  
130 
 
6. Conclusions and outlook 
Flux analysis offers only a static image of the metabolism. Advanced dynamical models of 
the metabolism could evolve from semi-empirical fitting to considering reaction kinetics 
(Chen et al., 2012), even at genome scale (Chakrabarti et al., 2013). Recent progress was 
made by applying metabolic flux analysis and kinetic modeling to understand the shift in 
to lactate consumption in mouse myeloma cells (Mulukutla et al., 2012). Besides the 
computational costs, kinetic modeling requires the determination of intracompartmental 
concentrations. There has been much progress in this area, including the development of 
sensors sensitive to intracompartmental concentrations (Frommer et al., 2009) or of 
protocols for sampling intracellular concentrations (Wahrheit and Heinzle, 2013; 
Wahrheit and Heinzle, 2014a). 
Improvements in experimental methods would bring an essential contribution to 
constructing realistic metabolic models. There are still many mitochondrial carriers that 
have not yet been annotated (Table 1.1) or characterized, and this fact introduces a great 
deal of uncertainty in models that include compartmentation. The development of 
methods for determining in vivo multi-enzyme complexes or enzyme-transporter 
association would contribute to adding a spatial component to cell models. Quantifying 
the electron chain uncoupling (Brand and Esteves, 2005), oxidative stress (Adam-Vizi, 
2005; Milne et al., 2007) or the activity of futile cycles (Locasale and Cantley, 2011) will 
permit a better stoichiometric quantification of the energy metabolism of mammalian 
cells, which is the core of mitochondria-related diseases and aging. 
In the spirit of systems biology, meaning embracing complexity, model layering should be 
the next natural step in dealing with the compartmentation of the living into organelles, 
cells, tissues, organs and bodies. Several types of mathematical models of different 
resolution could be integrated to exchange parameters and create complete organ or even 
body models (Bordbar et al., 2011; Eissing et al., 2011) that could constitute excellent 
platforms for in silico testing. This ambitious goal would lead to the minimization of 
animal testing, optimized time for strain engineering and to the design of personalized 
therapies or diagnosis platforms. 
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Supplem. Table S1.1. Average biomass composition of the CHO-K1 cell 
Component pg/cell 
Dry weight 290 
Proteins 171.86 
Carbohydrates 22.4 (Altamirano et al., 2001a) 
Lipids 24.64 (Altamirano et al., 2001a) 
DNA 13.41 
RNA 5.79 
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Supplem. Table S1.2. Precursor requirements for the synthesis of macromolecules in the 
CHO-K1 cell line 
Precursor Average composition 
[pmol/cell] 
Macromolecule 
(unit of quantitative reference) 
Alanine 0.103670 
Proteins 
(mole of amino acid) 
Arginine 0.081327 
Asparagine / aspartate 0.130177 
Glutamine / glutamate 0.151689 
Glycine 0.140649 
Histidine 0.031833 
Isoleucine 0.055419 
Leucine 0.108359 
Lysine 0.089150 
Methionine 0.009462 
Phenylalanine 0.047120 
Proline 0.046327 
Serine 0.076950 
Threonine 0.063611 
Tryptophane 0.001068 
Tyrosine 0.053013 
Cysteine 0.079279 
Valine 0.078340 
Glucose-6-phosphate 0.138272 Carbohydrates 
(mole of glucose) 
Lipids 0.035671 Lipids 
(1 mole = C38.925H74.2O6.95P0.85) 
DNA 0.042851 DNA 
(ribose-5-phosphate) 
RNA 0.017826 RNA 
(ribose-5-phosphate) 
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Appendix to Chapter 3 
Supplem. Fig. S3.1. Complete culture profile of CHO-K1 cells during the 
exponential growth phase. The lines represent the fitted concentration profiles to the 
experimental values (dots) and in the boxes are the determined extracellular rates 
[mmol/(L cell  h )] together with the 95% confidence intervals. Glutamine uptake was 
determined by considering a spontaneous degradation rate of 0.0033 h-1. The exponential 
growth phase is shown in the last plot. 
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Supplem. Table S3. 1. List of reactions in the non-compartmented central carbon metabolism of 
CHO-K1 (Table S3.1.1). List of metabolic reactions, fluxes and reversibilities in the compartmented 
central carbon metabolism of CHO-K1 cells (Table S3.1.2). Carbon transfer rules are provided in the 
parentheses after each reaction. Reversible reactions are designated by double arrows. Reversibility (rev) is 
computed as the ratio between the reverse flux and the net flux. lb – lower boundary; ub – upper boundary. 
Subscripts meaning: c – cytosolic; ex – extracellular; m – mitochondrial; Abbreviations: AcoA – acetyl-CoA; 
ALA – alanine; ASN – asparagine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLC – glucose; G6P – 
glucose-6-phosphate; PG – phosphoglycerate; PEP – phosphoenolpyruvate; GLN – glutamine; GLU – 
glutamate; GLY – glycine; ICI – isocitrate; ILE – isoleucine; LAC – lactate; LEU – leucine; LYS – lysine; MAL 
– malate; MET – methionine; OAA – oxaloacetate; PHE – phenylalanine; PYR – pyruvate; SER – serine; SUC 
– succinate; THR – threonine; TYR – tyrosine; VAL – valine. 
Table S3.1.1 
Flux Reaction 
v1 GLCex (abcdef) → G6P (abcdef) 
v2 G6P (abcdef) → PG (abc) + PG (def) 
v3 3 G6P (abcdef) → 5 PG (def) + 3 CO2 (a)  
v4 G6P (abcdef) → Biomass 
v5 PG (abc) → PEP (abc) 
v6 PEP (abc) → PYR (abc) 
v7 PYR (abc) → AcoA (bc) +CO2 (a) 
v8 OAA (abcd) + AcoA (ef) → CIT (efbcda) 
v9 CIT (abcdef)→ AKG (abcde)+ CO2 (f) 
v10 AKG (abcde)→ 0.5 MAL (abcd) + 0.5 MAL (dcba) + CO2 (e) 
v11 MAL (abcd) ↔ OAA (abcd) 
v12 PYR (abc) ↔ LAC (abc) 
v13 LAC (abc) ↔ LACex (abc) 
v14 OAA  (abcd) → PEP (abc) + CO2 (d) 
v15 MAL (abcd) → PYR (abc) + CO2 (d) 
v16 PYR (abc) + CO2 (d) → OAA (abcd) 
v17 PG (abc) → SER (abc) 
v18 SER  (abc) ↔ GLY (ab) + MTHF (c) 
v19 SERex (abc) ↔ SER (abc) 
v20 SER (abc)→ Biomass 
v21 GLY (abc) ↔ GLYex (abc) 
v22 GLY (abc) → Biomass 
v23 SER (abc) → PYR (abc) 
v24 PYR (abc) + GLU (defgh) ↔ ALA (abc)+ AKG (defgh) 
v25 ALA (abc) ↔ ALAex (abc) 
v26 ALA (abc)→ Biomass 
v27 PYR (abc) ↔ PYRex (abc) 
v28 ASP (abcd) + AKG (efghi) ↔ OAA (abcd) + GLU (efghi) 
v29 ASN (abcd) → ASP (abcd) 
v30 ASPex (abcd) ↔ ASP (abcd) 
v31 ASP (abcd) → Biomass 
v32 AKG (abcde) ↔  GLU (abcde) 
v33 GLU (abcde) ↔ GLUex (abcde) 
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v34 GLU (abcde) → Biomass 
v35 GLN (abcde) → GLU (abcde) 
v36 GLNex (abcde) ↔ GLN (abcde) 
v37 AcoA (ab) → Biomass 
v38 
AAex (ILE, VAL, MET, THR, TYR, PHE) → MAL (AA 
catabolism) 
v39 AAex (LEU, ILE, LYS, TYR, PHE) → ACOA (AA catabolism) 
v40 AKG (abcde) → GLU (abcde) (AA catabolism) 
v41 AA(PRO, HIS, ARG) → GLU (AA catabolism) 
v42 G6P (abcdef) → carbohydrates 
Table S3.1.1 
Flux Reaction 
Flux 
[mmol/L 
cell∙h] 
lb 
[mmol/L 
cell∙h] 
ub 
[mmol/L 
cell∙h] 
rev  rev lb rev ub 
v1 GLCex (abcdef) → G6P (abcdef) 371.0 326.7 415.3 0 0 0 
v2 G6P (abcdef) → PG (abc) + PG (def) 65.8 25.2 96.5 0 0 0 
v3 3 G6P (abcdef) → 5 PG (def) + 3 CO2(a)  97.5 87.6 111.0 0 0 0 
v4 G6P (abcdef) → Biomass 3.9 - - 0 - - 
v5 PG (abc) → PEPc (abc) 597.9 585.7 607.5 0 0 0 
v6 PEPc (abc) → PYRc1 (abc) 540.3 528.1 549.8 0 0 0 
v7 PYRc1 (abc)→ PYRm (abc) 375.2 363.0 384.7 0 0 0 
v8 PYRm (abc) → AcoAm (bc) +CO2 (a) 455.8 442.4 466.9 0 0 0 
v9 
OAAm (abcd) + AcoAm (ef) → CITm 
(efbcda) 
548.7 529.5 556.9 0 0 0 
v10 CITm (abcdef)→ AKGm (abcde)+ CO2 (f) 441.7 422.8 450.2 0 0 0 
v11 
AKGm (abcde)→ 0.5 MALm (abcd) + 0.5 
MALm(dcba) + CO2 (e) 
571.3 555.8 581.1 0 0 0 
v12 MALm (abcd) ↔ OAAm (abcd) 474.4 473.0 486.0 14.3 0.16 >100 
v13 PYRc2 (abc) ↔ LACc (abc) 290.8 261.1 320.4 15.3 0 >100 
v14 LACc (abc) ↔ LACex (abc) 290.8 261.1 320.4 n.d. n.d. n.d. 
v15 OAAc  (abcd) → PEPc (abc) + CO2 (d) 65.0 35.5 72.2 0 0 0 
v16 MALc (abcd) → PYRc1 (abc) + CO2 (d) 16.4 9.4 45.8 0 0 0 
v17 OAAc (abcd) ↔ MALc (abcd) 19.3 10.9 50.7 n.d. n.d. n.d. 
v18 PYRm (abc) + CO2 (d) → OAAm (abcd) 59.6 52.9 64.1 0 0 0 
v19 MALm (abcd) → PYRm (abc) + CO2 (d) 149.4 142.8 154.0 0 0 0 
v20 PG (abc) → SER (abc) 21.2 19.9 21.9 0 0 0 
v21 SER  (abc)↔ GLY (ab) + MTHF (c) 34.5 33.3 35.2 4.03 3.43 4.75 
v22 SERex (abc) ↔ SER (abc) 48.3 39.2 57.4 33.5 14.0 98.5 
v23 SER (abc)→ Biomass 4.9 - - 0 - - 
v24 GLY (abc) ↔ GLYex (abc) 25.5 22.0 29.0 4.6 2.2 6.9 
v25 GLY (abc) → Biomass 9.0 - - 0 - - 
v26 SER (abc) → PYRc1 (abc) 30.0 28.8 30.8 0 0 0 
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v27 
PYRc1 (abc) + GLUc (defgh) ↔ ALAc 
(abc)+ AKGc (defgh) 
40.1 38.3 129.2 36.6 17.3 >100 
v28 ALAc (abc) ↔ ALAex (abc)  42.7 39.9 45.5 0.154∙ 
∙e(t*0.036) 
0.142 
(0.038
) 
0.169 
(0.04
2) 
v29 ALAc (abc)→ Biomass 6.7 - - 0 - - 
v30 ALAm (abc)↔ ALAc (abc) 9.5 -10.6 13.6 0.15 0 1.15 
v31 
PYRm (abc) + GLUm (defgh) ↔ ALAm 
(abc)+ AKGm (defgh) 
9.5 -10.6 13.6 n.d. - - 
v32 PYRc1 (abc) ↔ PYRex (abc) 3.3 2.1 4.56 2700/t 2055/t 
2808/
t 
v33 
ASPc (abcd) + AKGc (efghi) ↔ OAAc 
(abcd) + GLUc (efghi) 
45.3 31.9 48.3 19.3 1.3 >100 
v34 
ASPc (abcd) + AKGm (edghi) → OAAm 
(abcd) + GLUm (efghi) 
14.5 11.4 27.9 0 0 0 
v35 ASN (abcd) → ASPc (abcd) 47.2 31.1 63.2 0 0 0 
v36 ASPex (abcd) ↔ ASPc (abcd) 20.9 1.1 40.7 0.7 0.34 0.84 
v37 ASPc (abcd) → Biomass 8.4 - - 0 - - 
v38 MALc (abcd) ↔ MALm (abcd) 2.9 0.9 5.0 6.9 0.8 15.1 
v39 CITm (abcdef) → CITc (abcdef) 106.6 40.1 n.d. 0 0 0 
v40 CITc (abcdef) → AKGc (abcde)+ CO2 (e) 67.6 1 n.d. 0 0 0 
v41 AKGm (abcde) ↔ AKGc (abcde) 26.3 -62.8 53.5 8.2 2.15 >100 
v42 AKGc (abcde) ↔  GLUc (abcde) 71.2 62.7 78.8 n.d. - - 
v43 GLUc (abcde) → GLUm (abcde) 74.8 66.4 82.5 0 0 0 
v44 GLUm (abcde) ↔ AKGm (abcde) 161.0 158.5 179.8 n.d. - - 
v45 GLUc (abcde) ↔ GLUex (abcde) 6.3 3.4 9.3 1.3 1.2 1.6 
v46 GLUc (abcde) → Biomass 9.7 - - 0 - - 
v47 GLNc (abcde) → GLUc (abcde) 14.6 13.3 15.8 0 0 0 
v48 GLNc (abcde) → GLUm (abcde) 81.0 80.1 82.4 0 0 0 
v49 GLNex (abcde) ↔ GLNc (abcde) 66.4 50.3 82.4 1.28 1.02 1.78 
v50 
CITc (abcdef) → OAAc (fcde) + AcoAc 
(ab) 
39.1 - - 0 - - 
v51 AcoAc (ab) → Biomass 39.1 - - 0  - - 
v52 
AAex (ILE, VAL, MET, THR, TYR, PHE) 
→ MALm (AA catabolism) 
49.6 5.1 99.9 0 - - 
v53 
AAex (LEU, ILE, LYS, TYR, PHE) → 
ACOAm (AA catabolism) 
92.6 27.9 161.4 0  - - 
v54 
AKGc (abcde) → GLUc (abcde) (AA 
catabolism) 
38.7 5.2 75.6 0 - - 
v55 
AA(PRO, HIS, ARG) → GLUc (AA 
catabolism) 
11.6 0.8 25.3 0 - - 
v56 PYRc1 (abcd) ↔ ALAc (abcd) 0 - - 0 - - 
v57 PYRm (abc) ↔ LAC (abc) 0 - - 0 - - 
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v58 PYRc1 (abc) ↔ PYRc2 (abc) 168.1 149.2 174.8 0.13 0 0.41 
v59 PEP (abc) → PYRc2 (abc) 122.7 103.8 129.4 0 0 0 
v60 G6P (abcdef) → carbohydrates 8.9 - - 0 0 0 
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Supplem. Table S3.2. Experimental (exp) and simulated (sim) mass isotopomer 
distributions of extracellular metabolites and used standard deviations (SD). 
exp Lactate Alanine Aspartate 
Time [h] M0 M1 M2 M3 M0 M1 M2 M3 M0 M1 M2 M3 M4 
1 0.889 0.027 0.003 0.081 0.963 0.031 0.002 0.004 0.972 0.028 0.000 0.000 0.000 
18 0.345 0.013 0.029 0.613 0.802 0.024 0.007 0.167 0.973 0.026 0.000 0.001 0.000 
24 0.267 0.012 0.037 0.684 0.728 0.023 0.010 0.239 0.965 0.032 0.000 0.002 0.000 
42 0.150 0.011 0.051 0.788 0.512 0.019 0.018 0.451 0.950 0.038 0.007 0.004 0.001 
48 0.128 0.012 0.055 0.805 0.409 0.018 0.024 0.549 0.948 0.038 0.007 0.005 0.001 
66 0.092 0.012 0.057 0.839 0.206 0.015 0.034 0.745 0.936 0.039 0.011 0.011 0.004 
72 0.082 0.012 0.058 0.848 0.149 0.014 0.038 0.799 0.932 0.035 0.014 0.014 0.005 
sim Lactate 
 
Alanine Aspartate 
Time [h] M0 M1 M2 M3 M0 M1 M2 M3 M0 M1 M2 M3 M4 
1 0.897 0.030 0.002 0.070 0.966 0.033 0.000 0.001 0.972 0.028 0.000 0.000 0.000 
18 0.301 0.020 0.025 0.654 0.824 0.030 0.006 0.140 0.969 0.029 0.001 0.001 0.000 
24 0.247 0.020 0.028 0.706 0.742 0.029 0.009 0.219 0.967 0.030 0.002 0.001 0.000 
42 0.169 0.019 0.032 0.780 0.475 0.026 0.021 0.478 0.959 0.032 0.005 0.004 0.001 
48 0.156 0.019 0.033 0.792 0.392 0.025 0.025 0.558 0.954 0.033 0.007 0.005 0.002 
66 0.131 0.019 0.035 0.814 0.207 0.024 0.035 0.734 0.929 0.038 0.016 0.013 0.004 
72 0.125 0.020 0.036 0.819 0.170 0.025 0.038 0.767 0.915 0.042 0.021 0.017 0.005 
  
exp SD Lactate          Alanine Aspartate
 Time [h] M0 M1 M2 M3 M0 M1 M2 M3 M0 M1 M2 M3 M4 
1 0.039 0.005 0.005 0.005 0.036 0.022 0.009 0.005 0.011 0.022 0.005 0.005 0.010 
18 0.038 0.020 0.022 0.038 0.041 0.011 0.005 0.037 0.022 0.007 0.005 0.008 0.021 
24 0.035 0.008 0.035 0.044 0.021 0.010 0.024 0.032 0.006 0.023 0.023 0.005 0.026 
42 0.035 0.006 0.042 0.040 0.036 0.022 0.024 0.025 0.024 0.005 0.023 0.021 0.022 
48 0.023 0.024 0.026 0.028 0.026 0.007 0.023 0.036 0.022 0.011 0.010 0.005 0.025 
66 0.036 0.006 0.038 0.037 0.023 0.022 0.021 0.005 0.025 0.009 0.022 0.022 0.024 
72 0.005 0.022 0.030 0.035 0.038 0.009 0.024 0.028 0.009 0.023 0.005 0.006 0.024 
(Table S3.2.cont.) 
exp Glutamate Glutamine 
Time [h] M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 
1 0.943 0.048 0.000 0.009 0.000 0.000 0.956 0.042 0.000 0.000 0.002 0.000 
18 0.915 0.050 0.020 0.011 0.003 0.001 0.953 0.043 0.000 0.001 0.002 0.000 
24 0.895 0.052 0.034 0.011 0.005 0.002 0.951 0.043 0.002 0.001 0.003 0.000 
42 0.848 0.050 0.065 0.017 0.014 0.007 0.927 0.057 0.011 0.001 0.004 0.001 
48 0.830 0.041 0.080 0.024 0.017 0.009 0.937 0.045 0.007 0.002 0.007 0.001 
66 0.699 0.048 0.146 0.036 0.045 0.026 0.898 0.043 0.026 0.009 0.016 0.007 
72 0.634 0.049 0.175 0.045 0.059 0.038 0.780 0.054 0.078 0.023 0.042 0.024 
sim Glutamate Glutamine 
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Time [h] M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 
1 0.957 0.042 0.000 0.000 0.000 0.000 0.958 0.042 0.000 0.000 0.000 0.000 
18 0.932 0.045 0.014 0.004 0.004 0.001 0.955 0.043 0.002 0.000 0.001 0.000 
24 0.917 0.047 0.021 0.006 0.008 0.001 0.952 0.043 0.003 0.001 0.001 0.000 
42 0.845 0.053 0.054 0.019 0.024 0.005 0.941 0.044 0.008 0.003 0.004 0.001 
48 0.812 0.055 0.069 0.025 0.032 0.007 0.934 0.044 0.011 0.004 0.005 0.001 
66 0.680 0.065 0.128 0.050 0.063 0.014 0.879 0.049 0.036 0.014 0.018 0.004 
72 0.627 0.069 0.150 0.060 0.076 0.017 0.793 0.056 0.073 0.030 0.039 0.009 
 Exp SD 
Time [h] 
Glutamate Glutamine 
M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 
1 0.005 0.005 0.009 0.008 0.023 0.007 0.009 0.005 0.008 0.005 0.005 0.023 
18 0.020 0.005 0.005 0.026 0.025 0.010 0.024 0.005 0.023 0.022 0.005 0.007 
24 0.023 0.011 0.010 0.010 0.005 0.024 0.022 0.023 0.006 0.005 0.005 0.022 
42 0.023 0.005 0.023 0.009 0.010 0.023 0.008 0.024 0.025 0.005 0.005 0.023 
48 0.039 0.036 0.039 0.011 0.009 0.008 0.006 0.025 0.025 0.010 0.005 0.005 
66 0.028 0.033 0.041 0.025 0.010 0.024 0.030 0.005 0.025 0.005 0.035 0.005 
72 0.037 0.034 0.030 0.023 0.005 0.005 0.035 0.005 0.007 0.023 0.026 0.022 
(Table S3.2.cont.) 
exp Glycine Serine Pyruvate 
Time [h] M0 M1 M2 M0 M1 M2 M3 M0 M1 M2 M3 M5 
1 0.984 0.016 0.000 0.993 0.007 0.000 0.000 0.873 0.027 0.002 0.098 0.000 
18 0.977 0.017 0.006 0.969 0.013 0.000 0.018 0.318 0.014 0.025 0.643 0.000 
24 0.975 0.016 0.009 0.958 0.016 0.000 0.026 0.241 0.012 0.029 0.717 0.000 
42 0.961 0.017 0.022 0.913 0.029 0.010 0.049 0.177 0.012 0.034 0.777 0.001 
48 0.950 0.018 0.032 0.885 0.035 0.017 0.063 0.160 0.012 0.037 0.791 0.001 
66 0.904 0.018 0.079 0.757 0.084 0.056 0.103 0.149 0.013 0.041 0.797 0.007 
72 0.879 0.017 0.104 0.670 0.118 0.085 0.128 0.124 0.014 0.051 0.811 0.024 
sim Glycine Serine Pyruvate 
Time [h] M0 M1 M2 M0 M1 M2 M3 M0 M1 M2 M3 M5 
1 0.978 0.022 0.000 0.992 0.007 0.000 0.000 0.887 0.030 0.003 0.080 0.000 
18 0.978 0.019 0.003 0.978 0.009 0.002 0.012 0.293 0.022 0.027 0.659 0.000 
24 0.977 0.018 0.005 0.969 0.010 0.003 0.018 0.228 0.021 0.030 0.720 0.000 
42 0.966 0.014 0.020 0.925 0.020 0.010 0.045 0.160 0.021 0.035 0.784 0.001 
48 0.958 0.013 0.029 0.900 0.028 0.015 0.057 0.153 0.021 0.036 0.789 0.001 
66 0.905 0.011 0.084 0.754 0.084 0.053 0.108 0.137 0.024 0.038 0.801 0.004 
72 0.873 0.011 0.116 0.665 0.124 0.079 0.132 0.129 0.025 0.040 0.806 0.009 
exp SD Glycine Serine Pyruvate 
Time [h] M0 M1 M2 M0 M1 M2 M3 M0 M1 M2 M3 M5 
1 0.010 0.022 0.022 0.025 0.006 0.005 0.005 0.032 0.025 0.011 0.024 0.023 
18 0.024 0.026 0.011 0.011 0.007 0.022 0.022 0.005 0.023 0.020 0.042 0.007 
24 0.024 0.025 0.006 0.035 0.025 0.005 0.005 0.023 0.024 0.040 0.036 0.022 
42 0.023 0.008 0.007 0.007 0.022 0.005 0.009 0.031 0.021 0.022 0.038 0.023 
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48 0.005 0.025 0.008 0.007 0.005 0.005 0.010 0.045 0.022 0.024 0.040 0.005 
66 0.022 0.026 0.010 0.024 0.008 0.005 0.024 0.021 0.025 0.025 0.038 0.005 
72 0.022 0.010 0.005 0.024 0.021 0.005 0.005 0.007 0.005 0.029 0.030 0.022 
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Appendix to Chapter 4 
Supplem. Figure 4.1. Cultivation profile of the CHO-K1 cells culture during 48 h in 250 ml baffled shake 
flask with a working volume of 120 mL. The represented extracellular concentrations are in [µmol / L] and 
the time is in [h]. The values represent the average from 4 parallel cultivations. The curves are the fitted 
values of extracellular concentrations simulating an exponential growth model with balanced growth 
(metabolic steady state) over the first 18 h. 
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Supplem. Table S4. 1. List of reactions used in the stoichiometric model for dynamic metabolic flux 
analysis. Reactions represented with a simple arrow were constrained to be unidirectional, while those 
represented by double arrow can be reversible. Abbreviations: AcoA – acetyl-CoA; ALA – alanine; ASN – 
asparagine; ASP – aspartate; CIT – citrate; CYS – cysteine; DHAP - dihydroxyacetone-3-phosphate; FUM – 
fumarate; GLC – glucose; G6P – glucose-6-phosphate; GAP – glycerine aldehyde 3-phosphate; GLN – 
glutamine; GLU – glutamate; GLY – glycine; HIS – histidine;  ICI – isocitrate; ILE – isoleucine; LAC – lactate; 
LEU – leucine; LYS – lysine; MAL – malate; MET – methionine; MTHF – methyltetrahydrofolate; OAA – 
oxaloacetate; PEP – phosphoenolpyruvate; PG – phosphoglycerate; PHE – phenylalanine; PYR – pyruvate; 
R5P – ribose-5-phosphate; S7P – sedoheptulose-7-phosphate; SER – serine; SUC – succinate; THR – 
threonine; TYR – tyrosine; VAL – valine. 
Reaction 
GLCex  → G6P  
G6P → F6P  
F6P → GAP + DHAP 
DHAP ↔ GAP 
GAP → 1,3PG 
1,3PG → 3PG 
3PG → PEP 
PEP → PYR 
G6P → Carbohydrates 
PYR → AcoA +CO2  
OAA + AcoA  → CIT 
CIT→ AKG + CO2 
AKG → SUC + CO2 
SUC → FUM 
FUM → MAL 
MAL ↔ OAA 
PEP ↔OAA (generic C3 – C4 reaction) 
PYR ↔ LAC 
G6P → R5P + CO2 
2R5P ↔ S7P + GAP 
GAP + S7P ↔ F6P + E4P 
R5P + E4P ↔ F6P + GAP 
R5P + 1.215 GLN + 0.5 GLY + 1.285 ASP + 0.715 NH3 + 0.285 MTHF → DNA + 1.215 GLU + 0.785 FUM 
R5P + 1.215 GLN + 0.5 GLY + 1.285 ASP + 0.715 NH3 → RNA + 1.215 GLU + 0.785 FUM 
0.775 DHAP + 17.075 AcoA + 0.15 SER→ Lipids 
ALA→ Proteins 
ASP → Proteins 
CYS → Proteins 
GLU → Proteins 
GLY → Proteins 
HIS → Proteins 
ILE → Proteins 
LEU → Proteins 
MET → Proteins 
LYS → Proteins 
PHE → Proteins 
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PRO → Proteins 
SER → Proteins 
THR → Proteins 
TYR → Proteins 
VAL → Proteins 
ALA + AKG ↔ PYR + GLU 
ASP + AKG ↔ OAA + GLU  
ASP + NH3 ↔ ASN 
ARG → GLU (arginine catabolism) 
CYS → PYR (cysteine catabolism) 
GLN ↔ GLU + NH3 
LEU + AKG → 3 AcoA + GLU (leucine catabolism) 
VAL + AKG → SUC + CO2 + GLU 
GLU → AKG + NH3 
SER ↔ GLY + MTHF 
HIS → GLU + MTHF (histidine catabolism) 
LYS+ AKG →2 AcoA + 2 CO2  + GLU (lysine catabolism) 
MET + AKG → SUC + MTHF + GLU (methionine catabolism) 
PHE + AKG → TYR + GLU 
PRO → GLU 
SER → PYR + NH3 (serine catabolism) 
THR → SUC (threonine catabolism) 
TYR →2 AcoA + FUM + CO2 + GLU (tyrosine catabolism) 
GLNex →GLN 
LACex → LAC 
PYRex → PYR 
NH3 → NH3ex  
ALAex ↔ ALA 
ASPex ↔ ASP 
ASNex → ASN 
ARGex → ARG 
CYSex → CYS 
GLUex ↔GLU 
GLYex ↔GLY 
HISex → HIS 
ILEex → ILE 
LEUex → LEU 
LYEex → LYS 
METex → MET 
PHEex →PHE 
PROex → PRO 
SERex → SER 
THRex → THR 
TYRex → TYR 
VALex →VAL 
MTHFsink ↔ MTHF 
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Supplem. Table S4.2. List of reactions, fluxes and reversibilities in the central carbon metabolism of CHO-
K1 estimated for the first 2 – 18 h cultivation period. Carbon transfer rules are given in parentheses for each 
reaction. Reversible reactions are indicated by double arrows. Reversibility (rev) is computed as the ratio 
between the reverse flux and the net flux. The 95% confidence interval was evaluated by refitting the model 
until the minimized objective function took the value of χ2(0.95, nr. experimental points – nr. parameters). 
lb – lower boundary; ub – upper boundary; Subscripts meaning: c – cytosolic; ex – extracellular; m – 
mitochondrial; Abbreviations: AcoA – acetyl-CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT – 
citrate; FUM – fumarate; GLC – glucose; G6P – glucose-6-phosphate; PG – phosphoglycerate; PEP – 
phosphoenolpyruvate; GLN – glutamine; GLU – glutamate; GLY – glycine; ICI – isocitrate; ILE – isoleucine; 
LAC – lactate; LEU – leucine; LYS – lysine; MAL – malate; MET – methionine; OAA – oxaloacetate; PHE – 
phenylalanine; PYR – pyruvate; SER – serine; SUC – succinate; THR – threonine; TYR – tyrosine; VAL – 
valine. 
Flux Reaction 
Flux 
[mmol/L 
cell  h] 
lb 
[mmol/L 
cell h] 
ub 
[mmol/L 
cell h] 
rev 
rev  
lb 
rev  
ub 
v1 GLCex (abcdef) + ATPc→ G6P 
(abcdef) + ADPc 
289.7 246.3 333.0 0 0 0 
v2 G6P (abcdef) + ADPc + 2 NAD+c→ 
PG (abc) + PG (def)+ ATPc + 2 
NADHc 
24.3 18.6 29.2 0 0 0 
v3 3 G6P (abcdef) + 3 ADPc + 5 NAD+c 
+ 6 NADP+c→ 5 PG (def) + 3 
CO2(a) + 3 ATPc + 5 NADHc + 6 
NADPHc 
87.4 85.4 89.6 0 0 0 
v4 G6P (abcdef) + 6.43ATPc + 0.72 
NADHc→ (DNA, RNA) + 6.43 
ADPc + 0.72 NAD+c 
3.3 3.3 3.3 0 0 0 
v5 PG (abc) → PEPc (abc) 464.9 464.7 465.0 0 0 0 
v6 PEPc (abc) + ADPc → PYRc1 (abc) + 
ATPc 
498.2 492.3 500.2 0 0 0 
v7 PYRc1 (abc)→ PYRm2 (abc) 118.9 113.7 119.0 0 0 0 
v8 PYRm2 (abc) + NAD+m→ AcoAm 
(bc) +CO2 (a) + NADHm 
77.5 77.2 77.6 0 0 0 
v9 OAAm (abcd) + AcoAm (ef) → 
CITm (efbcda) 
100.8 100.6 100.9 0 0 0 
v10 CITm (abcdef) + NAD(P)+m→ 
AKGm (abcde)+ CO2 (f) + 
NAD(P)Hm 
58.7 57.0 67.7 0 0 0 
v11 AKGm (abcde) + NAD+m→ 0.5 
MALm (abcd) + 0.5 MALm(dcba) + 
CO2 (e) + NADHm 
105.6 105.4 105.7 0 0 0 
v12 MALm (abcd) + NAD+m↔ OAAm 
(abcd) + NADH 
191.6 185.1 198.9 10.3 10.2 11.3 
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v13 PYRc2 (abc) + NADHc↔ LACc2 
(abc) + NAD+c 
431.7 391.0 472.3 31.9 18.6 32.0 
v14 LACc (abc) ↔ LACex (abc) 431.7 391.0 472.3 28.2 28.1 28.3 
v15 OAAc  (abcd) + GDPc→ PEPc (abc) 
+ CO2 (d) + GTPc 
66.4 61.2 68.5 0 0 0 
v16 MALc (abcd) + NADP+c→ PYRc1 
(abc) + CO2 (d) + NADPHc 
5.4 0 11.0 0 0 0 
v17 OAAc (abcd) + NADHc↔ MALc 
(abcd) + NAD+c 
90.5 88.6 90.7 22.7 21.7 23.0 
v18 PYRm1 (abc) + CO2 (d) +GTPm→ 
OAAm (abcd) + GDPm 
23.1 15.1 24.8 0 0 0 
v19 MALm (abcd) + NADP+m→ PYRm1 
(abc) + CO2 (d) + NADPHm 
8.3 5.9 9.2 0 0 0 
v20 PG (abc) + NH3c→ SER (abc) 20.5 20.4 20.5 0 0 0 
v21 SER  (abc)↔ GLY (ab) + MTHF (c) 21.9 21.9 21.9 3.8 3.2 3.8 
v22 SERex (abc) ↔ SER (abc) 20.8 17.8 23.4 13.3 13.1 13.9 
v23 SER (abc) + 4 ATPc→ Proteins + 4 
ADPc 
4.2 4.1 4.2 0 0 0 
v24 GLY (abc) ↔ GLYex (abc) 14.3 8.7 19.9 2.9 1.9 3.1 
v25 GLY (abc) + 4 ATPc→ Proteins + 4 
ADPc 
7.6 7.5 7.7 0 0 0 
v26 SER (abc) → PYRc1 + NH3c(abc) 15.2 15.1 15.2 0 0 0 
v27 PYRc1 (abc) + GLUc (defgh) ↔ 
ALAc (abc)+ AKGc (defgh) 
5.3 4.4 6.0 0.5 0.4 0.5 
v28 ALAc (abc) ↔ ALAex (abc) 26.3 26.1 26.5 2.7 2.7 4.1 
v29 ALAc (abc) + 4 ATPc → Proteins + 
4 ADPc 
5.6 5.4 5.8 0 0 0 
v30 ALAm (abc)↔ ALAc (abc) 26.6 25.9 27.5 3.7 3.5 4.7 
v31 PYRm1 (abc) + GLUm (defgh) ↔ 
ALAm (abc)+ AKGm (defgh) 
26.6 25.9 27.5 14.4 12.9 14.6 
v32 PYRex(abc) ↔ PYRc1(abc) 4.0 2.2 5.8 1714/ 
time 
[h] 
1700/ 
time 
[h] 
>2500/ 
time 
[h] 
v33 ASPc (abcd) + AKGc (efghi) ↔ 
OAAc (abcd) + GLUc (efghi) 
123.8 118.8 124.0 30.0 1.9 n.d. 
v34 OAAm (abcd) + GLUm (efghi) ↔ 
ASPm (abcd) + AKGm (efghi) 
113.8 108.8 114.0 62.5 0 n.d. 
v35 ASN (abcd) → ASPc (abcd) 13.9 11.4 16.5 0 0 0 
v36 ASPex (abcd) ↔ ASPc (abcd) 3.1 0.0 6.7 5.8 4.4 6.4 
  
147 
 
Appendix 
v37 ASPc (abcd) + 4 ATPc → Proteins + 
4 ADPc 
7.1 7.0 7.2 0 0 0 
v38 MALm (abcd) ↔ MALc(abcd) 58.1 53.1 58.2 30.5 29.5 n.d. 
v39 CITm (abcdef) + MALc(ghij) → 
CITc (abcdef)+ MALm(ghij) 
42.1 33.1 43.7 0 0 0 
v40 CITc (abcdef) + NADPHc → AKGc 
(abcde)+ CO2 (e) + NADP+c 
9.0 0 10.6 3.1 2.9 3.1 
v41 AKGm (abcde) + MALc(fghi) ↔ 
AKGc (abcde)+ MALm (fghi) 
101.1 100.3 105.7 18.0 17.9 18.1 
v42 AKGc (abcde) + NH3c + NAD(P)Hc 
↔  GLUc (abcde) + NAD(P)+c 
0 0 0 n.d. - - 
v43 GLUm (abcde) → GLUc (abcde) 156.1 155.7 156.1 2.4 0 2.7 
v44 GLUm (abcde) + NAD(P)+m↔ 
AKGm (abcde) + NAD(P)Hm + 
NH3m 
7.5 7.5 7.6 9.5 7.1 9.5 
v45 GLUc (abcde) ↔ GLUex (abcde) 8.1 7.2 8.9 1.3 1.3 1.3 
v46 GLUc (abcde) + 4 ATPc→ Proteins 
+ 4 ADPc 
8.2 7.9 8.5 0 0 0 
v47 GLUc (abcde) + NH3c+ ATPc→ 
GLNc (abcde) + ADPc 
136.8 136.4 137.2 5.2 4.6 5.2 
v48 GLNm (abcde) → GLUm (abcde) + 
NH3m 
190.3 189.9 190.7 0 0 0 
v49 GLNex (abcde) ↔ GLNc (abcde) 53.5 51.3 55.6 0.6 0.5 0.6 
v50 CITc (abcdef) + ATPc→ OAAc 
(fcde) + AcoAc (ab) + ADPc 
33.1 32.7 33.5 0 0 0 
v51 AcoAc (ab) + 1.08 ATPc + 0.09 
NADHc + 1.61 NADPHc→ Lipids + 
1.08 ADPc + 0.09 NAD+c + 1.61 
NADP+c 
33.1 32.7 33.5 0 0 0 
v52 AAex (ILE, VAL, MET, THR, TYR, 
PHE) → SUCm (AA catabolism) 
8.9 4.9 12.9 0 0 0 
v53 AAex (LEU, ILE, LYS, TYR, PHE) 
→ ACOAm (AA catabolism) 
23.3 10.6 36.0 0 0 0 
v54 AKGc (abcde) → GLUc (abcde) 
(AA catabolism) 
12.2 3.4 20.5 0 0 0 
v55 AA(PRO, HIS, ARG) → GLUc (AA 
catabolism) 
0.7 0 3.1 0 0 0 
v56 SUCm (abcd) + ADPm + FADm ↔ 
FUMm (abcd) + ATPm + FADH2m 
114.5 114.3 114.6 0 0 0 
v57 FUMm (abcd) ↔ MALm (abcd) 114.7 114.5 114.8 47.6 45.5 83.6 
v58 PYRc1 (abc) ↔ PYRc2 (abc) 398.5 398.0 398.6 0.13 0 0.13 
v59 PEPc (abc) → PYRc2 (abc) 33.2 33.1 33.7 0 0 0 
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v60 AAex (abcd) → FUMm(abcd) (AA 
catabolism) 
0.2 0.1 0.3 0 0 0 
v61 GLUc(abcde) + ASPm(efgh) 
↔GLUm (abcde) + ASPc(efgh) 
113.8 108.8 114.0 5.6 5.6 5.6 
v62 PYRm2(abc) ↔ PYRm1(abc)  41.4 36.4 41.5 0.06 0 0.06 
 PYRc1(abc) ↔ LACc1(abc) - - - 60.0 59.9 60.2 
 PYRm1(abc) ↔ LACm(abc) - - - 71.3 68.9 80.0 
 
  
  
149 
 
Appendix 
Supplem. Table S4.3. Experimental (exp) and simulated (sim) mass isotopomer 
distributions of extracellular metabolites and standard deviations (SD) used in 
simulations. (_ex – extracellular; _cell – intracellular); 
Time 
[h] 
[U-13C6] Glucose 
exp Lactate_ex Alanine_ex Glycine_ex 
 M0 M1 M2 M3 M1 M2 M3 M4 M0 M1 M2 
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 0.978 0.022 0.000 
2 0.709 0.030 0.016 0.245 0.891 0.035 0.007 0.067 0.970 0.026 0.004 
4 0.504 0.023 0.028 0.445 0.824 0.033 0.011 0.132 0.967 0.026 0.007 
6 0.350 0.018 0.037 0.595 0.774 0.032 0.014 0.180 0.964 0.026 0.010 
12 0.214 0.015 0.046 0.725 0.604 0.028 0.025 0.343 0.953 0.026 0.021 
18 0.169 0.015 0.050 0.766 0.491 0.025 0.033 0.450 0.943 0.026 0.030 
sim            
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 0.978 0.022 0.000 
2 0.660 0.023 0.010 0.306 0.927 0.032 0.002 0.039 0.975 0.022 0.003 
4 0.474 0.020 0.018 0.488 0.853 0.031 0.006 0.110 0.971 0.022 0.007 
6 0.370 0.019 0.023 0.588 0.779 0.032 0.010 0.179 0.968 0.022 0.011 
12 0.238 0.019 0.030 0.712 0.599 0.033 0.021 0.348 0.953 0.022 0.025 
18 0.188 0.019 0.033 0.759 0.474 0.034 0.028 0.464 0.933 0.022 0.045 
SD            
0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
12 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Serine_ex Aspartate_ex 
 M0 M1 M2 M3 M0 M1 M2 M3 M4 
0.000 0.967 0.033 0.000 0.000 0.956 0.043 0.001 0.000 0.000 
0.004 0.954 0.035 0.003 0.007 0.951 0.047 0.002 0.000 0.000 
0.007 0.944 0.037 0.004 0.014 0.949 0.047 0.002 0.001 0.000 
0.010 0.937 0.039 0.005 0.019 0.948 0.048 0.003 0.001 0.000 
0.021 0.902 0.045 0.013 0.041 0.938 0.049 0.009 0.004 0.001 
0.030 0.868 0.054 0.021 0.057 0.942 0.044 0.007 0.006 0.001 
sim          
0.000 0.967 0.033 0.000 0.000 0.972 0.028 0.000 0.000 0.000 
0.003 0.958 0.034 0.002 0.007 0.971 0.029 0.001 0.000 0.000 
0.007 0.947 0.036 0.003 0.014 0.968 0.029 0.002 0.001 0.000 
0.011 0.936 0.037 0.005 0.022 0.964 0.029 0.004 0.002 0.001 
0.025 0.895 0.046 0.013 0.046 0.949 0.031 0.012 0.006 0.002 
0.045 0.844 0.058 0.024 0.074 0.931 0.033 0.021 0.011 0.004 
SD          
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
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0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Glutamate_ex Glutamine_ex 
 M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 
0 0.946 0.053 0.001 0.000 0.000 0.000 0.946 0.053 0.001 0.000 0.000 0.000 
2 0.923 0.043 0.004 0.025 0.003 0.002 0.938 0.056 0.002 0.000 0.003 0.000 
4 0.915 0.045 0.008 0.026 0.003 0.002 0.936 0.057 0.003 0.000 0.003 0.000 
6 0.908 0.047 0.011 0.028 0.004 0.002 0.935 0.058 0.003 0.000 0.003 0.001 
12 0.880 0.046 0.036 0.028 0.007 0.003 0.945 0.052 0.000 0.000 0.003 0.000 
18 0.841 0.053 0.059 0.031 0.011 0.005 0.936 0.054 0.005 0.001 0.004 0.001 
sim             
0 0.958 0.042 0.000 0.000 0.000 0.000 0.958 0.042 0.000 0.000 0.000 0.000 
2 0.954 0.043 0.003 0.000 0.000 0.000 0.957 0.043 0.001 0.000 0.000 0.000 
4 0.943 0.045 0.010 0.001 0.001 0.000 0.955 0.043 0.002 0.000 0.000 0.000 
6 0.929 0.047 0.018 0.003 0.002 0.000 0.951 0.043 0.004 0.001 0.000 0.000 
12 0.884 0.053 0.044 0.010 0.008 0.002 0.939 0.045 0.011 0.002 0.002 0.000 
18 0.837 0.059 0.069 0.017 0.014 0.003 0.923 0.047 0.020 0.005 0.004 0.001 
SD             
0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
12 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Pyruvate_cell Lactate_cell 
 M0 M1 M2 M3 M0 M1 M2 M3 
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 
2 0.624 0.035 0.024 0.317 0.447 0.027 0.061 0.466 
4 0.459 0.029 0.037 0.475 0.412 0.026 0.052 0.510 
6 0.404 0.029 0.038 0.529 0.400 0.025 0.057 0.519 
12 0.378 0.028 0.040 0.554 0.368 0.024 0.062 0.546 
18 0.352 0.025 0.040 0.584 0.334 0.025 0.064 0.577 
sim         
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 
2 0.608 0.028 0.016 0.347 0.576 0.027 0.016 0.381 
4 0.481 0.031 0.025 0.462 0.442 0.029 0.026 0.502 
6 0.425 0.033 0.030 0.513 0.387 0.030 0.030 0.552 
12 0.340 0.034 0.036 0.590 0.310 0.032 0.036 0.623 
18 0.289 0.035 0.040 0.636 0.264 0.033 0.040 0.663 
SD         
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
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4 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Fumarate_cell Malate_cell 
 M0 M1 M2 M3 M4 M0 M1 M2 M3 M4 
0 0.956 0.043 0.001 0.000 0.000 0.956 0.043 0.001 0.000 0.000 
2 0.810 0.055 0.077 0.053 0.006 0.778 0.061 0.086 0.060 0.015 
4 0.751 0.056 0.099 0.082 0.012 0.725 0.059 0.107 0.089 0.020 
6 0.722 0.056 0.117 0.088 0.017 0.701 0.059 0.123 0.093 0.024 
12 0.688 0.058 0.140 0.091 0.023 0.665 0.061 0.148 0.097 0.030 
18 0.662 0.060 0.157 0.094 0.027 0.627 0.066 0.171 0.101 0.036 
sim           
0 0.972 0.028 0.000 0.000 0.000 0.957 0.043 0.000 0.000 0.000 
2 0.797 0.054 0.103 0.038 0.008 0.797 0.054 0.102 0.039 0.008 
4 0.710 0.062 0.145 0.065 0.018 0.710 0.062 0.144 0.065 0.018 
6 0.683 0.062 0.154 0.077 0.024 0.683 0.063 0.153 0.077 0.024 
12 0.656 0.062 0.161 0.090 0.031 0.656 0.062 0.160 0.091 0.031 
18 0.639 0.062 0.166 0.099 0.035 0.639 0.062 0.165 0.099 0.035 
SD           
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
4 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp AKG_cell Citrate_cell 
 M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 M6 
0 0.946 0.053 0.001 0.000 0.000 0.000 0.935 0.063 0.002 0.000 0.000 0.000 0.000 
2 0.796 0.090 0.063 0.027 0.014 0.010 0.426 0.062 0.377 0.059 0.045 0.028 0.003 
4 0.656 0.107 0.146 0.039 0.032 0.020 0.334 0.054 0.411 0.070 0.069 0.054 0.008 
6 0.688 0.104 0.123 0.053 0.019 0.013 0.269 0.049 0.440 0.071 0.091 0.068 0.013 
12 0.618 0.099 0.162 0.059 0.036 0.026 0.227 0.050 0.444 0.069 0.115 0.076 0.020 
18 0.544 0.103 0.185 0.070 0.057 0.040 0.195 0.050 0.449 0.073 0.133 0.080 0.021 
sim              
0 0.947 0.053 0.000 0.000 0.000 0.000 0.942 0.059 0.000 0.000 0.000 0.000 0.000 
2 0.756 0.078 0.139 0.017 0.009 0.001 0.464 0.066 0.367 0.044 0.041 0.015 0.003 
4 0.653 0.090 0.187 0.039 0.027 0.005 0.326 0.066 0.419 0.066 0.080 0.034 0.009 
6 0.624 0.091 0.196 0.047 0.035 0.008 0.289 0.065 0.426 0.072 0.093 0.043 0.013 
12 0.600 0.091 0.202 0.053 0.043 0.011 0.263 0.063 0.424 0.076 0.103 0.053 0.017 
18 0.585 0.092 0.206 0.057 0.048 0.013 0.252 0.063 0.419 0.079 0.109 0.059 0.019 
SD              
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
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2 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
4 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Alanine_cell Glycine_cell Serine_cell 
 M0 M1 M2 M3 M0 M1 M2 M0 M1 M2 M3 
0 0.967 0.033 0.000 0.000 0.978 0.022 0.000 0.967 0.033 0.000 0.000 
2 0.547 0.078 0.107 0.267 0.939 0.019 0.042 0.882 0.050 0.016 0.053 
4 0.526 0.043 0.094 0.337 0.916 0.022 0.062 0.875 0.045 0.013 0.066 
6 0.310 0.055 0.232 0.404 0.917 0.018 0.065 0.849 0.054 0.023 0.074 
12 0.391 0.056 0.149 0.404 0.900 0.019 0.080 0.826 0.062 0.028 0.084 
18 0.350 0.076 0.171 0.402 0.880 0.021 0.098 0.796 0.073 0.040 0.091 
sim            
0 0.967 0.033 0.000 0.000 0.978 0.022 0.000 0.967 0.033 0.000 0.000 
2 0.739 0.030 0.010 0.221 0.930 0.022 0.048 0.888 0.044 0.012 0.055 
4 0.633 0.032 0.018 0.317 0.923 0.022 0.055 0.877 0.047 0.015 0.061 
6 0.570 0.033 0.022 0.376 0.916 0.022 0.062 0.866 0.050 0.017 0.067 
12 0.447 0.034 0.030 0.489 0.892 0.022 0.087 0.826 0.061 0.027 0.086 
18 0.366 0.035 0.036 0.563 0.861 0.022 0.117 0.775 0.076 0.041 0.108 
SD            
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
4 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C6] Glucose 
exp Aspartate_cell Glutamate_cell 
 M0 M1 M2 M3 M4 M0 M1 M2 M3 M4 M5 
0 0.956 0.043 0.001 0.000 0.000 0.946 0.053 0.001 0.000 0.000 0.000 
2 0.780 0.061 0.093 0.060 0.007 0.731 0.063 0.162 0.024 0.014 0.006 
4 0.721 0.058 0.113 0.096 0.014 0.677 0.056 0.190 0.034 0.030 0.013 
6 0.690 0.057 0.130 0.101 0.022 0.645 0.053 0.205 0.040 0.039 0.019 
12 0.644 0.062 0.159 0.104 0.031 0.585 0.055 0.230 0.050 0.054 0.026 
18 0.606 0.067 0.189 0.105 0.033 0.534 0.058 0.244 0.061 0.069 0.034 
sim            
0 0.972 0.028 0.000 0.000 0.000 0.954 0.046 0.000 0.000 0.000 0.000 
2 0.797 0.054 0.101 0.039 0.008 0.758 0.077 0.138 0.017 0.009 0.001 
4 0.712 0.062 0.142 0.066 0.018 0.655 0.089 0.186 0.039 0.026 0.005 
6 0.685 0.062 0.151 0.078 0.024 0.627 0.090 0.195 0.047 0.035 0.008 
12 0.658 0.062 0.158 0.091 0.031 0.603 0.090 0.201 0.053 0.043 0.011 
18 0.641 0.062 0.163 0.100 0.035 0.587 0.091 0.205 0.057 0.048 0.013 
SD            
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0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
4 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Lactate_ex Alanine_ex Glycine_ex 
 M0 M1 M2 M3 M0 M1 M2 M3 M0 M1 M2 
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 0.978 0.022 0.000 
2 0.957 0.036 0.002 0.005 0.960 0.036 0.001 0.002 0.976 0.024 0.000 
6 0.945 0.037 0.006 0.012 0.952 0.038 0.003 0.006 0.974 0.026 0.000 
12 0.936 0.039 0.007 0.018 0.941 0.041 0.006 0.013 0.973 0.026 0.001 
18 0.927 0.042 0.009 0.022 0.933 0.042 0.007 0.018 0.971 0.027 0.002 
sim            
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 0.978 0.022 0.000 
2 0.959 0.032 0.002 0.007 0.963 0.032 0.001 0.004 0.978 0.022 0.000 
6 0.938 0.033 0.007 0.021 0.943 0.034 0.006 0.017 0.978 0.022 0.000 
12 0.926 0.035 0.010 0.028 0.918 0.037 0.012 0.033 0.978 0.022 0.000 
18 0.922 0.036 0.012 0.031 0.901 0.039 0.016 0.043 0.978 0.022 0.000 
SD            
0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
12 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Serine_ex Aspartate_ex 
 M0 M1 M2 M3 M0 M1 M2 M3 M4 
0 0.967 0.033 0.000 0.000 0.956 0.043 0.001 0.000 0.000 
2 0.962 0.036 0.002 0.000 0.946 0.050 0.001 0.000 0.002 
6 0.961 0.037 0.002 0.000 0.945 0.048 0.001 0.001 0.006 
12 0.967 0.033 0.000 0.000 0.935 0.045 0.004 0.004 0.013 
18 0.964 0.034 0.002 0.000 0.925 0.047 0.005 0.005 0.018 
sim          
0 0.967 0.033 0.000 0.000 0.972 0.028 0.000 0.000 0.000 
2 0.967 0.032 0.000 0.000 0.969 0.029 0.000 0.000 0.002 
6 0.967 0.032 0.000 0.000 0.956 0.030 0.003 0.002 0.009 
12 0.967 0.032 0.000 0.000 0.934 0.033 0.008 0.004 0.021 
18 0.968 0.032 0.000 0.000 0.908 0.036 0.014 0.007 0.035 
SD          
0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
12 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
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18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Glutamate_ex Glutamine_ex 
 M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 
0 0.946 0.053 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.004 0.092 0.904 
2 0.916 0.057 0.000 0.004 0.003 0.020 0.003 0.000 0.001 0.009 0.108 0.879 
6 0.874 0.053 0.000 0.011 0.008 0.053 0.004 0.001 0.001 0.009 0.106 0.879 
12 0.809 0.049 0.003 0.024 0.015 0.100 0.006 0.001 0.001 0.009 0.107 0.876 
18 0.720 0.048 0.010 0.037 0.019 0.166 0.008 0.001 0.002 0.010 0.105 0.874 
sim             
0 0.958 0.042 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.096 0.904 
2 0.941 0.042 0.000 0.002 0.002 0.013 0.005 0.000 0.000 0.000 0.096 0.899 
6 0.885 0.043 0.004 0.011 0.008 0.048 0.010 0.001 0.001 0.002 0.095 0.890 
12 0.799 0.046 0.011 0.026 0.018 0.100 0.020 0.004 0.003 0.006 0.095 0.873 
18 0.715 0.049 0.018 0.040 0.028 0.150 0.032 0.006 0.005 0.012 0.094 0.851 
SD             
0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
12 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Pyruvate_cell Lactate_cell 
 M0 M1 M2 M3 M0 M1 M2 M3 
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 
2 0.864 0.084 0.018 0.034 0.871 0.085 0.036 0.008 
6 0.902 0.065 0.010 0.023 0.912 0.057 0.028 0.004 
12 0.857 0.098 0.015 0.030 0.926 0.046 0.017 0.012 
18 0.929 0.038 0.006 0.027 0.939 0.035 0.006 0.020 
sim         
0 0.967 0.033 0.000 0.000 0.967 0.033 0.000 0.000 
2 0.923 0.034 0.010 0.033 0.926 0.034 0.009 0.031 
6 0.896 0.039 0.017 0.047 0.900 0.039 0.017 0.045 
12 0.885 0.041 0.020 0.054 0.889 0.041 0.019 0.051 
18 0.878 0.043 0.022 0.057 0.883 0.042 0.021 0.054 
SD         
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
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Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Fumarate_cell Malate_cell 
 M0 M1 M2 M3 M4 M0 M1 M2 M3 M4 
0 0.956 0.043 0.001 0.000 0.000 0.956 0.043 0.001 0.000 0.000 
2 0.584 0.058 0.076 0.057 0.225 0.552 0.071 0.076 0.064 0.237 
6 0.515 0.059 0.082 0.080 0.264 0.498 0.066 0.082 0.083 0.271 
12 0.464 0.068 0.100 0.075 0.293 0.489 0.058 0.094 0.072 0.288 
18 0.461 0.073 0.109 0.072 0.285 0.443 0.083 0.111 0.072 0.290 
sim           
0 0.972 0.028 0.000 0.000 0.000 0.957 0.043 0.000 0.000 0.000 
2 0.563 0.063 0.078 0.047 0.249 0.568 0.063 0.078 0.047 0.244 
6 0.498 0.083 0.104 0.054 0.261 0.503 0.083 0.104 0.054 0.256 
12 0.492 0.085 0.108 0.055 0.260 0.496 0.085 0.107 0.055 0.256 
18 0.488 0.087 0.111 0.056 0.258 0.492 0.088 0.110 0.056 0.254 
SD           
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp AKG_cell Citrate_cell 
 M0 M1 M2 M3 M4 M5 M0 M1 M2 M3 M4 M5 M6 
0 0.946 0.053 0.001 0.000 0.000 0.000 0.935 0.063 0.002 0.000 0.000 0.000 0.000 
2 0.253 0.081 0.088 0.282 0.041 0.254 0.539 0.073 0.079 0.062 0.193 0.047 0.006 
6 0.173 0.114 0.093 0.395 0.036 0.189 0.485 0.071 0.084 0.081 0.212 0.058 0.009 
12 0.119 0.158 0.051 0.545 0.009 0.118 0.420 0.082 0.101 0.085 0.228 0.072 0.011 
18 0.126 0.194 0.056 0.584 0.011 0.029 0.403 0.090 0.110 0.088 0.233 0.064 0.011 
sim              
0 0.947 0.053 0.000 0.000 0.000 0.000 0.942 0.059 0.000 0.000 0.000 0.000 0.000 
2 0.367 0.043 0.028 0.091 0.070 0.401 0.514 0.083 0.076 0.051 0.208 0.050 0.019 
6 0.288 0.062 0.050 0.114 0.077 0.409 0.433 0.100 0.108 0.062 0.221 0.053 0.024 
12 0.283 0.065 0.053 0.117 0.077 0.405 0.426 0.102 0.111 0.064 0.220 0.053 0.024 
18 0.281 0.068 0.055 0.119 0.077 0.399 0.422 0.104 0.114 0.065 0.219 0.052 0.024 
SD              
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 1 1 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Alanine_cell Glycine_cell Serine_cell 
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 M0 M1 M2 M3 M0 M1 M2 M0 M1 M2 M3 
0 0.967 0.033 0.000 0.000 0.978 0.022 0.000 0.967 0.033 0.000 0.000 
2 0.818 0.097 0.044 0.041 0.954 0.029 0.017 0.959 0.038 0.001 0.002 
6 0.775 0.104 0.056 0.066 0.965 0.029 0.006 0.949 0.042 0.004 0.005 
12 0.794 0.063 0.031 0.112 0.974 0.024 0.002 0.933 0.042 0.007 0.018 
18 0.857 0.082 0.019 0.042 0.980 0.020 0.000 0.966 0.033 0.000 0.002 
sim            
0 0.967 0.033 0.000 0.000 0.978 0.022 0.000 0.967 0.033 0.000 0.000 
2 0.937 0.034 0.007 0.022 0.978 0.022 0.000 0.967 0.032 0.000 0.000 
6 0.913 0.038 0.013 0.036 0.978 0.022 0.000 0.968 0.032 0.000 0.000 
12 0.896 0.040 0.017 0.046 0.978 0.022 0.000 0.968 0.032 0.000 0.000 
18 0.885 0.042 0.020 0.053 0.978 0.022 0.000 0.968 0.032 0.000 0.000 
SD            
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 1 1 1 1 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Supplem. Table S4.3.(cont.) 
Time 
[h] 
[U-13C5] Glutamine 
exp Aspartate_cell Glutamate_cell 
 M0 M1 M2 M3 M4 M0 M1 M2 M3 M4 M5 
0 0.956 0.043 0.001 0.000 0.000 0.946 0.053 0.001 0.000 0.000 0.000 
2 0.555 0.066 0.091 0.064 0.223 0.314 0.055 0.117 0.107 0.047 0.361 
6 0.497 0.063 0.107 0.082 0.252 0.283 0.047 0.053 0.110 0.052 0.455 
12 0.460 0.071 0.114 0.069 0.286 0.270 0.052 0.047 0.129 0.043 0.458 
18 0.462 0.077 0.116 0.062 0.283 0.273 0.064 0.054 0.138 0.037 0.433 
sim            
0 0.972 0.028 0.000 0.000 0.000 0.954 0.046 0.000 0.000 0.000 0.000 
2 0.574 0.064 0.077 0.047 0.239 0.366 0.043 0.028 0.091 0.070 0.404 
6 0.509 0.083 0.103 0.054 0.251 0.287 0.062 0.049 0.113 0.077 0.412 
12 0.503 0.085 0.106 0.055 0.251 0.282 0.064 0.052 0.116 0.077 0.408 
18 0.499 0.088 0.109 0.056 0.249 0.280 0.067 0.055 0.119 0.077 0.402 
SD            
0 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
2 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
6 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
18 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
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Supplem. Table S4.4. Extracellular concentrations sampled in a 100 mL shake flask culture of CHO-
K1 cells. (AVG – average from 4 parallel cultivations; SD – standard deviation) 
 Time 
[h] 
Cells/mL Glucose Lactate Pyruvate Alanine Arginine Asparagine 
AVG 0 1.55E+06 4.42E+04 3.74E+02 7.50E+02 5.80E+02 4.92E+03 4.25E+03 
 6.25 2.23E+06 4.11E+04 3.71E+03 6.82E+02 7.61E+02 4.87E+03 4.11E+03 
 12.5 2.58E+06 3.90E+04 7.68E+03 6.74E+02 9.87E+02 4.86E+03 4.05E+03 
 17.75 2.98E+06 3.66E+04 1.05E+04 6.45E+02 1.21E+03 4.81E+03 3.90E+03 
 23.75 3.60E+06 3.39E+04 1.49E+04 5.86E+02 1.53E+03 4.75E+03 3.63E+03 
 29.75 4.30E+06 3.15E+04 1.70E+04 4.87E+02 1.87E+03 4.64E+03 3.40E+03 
 35.75 5.45E+06 2.96E+04 1.92E+04 4.43E+02 2.27E+03 4.56E+03 3.19E+03 
 42 6.55E+06 2.71E+04 2.09E+04 3.44E+02 2.69E+03 4.49E+03 2.84E+03 
 47.75 8.40E+06 2.64E+04 2.17E+04 2.84E+02 3.23E+03 4.56E+03 2.58E+03 
          
SD 0 0.00E+00 3.49E+03 3.64E+01 7.96E+01 1.43E+01 2.81E+02 1.29E+02 
 6.25 2.53E+05 4.44E+03 2.98E+02 6.32E+01 6.29E+00 2.78E+02 1.12E+02 
 12.5 1.76E+05 5.84E+03 1.16E+03 9.92E+01 1.30E+01 2.06E+02 9.74E+01 
 17.75 1.71E+05 5.43E+03 1.22E+03 7.56E+01 2.94E+01 2.53E+02 1.19E+02 
 23.75 2.16E+05 2.82E+03 1.88E+03 6.86E+01 4.69E+01 2.17E+02 1.04E+02 
 29.75 4.58E+05 3.37E+03 1.68E+03 9.80E+01 7.71E+01 2.27E+02 1.47E+02 
 35.75 6.81E+05 3.02E+03 1.54E+03 8.50E+01 7.45E+01 2.03E+02 7.62E+01 
 42 6.40E+05 3.49E+03 2.04E+03 9.10E+01 1.16E+02 2.31E+02 1.23E+02 
 47.75 1.52E+06 2.65E+03 1.77E+03 7.18E+01 1.73E+02 2.40E+02 1.07E+02 
Supplem. Table S4.4. (cont.) 
 Time 
[h] 
Aspartic 
Acid 
Cysteine Glutamic 
Acid 
Glutamine Glycine Histidine 
AVG 0 2.89E+03 1.29E+01 8.66E+02 6.43E+03 1.54E+03 8.10E+02 
 6.25 2.79E+03 1.31E+01 9.12E+02 5.93E+03 1.67E+03 7.91E+02 
 12.5 2.83E+03 1.29E+01 9.98E+02 5.41E+03 1.79E+03 7.92E+02 
 17.75 2.79E+03 1.33E+01 1.05E+03 4.84E+03 1.88E+03 7.70E+02 
 23.75 2.64E+03 1.44E+01 1.09E+03 4.10E+03 2.03E+03 7.12E+02 
 29.75 2.58E+03 1.47E+01 1.13E+03 3.34E+03 2.10E+03 7.08E+02 
 35.75 2.55E+03 1.37E+01 1.16E+03 2.68E+03 2.15E+03 7.18E+02 
 42 2.34E+03 1.48E+01 1.15E+03 2.09E+03 2.25E+03 6.61E+02 
 47.75 2.27E+03 1.19E+01 1.16E+03 1.62E+03 2.38E+03 6.81E+02 
        
SD 0 1.36E+02 1.54E+00 4.33E+01 5.47E+02 4.46E+01 4.45E+01 
 6.25 8.39E+01 1.79E+00 3.92E+01 5.21E+02 8.31E+01 3.72E+01 
 12.5 8.76E+01 2.00E+00 3.73E+01 4.41E+02 5.74E+01 4.40E+01 
 17.75 1.09E+02 2.12E+00 5.04E+01 4.35E+02 4.48E+01 3.72E+01 
 23.75 1.27E+02 2.26E+00 4.32E+01 3.73E+02 8.22E+01 6.33E+01 
 29.75 1.72E+02 3.10E+00 5.85E+01 3.32E+02 1.10E+02 8.34E+01 
 35.75 5.70E+01 2.89E+00 4.03E+01 2.65E+02 5.91E+01 3.59E+01 
 42 1.69E+02 4.01E+00 7.44E+01 2.74E+02 3.93E+01 8.53E+01 
 47.75 9.87E+01 2.27E+00 7.40E+01 3.08E+02 1.05E+02 3.97E+01 
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Supplem. Table S4.4. (cont.) 
 Time 
[h] 
Isoleucine Leucine Lysine Methionine Phenylalanine Proline 
AVG 0 2.66E+03 3.36E+03 3.17E+03 9.00E+02 1.15E+03 1.18E+03 
 6.25 2.54E+03 3.23E+03 3.08E+03 8.76E+02 1.12E+03 1.14E+03 
 12.5 2.52E+03 3.18E+03 3.05E+03 8.62E+02 1.10E+03 1.12E+03 
 17.75 2.47E+03 3.10E+03 2.98E+03 8.36E+02 1.07E+03 1.09E+03 
 23.75 2.37E+03 3.00E+03 2.84E+03 8.04E+02 1.01E+03 1.05E+03 
 29.75 2.31E+03 2.87E+03 2.73E+03 7.57E+02 9.63E+02 9.67E+02 
 35.75 2.30E+03 2.76E+03 2.64E+03 7.16E+02 9.23E+02 9.16E+02 
 42 2.21E+03 2.64E+03 2.50E+03 6.76E+02 8.64E+02 8.63E+02 
 47.75 2.25E+03 2.62E+03 2.52E+03 6.56E+02 8.43E+02 8.45E+02 
        
SD 0 1.34E+02 1.89E+02 2.38E+02 4.76E+01 6.47E+01 6.79E+01 
 6.25 1.03E+02 1.75E+02 2.26E+02 4.81E+01 5.57E+01 5.23E+01 
 12.5 9.22E+01 1.34E+02 1.92E+02 3.39E+01 4.56E+01 4.27E+01 
 17.75 1.14E+02 1.62E+02 2.32E+02 3.77E+01 5.62E+01 7.27E+01 
 23.75 9.28E+01 1.25E+02 1.98E+02 3.03E+01 4.10E+01 8.46E+01 
 29.75 1.30E+02 1.41E+02 2.20E+02 3.24E+01 5.13E+01 6.62E+01 
 35.75 8.19E+01 1.15E+02 1.89E+02 2.48E+01 3.80E+01 5.05E+01 
 42 1.44E+02 1.33E+02 2.26E+02 2.71E+01 5.19E+01 5.86E+01 
 47.75 1.02E+02 1.36E+02 1.81E+02 3.32E+01 4.69E+01 5.42E+01 
Supplem. Table S4.4. (cont.) 
 Time 
[h] 
Serine Threonine Tryptophane Tyrosine Valine 
AVG 0 4.00E+03 1.87E+03 3.18E+02 1.52E+03 2.76E+03 
 6.25 3.79E+03 1.84E+03 3.13E+02 1.49E+03 2.66E+03 
 12.5 3.66E+03 1.84E+03 3.15E+02 1.48E+03 2.65E+03 
 17.75 3.49E+03 1.78E+03 3.11E+02 1.46E+03 2.58E+03 
 23.75 3.30E+03 1.66E+03 2.98E+02 1.38E+03 2.45E+03 
 29.75 3.08E+03 1.64E+03 2.85E+02 1.33E+03 2.39E+03 
 35.75 2.87E+03 1.68E+03 2.78E+02 1.30E+03 2.37E+03 
 42 2.64E+03 1.56E+03 2.63E+02 1.25E+03 2.25E+03 
 47.75 2.48E+03 1.60E+03 2.58E+02 1.25E+03 2.27E+03 
       
SD 0 1.55E+02 7.63E+01 3.01E+01 1.05E+02 1.24E+02 
 6.25 1.68E+02 7.01E+01 2.92E+01 8.12E+01 9.09E+01 
 12.5 1.26E+02 7.19E+01 2.42E+01 7.17E+01 8.70E+01 
 17.75 1.37E+02 6.40E+01 2.03E+01 8.32E+01 1.04E+02 
 23.75 1.25E+02 1.20E+02 1.37E+01 6.13E+01 9.61E+01 
 29.75 1.36E+02 1.63E+02 1.59E+01 7.64E+01 1.36E+02 
 35.75 9.68E+01 5.89E+01 1.20E+01 6.53E+01 7.33E+01 
 42 1.05E+02 1.76E+02 2.11E+01 8.01E+01 1.44E+02 
 47.75 1.16E+02 5.79E+01 2.28E+01 8.35E+01 9.37E+01 
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Appendix to Chapter 5 
Supplem. Figure S5.1. Experimental (o) and fitted (-) extracellular concentrations in the 
experiments with permeabilized CHO-K1 cells. r – production rate [fmol/ (cell  min)]. 
The brackets contain the 95% confidence interval for the rate. 
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Supplem. Table S5.1. Selection of the elementary modes that can describe the 
observed metabolite uptake and production. The modes are selected accordingly to 
the following criteria:  u - the metabolite is taken up; p - the metabolite is produced; xu - 
the metabolite is not taken up; xp - the metabolite is not produced; iu - the metabolite is 
or is not taken up; ip - the metabolite is or is not produced. 
SUBSTATE(S) / 
PRODUCT(S) 
pyruvate 
/ - 
pyruvate, 
ADP / ATP 
pyruvate, 
aspartate / 
glutamate 
pyruvate, 
aspartate, ADP / 
glutamate, ATP 
citrate 
/ - 
citrate, 
ADP / 
ATP 
External Flux 1a 1b 2a 2b 3a 3b 
Pyruvate u / xp u / xp iu / xp iu / xp xu / xp xu / xp 
Malate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Succinate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Fumarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Citrate xu / xp xu / xp xu / xp xu / xp u / xp u / xp 
Aspartate xu / xp xu / xp iu / xp iu / xp xu / xp xu / xp 
α-ketoglutarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamate xu / xp xu / xp xu / ip xu / ip xu / xp xu / xp 
Glutamine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
C1 xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
O2 iu / xp iu / xp iu / xp iu / xp iu / xp iu / xp 
NH3 xp / xp xp / xp xp / xp xp / xp xu / xp xu / xp 
ADP xu / xp u / xp xu / xp u / xp xu / xp u / xp 
ATP xu / xp xu / ip xu / xp xu / ip xu / xp xu / ip 
(cont. Table S5.1) 
SUBSTATE(S) 
/ 
PRODUCT(S) 
α-
ketoglutarate 
/ - 
α-
ketoglutarate
, ADP /  
fumarate, 
ATP 
succinate 
/ 
fumarate
, malate, 
citrate 
succinate
, ADP / 
fumarate, 
malate, 
citrate, 
ATP 
malate 
(fumarate
) / citrate 
malate 
(fumarate)
, ADP / 
citrate, 
ATP 
External Flux 4a 4b 5a 5b 6a/7a 6b/7b 
Pyruvate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Malate xu / xp xu / xp xu / ip xu / ip u / xp u / xp 
Succinate xu / xp xu / xp u / xp u / xp xu / xp xu / xp 
Fumarate xu / xp xu / ip xu / ip xu / ip xu / xp xu / xp 
Citrate xu / xp xu / xp xu / ip xu / ip xu / ip xu / ip 
Aspartate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
α-ketoglutarate u / xp u / xp xu / xp xu / xp xu / xp xu / xp 
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Glutamate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
C1 xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
O2 iu / xp iu / xp iu / xp iu / xp iu / xp iu / xp 
NH3 xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
ADP xu / xp u / xp xu / xp xu / xp xu / xp xu / xp 
ATP xu / xp xu / ip xu / xp xu / ip xu / xp xu / ip 
(cont. Table S5.1) 
SUBSTATE(S) / 
PRODUCT(S) 
glutamine / 
glutamate, 
aspartate 
glutamine, ADP / 
glutamate, 
aspartate, ATP 
glutamate / 
aspartate 
glutamate, 
ADP / 
aspartate, ATP 
serine / 
glycine 
External Flux 8a 8b 9a 9b 11a 
Pyruvate xu / xp xu / xp xu / xp xu / xp xu / xp 
Malate xu / xp xu / xp xu / xp xu / xp xu / xp 
Succinate xu / xp xu / xp xu / xp xu / xp xu / xp 
Fumarate xu / xp xu / xp xu / xp xu / xp xu / xp 
Citrate xu / xp xu / xp xu / xp xu / xp xu / xp 
Aspartate xu / ip xu / ip xu / ip xu / ip xu / xp 
α-ketoglutarate xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamate xu / ip xu / ip xu / xp u / xp xu / xp 
Glutamine u / xp u / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp u / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / ip 
C1 xu / xp xu / xp xu / xp xu / xp xu / ip 
O2 iu / xp iu / xp iu / xp iu / xp xu / xp 
NH3 xu / ip xu / ip xu / ip xu / ip xu / ip 
ADP xu / xp iu / xp xu / xp u / xp xu / xp 
ATP xu / xp xu / ip xu / xp xu / ip xu / xp 
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Supplem. Table S5.2. Mitochondrial fluxes [fmol / cell  min] in selectively 
permeabilized CHO-K1 cells under various feeding conditions. The fluxes were computed 
using the determined extracellular rates and the stoichiometry indicated by reactions R1-
R50. By addition of ADP it was assumed that the flux R44=0.  
Reaction 
Uptake / 
Production 
pyruvate 
/ - 
pyruvate, 
aspartate / 
glutamate 
citrate 
/ - 
α-
ketoglutarate / 
- 
  Exp. No. 
1a 2a 3a 4a   
Flux [fmol / 
cell  min] 
--> PYRc R1 4.6 11.9 0 0 
<--> MALc R2 0 0 0 0 
<--> SUCc R3 0 0 0 0 
<--> FUMc R4 0 0 0 -0.48 
<--> CITc R5 0 0 5.6 0 
<--> ASPc R6 0 6.1 0 0 
 --> AKGc R7 0 0 0 12.7 
<--> GLUc R8 0 -3 0 0 
 --> GLNc R9 0 0 0 0 
<--> SERc R11 0 0 0 0 
<--> GLYc R12 0 0 0 0 
<--> ADPc R24 0 0 0 0 
<--> CO2c R10 -13.8 -45.1 -33.6 -61.58 
<--> C1c R13 0 0 0 0 
C1c <--> C1m R14 0 0 0 0 
GLYc <--> GLYm R15 0 0 0 0 
SERc <--> SERm R16 0 0 0 0 
CO2c <--> CO2m R17 -13.8 -45.1 -33.6 -61.58 
SERm <--> GLYm + MTHFm R18 0 0 0 0 
MTHFm --> C1m + THFm R19 0 0 0 0 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm 
R20 0 0 0 0 
--> O2m R21 11.5 34.55 25.2 49.36 
<--> NH3c R22 0 -3.1 0 0 
NH3c <--> NH3m R23 0 -3.1 0 0 
<--> ATPc R25 0 0 0 0 
ADPc + ATPm <--> ADPm + 
ATPc 
R26 0 0 0 0 
PYRc --> PYRm R27 4.6 11.9 0 0 
FUMc <--> FUMm R28 0 0 0 -0.48 
MALc <--> MALm R29 0 0 5.6 12.7 
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SUCc <--> SUCm R30 0 0 0 0 
MALm + AKGc --> MALc + 
AKGm 
R31 0 0 0 12.7 
ASPm + GLUc <--> ASPc + 
GLUm 
R32 0 -6.1 0 0 
CITm + MALc <--> CITc + 
MALm 
R33 0 0 -5.6 0 
GLNc --> GLNm R34 0 0 0 0 
GLUc <--> GLUm R35 0 3.1 0 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 
R36 4.6 15 5.6 12.22 
ACOAm + OAAm --> CITm R37 4.6 15 5.6 12.22 
CITm + NADm --> AKGm + 
NADHm + CO2m 
R38 4.6 15 11.2 12.22 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 
R39 4.6 12 11.2 24.92 
SUCm + FADm <--> FUMm + 
FADHm 
R40 4.6 12 11.2 24.92 
FUMm <--> MALm R41 4.6 12 11.2 24.44 
MALm + NADm <--> OAAm + 
NADHm 
R42 -52.9 -163.85 -120.4 -234.58 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 
R43 57.5 175.85 131.6 259.02 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 
R44 57.5 172.75 126 246.8 
AKGm + ASPm <--> GLUm + 
OAAm 
R45 0 6.1 0 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 
R46 0 3.1 0 0 
GLNm --> GLUm + NH3m R47 0 0 0 0 
2 NADHm + O2m + 5 ADPm --> 
2 NADm + 5 ATPm 
R48 9.2 28.55 19.6 36.9 
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm 
R49 2.3 6 5.6 12.46 
NADPHm + NADm <--> 
NADPm + NADHm 
R50 57.5 175.85 131.6 259.02 
  
  
164 
 
Appendix 
(cont. Table S5.2) 
Reaction 
succinate / 
fumarate, 
malate, 
citrate 
malate 
(fumarate) 
/ citrate 
glutamine / 
glutamate, 
aspartate 
glutamate 
/ aspartate 
serine / 
glycine 
  
5a 6a/7a 8a 9a 11a   
--> PYRc 0 0 0 0 0 
<--> MALc -14.5 16.5 0 0 0 
<--> SUCc 24.5 0 0 0 0 
<--> FUMc -2.2 0 0 0 0 
<--> CITc -1.9 -4.9 0 0 0 
<--> ASPc 0 0 -3.3 -3.38 0 
 --> AKGc 0 0 0 0 0 
<--> GLUc 0 0 -14.4 2.29 0 
 --> GLNc 0 0 20 0 0 
<--> SERc 0 0 0 0 4.5 
<--> GLYc 0 0 0 0 -2.6 
<--> ADPc 0 0 0 0 0 
<--> CO2c -19.8 -36.6 -14.8 2.07 -1.9 
<--> C1c 0 0 0 0 -6.4 
C1c <--> C1m 0 0 0 0 -6.4 
GLYc <--> GLYm 0 0 0 0 -2.6 
SERc <--> SERm 0 0 0 0 4.5 
CO2c <--> CO2m -19.8 -36.6 -14.8 2.07 -1.9 
SERm <--> GLYm + MTHFm 0 0 0 0 4.5 
MTHFm --> C1m + THFm 0 0 0 0 6.4 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm 
0 0 0 0 1.9 
--> O2m 27.1 27.45 15.3 0.165 0.95 
<--> NH3c 0 0 -22.3 1.09 0 
NH3c <--> NH3m 0 0 -22.3 1.09 0 
<--> ATPc 0 0 0 0 0 
ADPc + ATPm <--> ADPm + 
ATPc 
0 0 0 0 0 
PYRc --> PYRm 0 0 0 0 0 
FUMc <--> FUMm -2.2 0 0 0 0 
MALc <--> MALm -16.4 11.6 0 0 0 
SUCc <--> SUCm 24.5 0 0 0 0 
MALm + AKGc --> MALc + 0 0 0 0 0 
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AKGm 
ASPm + GLUc <--> ASPc + 
GLUm 
0 0 3.3 3.38 0 
CITm + MALc <--> CITc + 
MALm 
1.9 4.9 0 0 0 
GLNc --> GLNm 0 0 20 0 0 
GLUc <--> GLUm 0 0 -17.7 -1.09 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 
5.9 11.6 2.3 -1.09 0 
ACOAm + OAAm --> CITm 5.9 11.6 2.3 -1.09 0 
CITm + NADm --> AKGm + 
NADHm + CO2m 
4 6.7 2.3 -1.09 0 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 
4 6.7 7.9 1.2 0 
SUCm + FADm <--> FUMm + 
FADHm 
28.5 6.7 7.9 1.2 0 
FUMm <--> MALm 26.3 6.7 7.9 1.2 0 
MALm + NADm <--> OAAm + 
NADHm 
-105.1 -125.65 -70.9 1.465 -4.75 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 
116.9 148.85 78.8 -0.265 4.75 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 
111 137.25 76.5 0.825 4.75 
AKGm + ASPm <--> GLUm + 
OAAm 
0 0 -3.3 -3.38 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 
0 0 2.3 -1.09 0 
GLNm --> GLUm + NH3m 0 0 20 0 0 
2 NADHm + O2m + 5 ADPm --
> 2 NADm + 5 ATPm 
12.85 24.1 11.35 -0.435 0.95 
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm 
14.25 3.35 3.95 0.6 0 
NADPHm + NADm <--> 
NADPm + NADHm 
116.9 148.85 78.8 -0.265 4.75 
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(cont. Table S5.2) 
  
Uptake / 
Production 
pyruvate, 
ADP / ATP 
pyruvate, 
aspartate, ADP / 
glutamate, ATP 
citrate, ADP / 
ATP 
Reaction Exp. No. 
1b 2b 3b   
Flux [fmol / 
cell  min] 
--> PYRc R1 14.2 15.6 0 
<--> MALc R2 0 0 0 
<--> SUCc R3 0 0 0 
<--> FUMc R4 0 0 0 
<--> CITc R5 0 0 38 
<--> ASPc R6 0 12.2 0 
 --> AKGc R7 0 0 0 
<--> GLUc R8 0 -6.7 0 
 --> GLNc R9 0 0 0 
<--> SERc R11 0 0 0 
<--> GLYc R12 0 0 0 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 
R44 0 0 0 
<--> CO2c R10 -42.6 -62.1 -228 
<--> C1c R13 0 0 0 
C1c <--> C1m R14 0 0 0 
GLYc <--> GLYm R15 0 0 0 
SERc <--> SERm R16 0 0 0 
CO2c <--> CO2m R17 -42.6 -62.1 -228 
SERm <--> GLYm + MTHFm R18 0 0 0 
MTHFm --> C1m + THFm R19 0 0 0 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm 
R20 0 0 0 
--> O2m R21 35.5 45.45 171 
<--> NH3c R22 0 -5.5 0 
NH3c <--> NH3m R23 0 -5.5 0 
<--> ADPc R24 177.5 227.25 855 
<--> ATPc R25 -177.5 -227.25 -855 
ADPc + ATPm <--> ADPm + 
ATPc 
R26 177.5 227.25 855 
PYRc --> PYRm R27 14.2 15.6 0 
FUMc <--> FUMm R28 0 0 0 
MALc <--> MALm R29 0 0 38 
SUCc <--> SUCm R30 0 0 0 
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MALm + AKGc --> MALc + 
AKGm 
R31 0 0 0 
ASPm + GLUc <--> ASPc + 
GLUm 
R32 0 -12.2 0 
CITm + MALc <--> CITc + 
MALm 
R33 0 0 -38 
GLNc --> GLNm R34 0 0 0 
GLUc <--> GLUm R35 0 5.5 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 
R36 14.2 21.1 38 
ACOAm + OAAm --> CITm R37 14.2 21.1 38 
CITm + NADm --> AKGm + 
NADHm + CO2m 
R38 14.2 21.1 76 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 
R39 14.2 14.4 76 
SUCm + FADm <--> FUMm + 
FADHm 
R40 14.2 14.4 76 
FUMm <--> MALm R41 14.2 14.4 76 
MALm + NADm <--> OAAm + 
NADHm 
R42 14.2 8.9 38 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 
R43 0 5.5 38 
AKGm + ASPm <--> GLUm + 
OAAm 
R45 0 12.2 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 
R46 0 5.5 0 
GLNm --> GLUm + NH3m R47 0 0 0 
2 NADHm + O2m + 5 ADPm --
> 2 NADm + 5 ATPm 
R48 28.4 38.25 133 
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm 
R49 7.1 7.2 38 
NADPHm + NADm <--> 
NADPm + NADHm 
R50 0 5.5 38 
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(cont. Table S5.2) 
Reaction 
Uptake / 
Production 
α-
ketoglutarate, 
ADP /  
fumarate,  ATP 
succinate, 
ADP / 
fumarate, 
malate, 
citrate, 
ATP 
malate 
(fumarate), 
ADP / 
citrate, 
ATP 
glutamine, 
ADP / 
glutamate, 
aspartate, 
ATP 
  Exp. No. 
4b 5b 6b/7b 8b   
Flux [fmol / 
cell  min] 
--> PYRc R1 0 0 0 0 
<--> MALc R2 0 -14.6 21.4 0 
<--> SUCc R3 0 30.5 0 0 
<--> FUMc R4 -2.5 -2.1 0 0 
<--> CITc R5 0 -1.9 -4.9 0 
<--> ASPc R6 0 0 0 -11.4 
 --> AKGc R7 40.2 0 0 0 
<--> GLUc R8 0 0 0 -19 
 --> GLNc R9 0 0 0 44.7 
<--> SERc R11 0 0 0 0 
<--> GLYc R12 0 0 0 0 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 
R44 0 0 0 0 
<--> CO2c R10 -191 -43.8 -56.2 -82.9 
<--> C1c R13 0 0 0 0 
C1c <--> C1m R14 0 0 0 0 
GLYc <--> GLYm R15 0 0 0 0 
SERc <--> SERm R16 0 0 0 0 
CO2c <--> CO2m R17 -191 -43.8 -56.2 -82.9 
SERm <--> GLYm + MTHFm R18 0 0 0 0 
MTHFm --> C1m + THFm R19 0 0 0 0 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm 
R20 0 0 0 0 
--> O2m R21 153.3 48.1 42.15 81.45 
<--> NH3c R22 0 0 0 -59 
NH3c <--> NH3m R23 0 0 0 -59 
<--> ADPc R24 766.5 210 210.75 407.25 
<--> ATPc R25 -766.5 -210 -210.75 -407.25 
ADPc + ATPm <--> ADPm + 
ATPc 
R26 766.5 210 210.75 407.25 
PYRc --> PYRm R27 0 0 0 0 
FUMc <--> FUMm R28 -2.5 -2.1 0 0 
MALc <--> MALm R29 40.2 -16.5 16.5 0 
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SUCc <--> SUCm R30 0 30.5 0 0 
MALm + AKGc --> MALc + 
AKGm 
R31 40.2 0 0 0 
ASPm + GLUc <--> ASPc + 
GLUm 
R32 0 0 0 11.4 
CITm + MALc <--> CITc + 
MALm 
R33 0 1.9 4.9 0 
GLNc --> GLNm R34 0 0 0 44.7 
GLUc <--> GLUm R35 0 0 0 -30.4 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 
R36 37.7 11.9 16.5 14.3 
ACOAm + OAAm --> CITm R37 37.7 11.9 16.5 14.3 
CITm + NADm --> AKGm + 
NADHm + CO2m 
R38 37.7 10 11.6 14.3 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 
R39 77.9 10 11.6 40 
SUCm + FADm <--> FUMm + 
FADHm 
R40 77.9 40.5 11.6 40 
FUMm <--> MALm R41 75.4 38.4 11.6 40 
MALm + NADm <--> OAAm + 
NADHm 
R42 37.7 11.9 16.5 25.7 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 
R43 37.7 11.9 16.5 14.3 
AKGm + ASPm <--> GLUm + 
OAAm 
R45 0 0 0 -11.4 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 
R46 0 0 0 14.3 
GLNm --> GLUm + NH3m R47 0 0 0 44.7 
2 NADHm + O2m + 5 ADPm --
> 2 NADm + 5 ATPm 
R48 114.35 27.85 36.35 61.45 
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm 
R49 38.95 20.25 5.8 20 
NADPHm + NADm <--> 
NADPm + NADHm 
R50 37.7 11.9 16.5 14.3 
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Supplem. Table S5.3. Stoichiometry of the modes selected using the Table S1 and 
the contribution to each mode to the total flux in each feeding experiment using 
selectively permeabilized CHO-K1 cells [fmol / cell  min]. 
Reaction 
Mode 
1 
Mode 
2 
Mode 
3 
Mode 
4 
Mode 
5 
Mode 
6 
Mode 
7 
Mode 
8 
Mode 
9 
Mode 
10 
--> PYRc 1 1 1 0 0 1 0 0 0 0 
<--> MALc 0 0 0 0 0 0 0 0 0 0 
<--> SUCc 0 0 0 0 0 0 0 0 0 0 
<--> FUMc 0 0 0 0 0 0 0 0 0 0 
<--> CITc 0 0 0 0 0 0 0 0 1 1 
<--> ASPc 0 0 1 1 1 1 1 1 0 0 
 --> AKGc 0 0 0 0 0 0 0 0 0 0 
<--> GLUc 0 0 -1 -0.5 0 -1 0 -0.5 0 0 
 --> GLNc 0 0 0 0 0 0 0 0 0 0 
<--> CO2c -3 -3 -2 -1.5 -4 2 -4 -1.5 -6 -6 
<--> SERc 0 0 0 0 0 0 0 0 0 0 
<--> GLYc 0 0 0 0 0 0 0 0 0 0 
<--> C1c 0 0 0 0 0 0 0 0 0 0 
C1c <--> C1m 0 0 0 0 0 0 0 0 0 0 
GLYc <--> GLYm 0 0 0 0 0 0 0 0 0 0 
SERc <--> SERm 0 0 0 0 0 0 0 0 0 0 
CO2c <--> CO2m -3 -3 -2 -1.5 -4 -2 -4 -1.5 -6 -6 
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0 0 0 
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0 0 0 
GLYm + THFm + NADm --> MTHFm 
+ CO2m + NADHm + NH3 0 0 0 0 0 0 0 0 0 0 
--> O2m 2.5 2.5 1 0.75 3 1 3 0.75 4.5 4.5 
<--> NH3c 0 0 0 -0.5 -1 0 -1 -0.5 0 0 
NH3c <--> NH3m 0 0 0 -0.5 -1 0 -1 -0.5 0 0 
<--> ADPc 0 12.5 0 0 0 5 15 3.75 0 22.5 
<--> ATPc 0 -12.5 0 0 0 -5 -15 -3.55 0 -22.5 
ADPc + ATPm <--> ADPm + ATPc 0 12.5 0 0 0 5 15 3.75 0 22.5 
PYRc --> PYRm 1 1 1 0 0 1 0 0 0 0 
FUMc <--> FUMm 0 0 0 0 0 0 0 0 0 0 
MALc <--> MALm 0 0 0 0 0 0 0 0 1 1 
SUCc <--> SUCm 0 0 0 0 0 0 0 0 0 0 
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0 0 0 
ASPm + GLUc <--> ASPc + GLUm 0 0 -1 -1 -1 -1 -1 -1 0 0 
CITm + MALc <--> CITc + MALm 0 0 0 0 0 0 0 0 -1 -1 
GLNc --> GLNm 0 0 0 0 0 0 0 0 0 0 
GLUc <--> GLUm 0 0 0 0.5 1 0 1 0.5 0 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 1 1 1 0.5 1 1 1 0.5 1 1 
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ACOAm + OAAm --> CITm 1 1 1 0.5 1 1 1 0.5 1 1 
CITm + NADm --> AKGm + NADHm 
+ CO2m 1 1 1 0.5 1 1 1 0.5 2 2 
AKGm + ADPm + NADm --> SUCm + 
ATPm + NADHm + CO2m 1 1 0 0 1 1 1 0 2 2 
SUCm + FADm <--> FUMm + 
FADHm 1 1 0 0 1 0 1 0 2 2 
FUMm <--> MALm 1 1 0 0 1 0 1 0 2 2 
MALm + NADm <--> OAAm + 
NADHm -11.5 1 -5 -4.25 -15 0 0 -0.5 -21.5 1 
MALm + NADPm --> PYRm + CO2m 
+ NADPHm 12.5 0 5 4.25 16 0 1 0.5 23.5 1 
PYRm + CO2m + ATPm --> OAAm + 
ADPm 12.5 0 5 3.75 15 0 0 0 22.5 0 
AKGm + ASPm <--> GLUm + OAAm 0 0 1 1 1 1 1 1 0 0 
GLUm + NADm <--> AKGm + NH3m 
+ NADHm 0 0 0 0.5 1 0 1 0.5 0 0 
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0 0 0 
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm 2 2 1 0.75 2.5 1 2.5 0.75 3.5 3.5 
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm 0.5 0.5 0 0 0.5 0 0.5 0 1 1 
NADPHm + NADm <--> NADPm + 
NADHm 12.5 0 5 4.25 16 0 1 0.5 23.5 1 
(cont. Table S5.3) 
Reaction 
Mode 
11 
Mode 
12 
Mode 
13 
Mode 
14 
Mode 
15 
Mode 
16 
Mode 
17 
Mod
e 18 
Mode 
19 
Mode 
20 
--> PYRc 0 0 0 0 0 0 0 0 0 0 
<--> MALc 0 0 0 0 0 -1 0 0 0 -1 
<--> SUCc 0 0 0 0 1 1 1 1 1 1 
<--> FUMc 0 -1 0 -1 0 0 0 -1 0 0 
<--> CITc 0 0 0 0 0 0 -0.5 0 0 0 
<--> ASPc 0 0 0 0 0 0 0 0 0 0 
 --> AKGc 1 1 1 1 0 0 0 0 0 0 
<--> GLUc 0 0 0 0 0 0 0 0 0 0 
 --> GLNc 0 0 0 0 0 0 0 0 0 0 
<--> CO2c -5 -1 -5 -1 -4 0 -1 0 -4 0 
<--> SERc 0 0 0 0 0 0 0 0 0 0 
<--> GLYc 0 0 0 0 0 0 0 0 0 0 
<--> C1c 0 0 0 0 0 0 0 0 0 0 
C1c <--> C1m 0 0 0 0 0 0 0 0 0 0 
GLYc <--> GLYm 0 0 0 0 0 0 0 0 0 0 
SERc <--> SERm 0 0 0 0 0 0 0 0 0 0 
CO2c <--> CO2m -5 -1 -5 -1 -4 0 -1 0 -4 0 
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0 0 0 
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0 0 0 
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GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3 0 0 0 0 0 0 0 0 0 0 
--> O2m 4 1 4 1 3.5 0.5 1.25 0.5 3.5 0.5 
<--> NH3c 0 0 0 0 0 0 0 0 0 0 
NH3c <--> NH3m 0 0 0 0 0 0 0 0 0 0 
<--> ADPc 0 0 20 5 0 0 0 0 16.5 1.5 
<--> ATPc 0 0 -20 -5 0 0 0 0 -16.5 -1.5 
ADPc + ATPm <--> ADPm + 
ATPc 0 0 20 5 0 0 0 0 16.5 1.5 
PYRc --> PYRm 0 0 0 0 0 0 0 0 0 0 
FUMc <--> FUMm 0 -1 0 -1 0 0 0 -1 0 0 
MALc <--> MALm 1 1 1 1 0 -1 -0.5 0 0 -1 
SUCc <--> SUCm 0 0 0 0 1 1 1 1 1 1 
MALm + AKGc --> MALc + 
AKGm 1 1 1 1 0 0 0 0 0 0 
ASPm + GLUc <--> ASPc + 
GLUm 0 0 0 0 0 0 0 0 0 0 
CITm + MALc <--> CITc + 
MALm 0 0 0 0 0 0 0.5 0 0 0 
GLNc --> GLNm 0 0 0 0 0 0 0 0 0 0 
GLUc <--> GLUm 0 0 0 0 0 0 0 0 0 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 1 0 1 0 1 0 0.5 0 1 0 
ACOAm + OAAm --> CITm 1 0 1 0 1 0 0.5 0 1 0 
CITm + NADm --> AKGm + 
NADHm + CO2m 1 0 1 0 1 0 0 0 1 0 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 2 1 2 1 1 0 0 0 1 0 
SUCm + FADm <--> FUMm + 
FADHm 2 1 2 1 2 1 1 1 2 1 
FUMm <--> MALm 2 0 2 0 2 1 1 0 2 1 
MALm + NADm <--> OAAm + 
NADHm -19 -5 1 0 -15.5 -1.5 
-
4.75 -1.5 1 0 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 21 5 1 0 17.5 1.5 5.75 1.5 1 0 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 20 5 0 0 16.5 1.5 5.25 1.5 0 0 
AKGm + ASPm <--> GLUm + 
OAAm 0 0 0 0 0 0 0 0 0 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 0 0 0 0 0 0 0 0 0 0 
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0 0 0 
2 NADHm + O2m + 5 ADPm --> 
2 NADm + 5 ATPm 3 0.5 3 0.5 2.5 0 0.75 0 2.5 0 
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm 1 0.5 1 0.5 1 -0.5 0.5 0.5 1 0.5 
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NADPHm + NADm <--> 
NADPm + NADHm 21 5 1 0 17.5 1.5 5.75 1.5 1 0 
(cont. Table S5.3) 
Reaction 
Mode 
21 
Mode 
22 
Mode 
23 
Mode 
24 
Mode 
25 
Mode 
26 
Mode 
27 
Mode 
28 
Mode 
29 
Mode 
30 
--> PYRc 0 0 0 0 0 0 0 0 0 0 
<--> MALc 0 0 1 1 1 1 0 0 0 0 
<--> SUCc 1 1 0 0 0 0 0 0 0 0 
<--> FUMc 0 -1 0 0 0 0 1 1 1 1 
<--> CITc -0.5 0 0 -0.5 0 -0.5 0 -0.5 0 -0.5 
<--> ASPc 0 0 0 0 0 0 0 0 0 0 
 --> AKGc 0 0 0 0 0 0 0 0 0 0 
<--> GLUc 0 0 0 0 0 0 0 0 0 0 
 --> GLNc 0 0 0 0 0 0 0 0 0 0 
<--> CO2c -1 0 -4 -1 -4 -1 -4 -1 -4 -1 
<--> SERc 0 0 0 0 0 0 0 0 0 0 
<--> GLYc 0 0 0 0 0 0 0 0 0 0 
<--> C1c 0 0 0 0 0 0 0 0 0 0 
C1c <--> C1m 0 0 0 0 0 0 0 0 0 0 
GLYc <--> GLYm 0 0 0 0 0 0 0 0 0 0 
SERc <--> SERm 0 0 0 0 0 0 0 0 0 0 
CO2c <--> CO2m -1 0 -4 -1 -4 -1 -4 -1 -4 -1 
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0 0 0 
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0 0 0 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3 0 0 0 0 0 0 0 0 0 0 
--> O2m 1.25 0.5 3 0.75 3 0.75 3 0.75 3 0.75 
<--> NH3c 0 0 0 0 0 0 0 0 0 0 
NH3c <--> NH3m 0 0 0 0 0 0 0 0 0 0 
<--> ADPc 5.75 1.5 0 0 15 3.75 0 0 15 3.75 
<--> ATPc -5.75 -1.5 0 0 -15 -3.75 0 0 -15 -3.75 
ADPc + ATPm <--> ADPm + 
ATPc 5.75 1.5 0 0 15 3.75 0 0 15 3.75 
PYRc --> PYRm 0 0 0 0 0 0 0 0 0 0 
FUMc <--> FUMm 0 -1 0 0 0 0 1 1 1 1 
MALc <--> MALm -0.5 0 1 0.5 1 0.5 0 -0.5 0 -0.5 
SUCc <--> SUCm 1 1 0 0 0 0 0 0 0 0 
MALm + AKGc --> MALc + 
AKGm 0 0 0 0 0 0 0 0 0 0 
ASPm + GLUc <--> ASPc + GLUm 0 0 0 0 0 0 0 0 0 0 
CITm + MALc <--> CITc + MALm 0.5 0 0 0.5 0 0.5 0 0.5 0 0.5 
GLNc --> GLNm 0 0 0 0 0 0 0 0 0 0 
GLUc <--> GLUm 0 0 0 0 0 0 0 0 0 0 
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PYRm + NADm --> ACOAm + 
NADHm + CO2m 0.5 0 1 0.5 1 0.5 1 0.5 1 0.5 
ACOAm + OAAm --> CITm 0.5 0 1 0.5 1 0.5 1 0.5 1 0.5 
CITm + NADm --> AKGm + 
NADHm + CO2m 0 0 1 0 1 0 1 0 1 0 
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m 0 0 1 0 1 0 1 0 1 0 
SUCm + FADm <--> FUMm + 
FADHm 1 1 1 0 1 0 1 0 1 0 
FUMm <--> MALm 1 0 1 0 1 0 2 1 2 1 
MALm + NADm <--> OAAm + 
NADHm 0.5 0 -14 -3.25 1 0.5 -14 -3.25 1 0.5 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 0.5 0 16 4.25 1 0.5 16 4.25 1 0.5 
PYRm + CO2m + ATPm --> 
OAAm + ADPm 0 0 15 3.75 0 0 15 3.75 0 0 
AKGm + ASPm <--> GLUm + 
OAAm 0 0 0 0 0 0 0 0 0 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 0 0 0 0 0 0 0 0 0 0 
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0 0 0 
2 NADHm + O2m + 5 ADPm --> 
2 NADm + 5 ATPm 0.75 0 2.5 0.75 2.5 0.75 2.5 0.75 2.5 0.75 
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm 0.5 0.5 0.5 0 0.5 0 0.5 0 0.5 0 
NADPHm + NADm <--> NADPm 
+ NADHm 0.5 0 16 4.25 1 0.5 16 4.25 1 0.5 
(cont. Table S5.3) 
Reaction / Mode  31 32 33 34 35 36 37 38 39 40 41 42 
--> PYRc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> MALc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> SUCc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> FUMc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> CITc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> ASPc 0 -1 0 0 -1 0 0 -1 0 -1 0 0 
 --> AKGc 0 0 0 0 0 0 0 0 0 0 0 0 
<--> GLUc 0 0 -1 0 0 -1 1 1 1 1 0 0 
 --> GLNc 1 1 1 1 1 1 0 0 0 0 0 0 
<--> CO2c -5 -1 0 -5 -1 0 -5 -1 -5 -1 0 -1 
<--> SERc 0 0 0 0 0 0 0 0 0 0 1 1 
<--> GLYc 0 0 0 0 0 0 0 0 0 0 -1 0 
<--> C1c 0 0 0 0 0 0 0 0 0 0 -1 -2 
C1c <--> C1m 0 0 0 0 0 0 0 0 0 0 -1 -2 
GLYc <--> GLYm 0 0 0 0 0 0 0 0 0 0 -1 0 
SERc <--> SERm 0 0 0 0 0 0 0 0 0 0 1 1 
CO2c <--> CO2m -5 -1 0 -5 -1 0 0 -1 0 -1 0 -1 
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SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0 0 0 1 1 
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0 0 0 1 2 
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + NH3 0 0 0 0 0 0 0 0 0 0 0 1 
--> O2m 4.5 1.5 0 4.5 1.5 0 4.5 1.5 4.5 1.5 0 0.5 
<--> NH3c -2 -1 -1 -2 -1 -1 -1 0 -1 0 0 -1 
NH3c <--> NH3m -2 -1 -1 -2 -1 -1 -1 0 -1 0 0 -1 
<--> ADPc 0 0 0 22.5 7.5 0 0 0 22.5 7.5 0 0 
<--> ATPc 0 0 0 -22.5 
-
7.5 0 0 0 -22.5 
-
7.5 0 0 
ADPc + ATPm <--> ADPm + ATPc 0 0 0 22.5 7.5 0 0 0 22.5 7.5 0 0 
PYRc --> PYRm 0 0 0 0 0 0 0 0 0 0 0 0 
FUMc <--> FUMm 0 0 0 0 0 0 0 0 0 0 0 0 
MALc <--> MALm 0 0 0 0 0 0 0 0 0 0 0 0 
SUCc <--> SUCm 0 0 0 0 0 0 0 0 0 0 0 0 
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0 0 0 0 0 
ASPm + GLUc <--> ASPc + GLUm 0 1 0 0 1 0 0 1 0 1 0 0 
CITm + MALc <--> CITc + MALm 0 0 0 0 0 0 0 0 0 0 0 0 
GLNc --> GLNm 1 1 1 1 1 1 0 0 0 0 0 0 
GLUc <--> GLUm 0 -1 -1 0 -1 -1 1 0 1 0 0 0 
PYRm + NADm --> ACOAm + 
NADHm + CO2m 1 0 0 1 0 0 1 0 1 0 0 0 
ACOAm + OAAm --> CITm 1 0 0 1 0 0 1 0 1 0 0 0 
CITm + NADm --> AKGm + 
NADHm + CO2m 1 0 0 1 0 0 1 0 1 0 0 0 
AKGm + ADPm + NADm --> SUCm 
+ ATPm + NADHm + CO2m 2 1 0 2 1 0 2 1 2 1 0 0 
SUCm + FADm <--> FUMm + 
FADHm 2 1 0 2 1 0 2 1 2 1 0 0 
FUMm <--> MALm 2 1 0 2 1 0 2 1 2 1 0 0 
MALm + NADm <--> OAAm + 
NADHm -21.5 
-
6.5 0 1 1 0 
-
21.5 -6.5 1 1 0 
-
2.5 
MALm + NADPm --> PYRm + 
CO2m + NADPHm 23.5 7.5 0 1 0 0 23.5 7.5 1 0 0 2.5 
PYRm + CO2m + ATPm --> OAAm 
+ ADPm 22.5 7.5 0 0 0 0 22.5 7.5 0 0 0 2.5 
AKGm + ASPm <--> GLUm + 
OAAm 0 -1 0 0 -1 0 0 -1 0 -1 0 0 
GLUm + NADm <--> AKGm + 
NH3m + NADHm 1 0 0 1 0 0 1 0 1 0 0 0 
GLNm --> GLUm + NH3m 1 1 1 1 1 1 0 0 0 0 0 0 
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm 3.5 1 0 3.5 1 0 3.5 1 3.5 1 0 0.5 
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm 1 0.5 0 1 0.5 0 1 0.5 1 0.5 0 0 
NADPHm + NADm <--> NADPm + 
NADHm 23.5 7.5 0 1 0 0 23.5 7.5 1 0 0 2.5 
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Experiment 1a 1b 2a*1 2b*2 3a 3b 4a 4b 5a 5b*3 6a/7a 6b/7b*4 8a 8b 9a 9b 12a 
  Contribution [fmol / cell  min] 
Mode 1 4.6 0 11.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 2 0 14.2 0 15.6 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 4 0 0 6.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 8 0 0 0 12.2 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 9 0 0 0 0 5.62 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 10 0 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0 0 
Mode 11 0 0 0 0 0 0 12.3 0 0 0 0 0 0 0 0 0 0 
Mode 12 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 
Mode 13 0 0 0 0 0 0 0 37.73 0 0 0 0 0 0 0 0 0 
Mode 14 0 0 0 0 0 0 0 2.47 0 0 0 0 0 0 0 0 0 
Mode 15 0 0 0 0 0 0 0 0 4.07 0 0 0 0 0 0 0 0 
Mode 16 0 0 0 0 0 0 0 0 14.5 0 0 0 0 0 0 0 0 
Mode 17 0 0 0 0 0 0 0 0 3.7 0 0 0 0 0 0 0 0 
Mode 18 0 0 0 0 0 0 0 0 2.23 0 0 0 0 0 0 0 0 
Mode 19 0 0 0 0 0 0 0 0 0 10.6 0 0 0 0 0 0 0 
Mode 20 0 0 0 0 0 0 0 0 0 14.6 0 0 0 0 0 0 0 
Mode 21 0 0 0 0 0 0 0 0 0 3.7 0 0 0 0 0 0 0 
Mode 22 0 0 0 0 0 0 0 0 0 2.14 0 0 0 0 0 0 0 
Mode 23 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 
Mode 24 0 0 0 0 0 0 0 0 0 0 9.72 0 0 0 0 0 0 
Mode 25 0 0 0 0 0 0 0 0 0 0 0 11.6 0 0 0 0 0 
Mode 26 0 0 0 0 0 0 0 0 0 0 0 9.72 0 0 0 0 0 
Mode 27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 31 0 0 0 0 0 0 0 0 0 0 0 0 2.31 0 0 0 0 
Mode 32 0 0 0 0 0 0 0 0 0 0 0 0 3.29 0 0 0 0 
Mode 33 0 0 0 0 0 0 0 0 0 0 0 0 14.4 0 0 0 0 
Mode 34 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3 0 0 0 
Mode 35 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4 0 0 0 
Mode 36 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 0 
Mode 37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.69 0 0 
Mode 38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mode 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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Mode 41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.61 
Mode 42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.84 
* 1 In the experiments 2a and 2b it is assumed that the modes that take up ASP and PYR together are not 
active (Mode 3 and Mode 6) . Also, the modes that use ASP to produce only CO2 (Mode 5 and Mode  7) are 
considered inactive when computing the contribution factors. 
*2 In the experiments 5b, 6b and 7b the CIT concentration could not be determined. Mode contribution 
factors were computed assuming the same factors for CIT production as in 5a, 6a and 7a respectively. 
*3 In the experiment 9b, GLU concentration could not be determined reliably, therefore the mode flux was 
not computed. 
*4 The contribution of Modes 27-30 to FUM metabolism could not be determined due to extracellular 
conversion of FUM to MAL. 
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Supplem. Table S5.4. Conclusions on mitochondrial enzymes and transporters activity and about regulation of 
the mitochondrial metabolism resulted by applying elementary mode analysis to the observations from feeding 
experiments with selectively permeabilized CHO-K1 cells. The gray areas indicate the experiments on which each 
corresponding conclusion was based. 
Experime
nt No. 1a 1b 2a 2b 3a 3b 4a 4b 5a 5b 6a/7a 6b/7b 8a 8b 9a 9b 11a 
Substrate pyru
vate 
pyruv
ate, 
ADP 
pyruv
ate, 
aspar
tate 
pyruv
ate, 
aspar
tate, 
ADP 
citr
ate 
citrat
e, 
ADP 
α-
ketogluta
rate 
α-
ketogluta
rate, ADP 
succi
nate 
succin
ate, 
ADP 
malat
e / 
fumar
ate 
malate
/ 
fumar
ate, 
ADP 
gluta
mine 
gluta
mine, 
ADP 
gluta
mate 
gluta
mate, 
ADP 
seri
ne 
Citrate 
synthase 
flux[fmol 
/ cell x 
min] 
4.6 14.2 15 21.1 5.6 38 12.22 37.7 5.9 11.9 11.6 16.5 2.3 14.3 - - 0 
  
Uptake rates increased by adding ADP. This happens because (1) ADP is a substrate for oxidative phosphorylation and allows regeneration of NAD+ and (2) ADP 
stimulates PDH, IDH and AKGH   
  
          
In the experiments where ADP was not supplied, the highly active PCX-
MDH-ME cycle disposed of the ATP 
        
  
  
          
ME provides PYR for replenishing 
the TCA 
                  
  
          
Reducing equivalents are transferred from NADPH to NAD+ via the NNT or using cycling by 
NAD- and NADP-dependent IDH isoenzymes 
      
  
            
Full metabolization to 
CO2 is possible 
                  
  
PYR and ASP had a reciprocal 
stimulating effect. This effect did 
not manifest for PYR in the 
presence of ADP. ASP was not 
taken up without PYR. 
                        
  
  
    
ASP and PYR 
are metabolized 
by separate 
modes 
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GLU is re-
transported 
into the 
mitochondria 
via the GLU 
carrier 
                        
  
  
PYR uptake is limited  in all 
stimulating conditions (ADP, ASP, 
ASP+ADP) by the MPC. PYR 
uptake  is in the same range with 
the uptake in vivo by the CHO-K1 
mitochondria (Nicolae et al., 2014) 
                        
  
  
        
Either 
complete 
reuptake of 
MAL occurs 
or CIT is 
transported 
without 
antiport 
                    
  
  
        
Highest complete TCA cycle flux, both 
with and w/o ADP 
                
  
  
        
High TCA cycle flux confirms that IDH 
and AKGDH are the bottlenecks of the 
TCA cycle 
                
  
  
            
High cytosolic 
concentrations of AKG 
did not inhibit ME 
                
  
  
                
Transported via the C4-dicarboxylate 
carrier (antiport with phosphate) 
        
  
  
                    
Extramitochondr
ial conversion of 
FUM to MAL  
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(cont. Table S5.4) 
Experime
nt No. 1a 1b 2a 2b 3a 3b 4a 4b 5a 5b 6a/7a 6b/7b 8a 8b 9a 9b 11a 
Substrate pyru
vate 
pyruv
ate, 
ADP 
pyruv
ate, 
aspar
tate 
pyruv
ate, 
aspart
ate, 
ADP 
citr
ate 
citra
te, 
ADP 
α-
ketoglut
arate 
α-
ketoglut
arate, 
ADP 
succi
nate 
succin
ate, 
ADP 
malat
e / 
fuma
rate 
malat
e/ 
fumar
ate, 
ADP 
gluta
mine 
gluta
mine, 
ADP 
gluta
mate 
gluta
mate, 
ADP 
serin
e 
Citrate 
synthase 
flux [fmol 
/ cell x 
min] 
4.6 14.2 15 21.1 5.6 38 12.22 37.7 5.9 11.9 11.6 16.5 2.3 14.3 - - 0 
  
        
Either 
complete 
reuptake of 
MAL occurs 
or CIT is 
transported 
without 
antiport 
                    
  
  
        
Highest complete TCA cycle flux, both 
with and w/o ADP 
                
  
  
        
High TCA cycle flux confirms that 
IDH and AKGDH are the bottlenecks 
of the TCA cycle 
                
  
  
            
High cytosolic 
concentrations of AKG 
did not inhibit ME 
                
  
  
                
Transported via the C4-
dicarboxylate carrier (antiport with 
phosphate) 
        
  
  
                    
Extramitochond
rial conversion 
of FUM to MAL  
        
  
  
                
MAL/CIT 
secretion is 
favored instead 
of a full TCA 
cycle 
            
  
  
First half of TCA cycle is controlled by (allosteric) effectors: ADP, ATP, 
NADH --> "effector-controlled" 
    
        
  
  
                
The TCA part involving the C4-
dicarboxylates is controlled by the 
concentration of dicarboxylates and 
not by ADP (, ATP, NADH)  --> 
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"concentration-controlled" second 
half of TCA cycle 
  
                
The C4-dicarboxylates may inhibit 
enzymes involved in the TCA cycle 
that do not process then directly 
        
  
  
                        
Most of the GLN 
was converted to 
GLU, then 
exported via the 
GLU carrier 
    
  
  
            
Control by GDH 
reduces the TCA cycle  
flux on GLN  
compared to when 
AKG  is used as 
subtrate 
        
Control by GDH 
reduces the TCA 
cycle  flux on 
GLN  compared 
to when AKG  is 
used as subtrate 
    
  
  
                        
Extracellular GLU induced ASP 
secretion   
  
    
GLU uptake 
occurs via the 
GLU-ASP 
carrier; GLU 
production 
occurs via the 
GLU carrier 
                
GLU uptake occurs via the GLU-ASP 
carrier; GLU production occurs via the 
GLU carrier 
  
  
                                
Serine 
was 
conve
rted 
by 
mSH
MT to 
glycin
e 
  
          
                      
Glycin
e was 
partia
lly 
cleave
d to 
C1 
and 
CO2 
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